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Abstract
RNA not only shuttles information between DNA and proteins but also carries out many
other essential cellular functions. Nearly all steps of an RNA’s life cycle are controlled by
approximately one thousand RNA binding proteins (RBPs) that direct RNA splicing, cleav-
age and polyadenylation, localization, translation, and degradation. Despite the central role
of RBPs in RNA processing and gene expression, they have been less well studied than
DNA binding proteins, in part due to the historical dearth of technologies to probe RBP
binding and activity in a high-throughput, comprehensive manner. In this thesis, I describe
the affinity landscapes of the largest set of human RBPs to date elucidated through a high-
throughput version of RNA Bind-N-Seq (RBNS), an unbiased in vitro assay that determines
the primary sequence, secondary structure, and contextual preferences of an RBP. The 78
RBPs bound an unexpectedly low diversity of RNA motifs, implying convergence of binding
specificity toward a small set of RNA motifs characterized by low compositional complexity.
Offsetting the low diversity of sequence motifs, extensive preferences for contextual features
beyond short linear motifs were observed, including bipartite motifs, flanking nucleotide
content, and preference for or against RNA structure. These features likely refine which
motif occurrences are selected in cells, enabling RBPs that bind the same linear motif to act
on distinct subsets of transcripts. Additionally, RBNS data is integrated with complemen-
tary in vivo binding sites from enhanced crosslinking and immunoprecipitation (eCLIP) and
functional (RNAi/RNA-seq) data produced through collaborative efforts with the ENCODE
consortium. These data enable creation of “RNA maps” of RBP activity in pre-mRNA splic-
ing and gene expression levels, either with (eCLIP) or without (RBNS) crosslinking-based
assays. The mapping and characterization of RNA elements recognized by over 200 human
RBPs is also presented in two human cell lines, K562 and HepG2 cells. Together, these novel
data augment the catalog of functional elements encoded in the human genome to include
those that act at the RNA level and provide a basis for how RBPs select their RNA targets,
a fundamental requirement in more fully understanding RNA processing mechanisms and
outcomes.
Thesis Supervisor: Christopher B. Burge
Title: Professor of Biology and Biological Engineering
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Chapter 1
Introduction
The central dogma of molecular biology, first stated nearly 60 years ago (Crick [1958]),
detailed that genetic information does not transfer from protein to DNA but instead typically
from DNA → RNA → protein. With proteins effecting most functions in the cell and
DNA being the central molecule of heredity passed from generation to generation, RNA
was originally viewed as a somewhat less important intermediary between information and
action. However, work over the past decades has revealed that RNA is a highly dynamic and
regulated molecule, subject to a wide range of RNA processing mechanisms in eukaryotes
(Mitchell and Parker [2014]). For messenger RNA (mRNA) molecules that encode protein
sequences, these processes include 5’ capping and 3’ polyadenylation of the newly transcribed
mRNA; constitutive and alternative pre-mRNA splicing; RNA editing; export from the
nucleus into the cytoplasm; subcellular localization within different parts of the cytoplasm;
regulation of translational efficiency; RNA surveillance and quality control; and regulation
of mRNA stability and eventual degradation of the RNA. RNA binding proteins (RBPs)
play critical roles in these post-transcriptional pathways, with each of the 1,000+ RBPs
in humans having unique RNA binding activity and protein-protein interaction partners to
produce a diverse assortment of highly regulated RNA molecules from the relatively modest
∼20,000 genes encoded in the genome.
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1.1 RNA binding proteins
In eukaryotic cells, each mRNA is bound by a dynamic repertoire of RNA binding pro-
teins (RBPs) such that it exists as an mRNA-protein complex (messenger ribonucleoprotein,
mRNP, Singh et al. [2015], Rissland [2017]). The proper pre-mRNA splicing, processing,
nuclear export, subcellular localization, and stability and degradation of mRNAs critically
depend on these RBP-RNA interactions. Some mRNP components are members of large
macromolecular machines, such as the spliceosome or ribosome, that bind mRNA in a coor-
dinated manner to direct processes such as splicing, nuclear export, translation, and mRNA
decay. These RBPs typically are deposited on mRNAs according to earlier RNA process-
ing events or through interaction with mRNA landmarks such as the 5’ cap, pre-mRNA
splice sites, or the poly(A) tail. In addition to these members of common machineries,
other RBPs interact with sequence-specific features of individual mRNAs. These proteins
often bind mRNAs concurrently with core machineries to regulate specific steps in RNA
processing, such as splicing factors binding introns or exons to influence alternative splicing
or AU-rich element binding proteins binding 3’ UTRs to influence mRNA stability or trans-
lation. However, not all RBPs fall into these extreme categories of high sequence specificity
or general machineries but instead often operate in the middle ground of a specificity con-
tinuum from promiscuous to selective (Mitchell and Parker [2014]). For instance, Pumilio
domain-containing proteins bind eight to ten RNA bases with high specificity at one extreme
(Zamore et al. [1997]) while DEAD-box helicases have shown little dependence on RNA se-
quence to rearrange their mRNA substrates (Linder and Jankowsky [2011]). In between,
SR (Serine/Arginine-rich) proteins and HNRNPs (hetergeneous nuclear ribonucleoproteins)
exhibit discernible sequence preferences but are able to bind a wide range of targets to effect
their transcriptome-wide splicing outcomes (Goren et al. [2006], Geuens et al. [2016]).
1.1.1 RNA binding domains (RBDs) and sequence-specific recog-
nition of RNA
The sequence and/or structural specificity of an RBP for RNA targets is typically medi-
ated through one or more well-defined RNA binding domains (Fig. 1-1). Among the ∼600
16
structurally distinct RBD classes catalogued by Gerstberger et al. [2014], just 20 have more
than ten members, with most having just one or two members. The three most prevalent
sequence-specific RNA binding domains in humans are the RNA Recognition Motif (RRM,
∼278 human RBPs), various types of Zinc Finger domains (ZF, ∼90 human RBPs though
also present hundreds of DNA binding proteins), and the hnRNPK homology domain (KH,
∼63 human RBPs) (Gerstberger et al. [2014]). The RNA binding properties of other preva-
lent RBDs, including those that bind double-stranded RNA, is less well understood and/or
thought to occur largely in a sequence-independent manner (see below).
A common feature of the most abundant RBD classes in mRNA binding proteins is
their frequent occurrence in multiple copies and/or in combination with different RBD types
(Gerstberger et al. [2014]), with such modular design providing greater specificity and affinity
to permit the diverse biological functions employed by eukaryotic RBPs (Lunde et al. [2007]).
Interestingly, the average number of RBDs within a protein is inversely correlated with the
number of nucleotides that RBD type commonly binds, ranging from ZFs binding an average
of ∼3 nt with more than 3 ZFs per protein to the Pumilio Homology Domain (PUM-HD)
binding ∼8 nt with just one RBD per protein on average (Mitchell and Parker [2014]).
17
Figure 1-1: Common RNA Binding Domain (RBD) types
Among the most prevalent RNA binding domains in eukaryotic proteomes include the RNA
Recognition Motif (RRM, present in ∼278 human RBPs); hnRNPK Homology Domain (KH,
present in∼63 human RBPs); and Zinc Finger Domain (ZF, present in∼961 human proteins,
though most bind DNA with only dozens currently implicated in RNA binding). Other well-
defined RBDs include the double-stranded RBD (dsRBD, present in 26 human RBPs) and
Pumilio Homology Domain (PUM-HD, present in 3 human RBPs). All numbers taken from
Uniprot human entries with example structures from PDB shown.
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RNA Recognition Motif (RRM) domain
The RRM is the most abundant RBD in higher eukaryotes, occurring in nearly 300 human
RBPs (Gerstberger et al. [2014]). Discovered in 1989 as the RNA binding domain of U1-70K
(Query et al. [1989]), it is present in all kingdoms of life including prokaryotes and viruses with
RRM-containing proteins involved in most post-transcriptional gene regulatory pathways
(Afroz et al. [2015]). RRMs are typically ∼90 amino acids in length with a characteristic
𝛽1 − 𝛼1 − 𝛽2 − 𝛽3 − 𝛼2 − 𝛽4 arrangement that folds into a four-stranded antiparallel 𝛽-sheet
packed against two 𝛼-helices. The loops between the secondary structural elements can vary
in length and are typically disordered in their free form, and variability is also occasionally
seen in the secondary structural elements themselves (for example, one 𝛼-helix in U2AF1 is
three times longer than usual) or extensions at the RRM extremities (Afroz et al. [2015]).
RRMs interact with anywhere from two to eight RNA nucleotides, though three to four is
most common. They typically recognize single-stranded RNA with the 𝛽-sheet surface con-
tacting the RNA bases spread on the protein surface across the 𝛽-sheet from 𝛽4 to 𝛽2. RRMs
are characterized by two consensus sequences: ribonucleoprotein (RNP) 1 and 2, which
are 8 and 6 amino acids long on the 𝛽3 and 𝛽1 strands (Lys/Arg-Gly-Phe/Tyr-Gly/Ala-
Phe/Tyr-Val/Ile/Leu- X-Phe/Tyr and Ile/Val/Leu-Phe/Tyr-Ile/Val/Leu-X-Asn-Leu, re-
spectively, X = any amino acid, Afroz et al. [2015]). Three key aromatic side chains in
RNP1 and RNP2 (bolded in the sequences above) recognize two nucleotides to provide affin-
ity, though these interactions do not explain the sequence-specificity of different RRMs.
Some nucleotide biases are observed at certain positions contacted by the RRM but all four
nucleotides are found in all five of the most commonly recognized positions, making the
RRM an incredibly plastic RNA binding domain. Though a 𝐾𝑑 in the nanomolar range has
been observed for a few RRMs, most bind RNA targets with micromolar affinity (Afroz et al.
[2015]).
hnRNPK homology (KH) domain
First identified in its namesake hnRNPK protein in 1993 (Siomi et al. [1993]), the KH domain
occurs in about 63 human RBPs and is present in diverse archaea, bacteria, and eukaryotes.
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KH domains are contained within proteins involved in diverse biological processes, including
transcription regulation, splicing regulation, and translational control (Valverde et al. [2008]).
The domain consists of a core 𝛽1𝛼1𝛼2𝛽2 motif with a highly conserved GXXG loop between
the two 𝛼-helices. Flanking the 𝛽1𝛼1𝛼2𝛽2 motif is another 𝛼-helix and 𝛽-strand, though
they can come after (type I) or before (type II) the core motif, separating KH domains into
two folds: type I (𝛽1𝛼1𝛼2𝛽2𝛽′𝛼′, more common in eukaryotes) and type II (𝛼′𝛽′𝛽1𝛼1𝛼2𝛽2,
more common in prokaryotes). Though the two folds have have different three-dimensional
structures, both have the three 𝛼-helices packed onto the surface of an anti-parallel 𝛽-sheet.
In addition to binding unpaired RNA, KH domains can bind single-stranded DNA, with
recognition occurring via backbone interactions between four nucleic acid bases and the
KH domain near the GXXG loop. A cleft in the protein structure near the GXXG loop
allows protein hydrophobic interactions as well as mainchain and sidechain hydrogen bonds
to mediate recognition of the four nucleobases. Due to two hydrogen bonds made with the
nucleobases, adenine or cytosine are typically at positions 2 and 3 of the RNA tetramer,
though one exception to this rule has been observed in a solution structure (Nicastro et al.
[2015], Nicastro et al. [2012]).
KH domains are often found in multiple copies within eukaryotic proteins, including up
to 14 in vigilin. For protein families whose members contain multiple KH domains, the first
KH domain (KH1) is typically more similar to other KH1 domains in different proteins than
it is to its other KH domains (KH2, KH3, etc.), with similar relationships seen for other
KH domains (Valverde et al. [2008]). Individual KH domains bind RNA and single-stranded
DNA with low-to-intermediate affinity in the micromolar range, though increased affinity and
specificity are achieved through use of multiple domains which can be structurally decoupled
or form a contiguous extended RNA binding surface. Similar longer RNA sequences can be
recognized by dimerization of RBPs that contain a single KH domain, as is crucial for the
biological activity of STAR (Signal Transduction and Activation of RNA) family proteins
(Nicastro et al. [2015]).
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Zinc Finger (ZF) domain
In addition to their more classically defined roles in binding double-stranded DNA, zinc
finger-containing proteins can act as RNA binding modules (Font and MacKay [2010]).
Indeed, the first ZFs discovered, in the transcription factor TFIIIA, were identified through
their binding to double-stranded 5S rRNA in Xenopus oocytes (Miller et al. [1985]). ZF
domains typically coordinate a zinc ion with pairs of cysteine and histidine residues, though
the arrangement of these residues within the ∼30 amino acid domain composed of a 𝛽-hairpin
and 𝛼-helix can vary, lending the most prevalent types of these domains to be commonly
characterized as C2H2, CCHC, and CCCH/C3H1 (another smaller class of ZFs, RanBP2-
type, is named for the RanBP2 protein in which it was discovered and is defined by a
W-X-C-X2−4-C-X3-N-X6-C-X2-C motif, with such ZFs included in the FET family of FUS,
EWSR1, and TAF15 RBPs).
While DNA recognition by ZFs is known to occur via major groove contacts with 3 base
pairs of DNA, the reported binding of ZFs to single- or double-stranded RNA is much more
varied and less well understood. For example, three of the nine ZFs in TFIIIA are important
for RNA binding activity, with two of these (fingers 4 and 6) making base-specific contacts
with ‘flipped-out’ RNA bases while finger 5 makes exclusively non-sequence-specific interac-
tions with the RNA phosphate backbone via amino acid basic side chains (Font and MacKay
[2010]). It has been proposed, based on conclusions from crystallography studies, that ZFs
can recognize complex structures comprising internal loops and double helicies both through
specific contacts with individual bases that are exposed for access out of a rigid RNA struc-
ture as well as sequence independent binding to the regularly folded portion of an RNA
double-helix (Lu et al. [2003]). It has also been proposed that a common mode of RNA
recognition of ZFs might be to bind structured RNAs. This is based on, among other stud-
ies of ZFs binding dsRNA or stem-loops with much greater affinity than ssRNA (Font and
MacKay [2010]), the characterization of Wilm’s tumor 1 (WT1) in vitro-selected RNA ap-
tamers as requiring a hairpin loop, with tolerance for compensatory mutations that maintain
proper base-pairing of the stem (Zhai et al. [2001]). Yet in contrast to this paradigm, numer-
ous CCCH zinc fingers have been shown to recognize single-stranded A/U-rich elements and
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promote degradation of their mRNAs (e.g., ZFP36, Lai et al. [1999], and Tis11d through
backbone interactions with the Watson-Crick edges of A and U bases, Hudson et al. [2004]),
underscoring the complexity of ZF RNA binding modes. Although CCCH and CCHC zinc
finger motifs have classically been known to bind RNA, an mRNA interactome study (see
Section 1.2.2) also identified a significant enrichment of AKAP95 and HC5HC2H-type zinc
fingers, making them likely bona-fide RNA binders (this study identified 69 total ZF contain-
ing proteins bound to poly(A)-selected RNA in HeLa cells, Castello et al. [2012]). Mirroring
their diverse RNA recognition modes, ZFs that bind to RNA are involved in many func-
tional processes including mRNA trafficking, stability, and transcriptional and translational
regulation (Wai et al. [2016]).
Other RNA binding domains and low-complexity domains
While a few other eukaryotic RBD types such as the PUM-HD bind RNA in a sequence-
specific manner, most others bind in a predominantly sequence-independent manner, rec-
ognizing secondary structure or being guided to target RNAs by other protein cofactors,
and/or they have not been studied in detail (Gerstberger et al. [2014]). RBDs containing a
Asp-Glu-Ala-Asp (DEAD) motif, present in ∼62 human RBPs that are typically RNA he-
licases, recognize five nucleotides exclusively through interactions with the sugar phosphate
backbone of the RNA in a characteristic bent conformation (Linder and Jankowsky [2011]).
The double-stranded RNA binding domain (dsRBD), present in ∼26 human RBPs, consists
of 65-70 amino acids that adopt an 𝛼𝛽𝛽𝛽𝛼 fold to recognize A-form double-stranded RNA
through contacts to bases and ribose sugars in two successive minor grooves as well as the
phosphate backbone in the intervening major groove. Traditionally thought to interact with
RNA without any sequence specificity, recent structural information shows that dsRBDs can
recognize additional sequence features beyond the A-form RNA helix (Masliah et al. [2013]).
In addition to well-defined RNA binding domains containing characteristic amino acids
that recognize specific RNA sequences and/or structures, some low-complexity domains may
also play roles in contacting RNA. The second most common RBD type in the human genome
after the RRM, the RG/RGG motif, is characterized by a region rich in arginines and glycines
and is present ∼80-100 human RBPs depending on domain definition. These domains display
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degenerate binding specificity yet still display different degrees of preference for RNA with
some domains achieving affinity approaching that of their full-length protein counterparts
(Thandapani et al. [2013], Ozdilek et al. [2017]). The RS (arginine/serine-rich) domains of
SR and other (e.g., U2AF) proteins are classically thought to contact one another to directly
mediate protein-protein interactions (Busch and Hertel [2012]), though work from Michael
Green’s lab has shown that these domains intermittently make direct contacts with RNA
sequences important for splicing, including the branchpoint and 5’ splice site (Shen et al.
[2004], Shen and Green [2004]). Changes in the phosphorylation state of serines within RS
repeats could potentially alter the RS domain interaction mode between making protein-
protein and making protein-RNA contacts (Hertel and Graveley [2005]).
Altogether, many of these other RNA binding and low-complexity domain types are less
well studied than RRM, ZF, and KH domains, and further investigation into how they impart
RNA specificity and/or affinity is warranted.
1.1.2 RBP-mediated regulation of pre-mRNA splicing, RNA sta-
bility, and RNA translation
The following sections contain an overview of the processes of pre-mRNA splicing and RNA
stability & translation, particularly noting steps in which RBPs are known to play regulatory
roles. Additionally, examples of RBPs regulating these processes are provided, often high-
lighting the context-dependent manner in which an RBP can have different effects on the
same post-transcriptional regulatory pathway depending on the cell state or type, binding
location, and competing or cooperating RBP(s).
Pre-mRNA splicing and cis-Splicing Regulatory Elements (SREs)
Metazoan protein-coding genes contain multiple exons split up by intervening introns which
must be removed from the pre-mRNA to produce a mature mRNA ready for nuclear export
and translation. This process of splicing is carried out by the complex macromolecular
machine known as the spliceosome, which contains five small nuclear ribonucleoproteins
(snRNPs) and ∼170 auxiliary proteins that enter and exit the spliceosome during various
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stages of the splicing reaction (Wahl et al. [2009]). Through the alternative inclusion or
exclusion of exons (or parts thereof), different isoforms of mature mRNAs are produced from
the same pre-mRNA through a process known as alternative splicing, creating messages with
different coding-potential or regulatory capacity.
Each splicing reaction requires three relatively short core RNA sequence elements in the
pre-mRNA: the 5’ splice site (5’ss), the 3’ splice site (3’ss), and the branchpoint sequence
(BPS). The 5’ss, at the end of the upstream exon and beginning of the intron, has human
consensus sequence CAG|GUAAGU (|=exon/intron boundary, Roca et al. [2013]) and is
recognized via complementarity to the 5’ portion of the U1 snRNA. At the other end of
the intron, the 3’ splice site consists of a ∼25 nt sequence rich in cytosine and uridine
known as the polypyrimidine tract, which is preceded upstream by a branchpoint sequence
(BPS) and downstream by an intron-terminal AG dinucleotide. The branchpoint sequence
is conserved in yeast with consensus UACUAAC but is quite degenerate in humans with
consensus YUNAY, Y = pyrimidine (Gao et al. [2008]). The polypyrimidine tract is initially
recognized the larger subunit of the U2 auxiliary factor (U2AF) heterodimer composed of
U2AF65 (also known as U2AF2) and U2AF35 (also known as U2AF1). The ternary complex
of U2AF65 with U2AF35 and splicing factor 1 (SF1) recognizes the surrounding BPS and 3’ss
AG, with U2AF65 recruiting the U2 snRNP to replace it in the active spliceosome (Agrawal
et al. [2016]). The branchpoint adenosine (bolded in previous sequences) is bulged out via
complementarity of the flanking RNA sequence with a ‘GUAGUA’ sequence in U2 snRNA
to act as the nucleophile in the first of two transesterification reactions during splicing. In
the first reaction, the 2’-OH of the branchpoint A attacks the conserved guanine at the 5’
end of the intron to produce a 2’-5’ phosphodiester RNA lariat structure and a free 3’-OH
at the upstream exon. In the second reaction, the 3’-OH of the upstream exon attacks
the phosphodiester bond of the guanosine at the 3’ end of the intron to ligate the two
exons, resulting in the exons being spliced together and the intron being released as a lariat
structure.
In addition to the ∼170 core spliceosomal proteins that partake in all splicing reac-
tions, alternative splicing is regulated by the binding of trans-acting RBPs (splicing factors)
to short cis-sequences in the pre-mRNA to enhance or inhibit the use of adjacent splice
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sites. These splicing regulatory elements (SREs) are broken down based on whether they
are located in the Exon or Intron and whether they Enhance or Silence splicing from that
location (ESE/ESS enhancing or silencing from exons, ISE/ISS from introns, Fig. 1-2).
Although regulatory elements can in principle exert their action from anywhere within the
pre-mRNA, most studies have focused on regulatory sequences within the exon or proximal
flanking introns (∼200-300 nt adjacent to splice sites). Though some splicing factors are
ubiquitously expressed, many act in a tissue- or developmental-specific manner to execute
alternative splicing programs central to tissue and organ development (Baralle and Giudice
[2017]). Thus, one challenge in identifying potential SREs and their corresponding RBPs
is that the same pre-mRNA sequences can be recognized differently in different cell types,
partially due other RBPs expressed or the different RBP:RNA stoichiometries in each cell
type. Additionally, the same cis-sequences, trans-factors, or combinations thereof can have
different effects on splicing outcomes depending on the sequence context and their position
within the intron or exon (Fu and Ares Jr [2014]). For example, G-runs can enhance splicing
from intronic locations (McCullough and Berget [1997]) or repress splicing from exonic loca-
tions (Chen et al. [1999]), and RBFOX2 and Nova typically suppress cassette exon inclusion
from upstream introns but enhance it from downstream introns (Yeo et al. [2009], Ule et al.
[2006]). As it has been estimated that the three core human splice site motifs (5’ss, 3’ss, and
BPS) only contain about half of the information needed to accurately define intron/exon
boundaries (Lim and Burge [2001]), these cis-sequences and their trans-factors likely play a
large role in ensuring the high fidelity of splicing.
Two key protein families that regulate pre-mRNA splicing and subsequent aspects of
RNA metabolism are the SR (serine/arginine-rich) and HNRNP (heterogeneous nuclear ri-
bonucleoprotein) proteins which often function by interacting with ESEs and ESSs/ISSs,
respectively. The SR proteins (∼12 in human, depending on definition) are characterized by
N-terminal RRM(s) which typically bind ESEs and C-terminal RS domains that participate
in protein-protein interactions and facilitate spliceosome assembly (Busch and Hertel [2012],
Graveley and Maniatis [1998]), though the RS domains have also been shown to directly con-
tact RNA splicing signals (see “Other RNA binding domains and low-complexity domains”
above). The study of SR proteins originates in Drosophila screens that identified splicing
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factors containing protein domains rich in arginine and serine dipeptides (Chou et al. [1987],
Moretti et al. [1987], Amrein et al. [1988]), with subsequent identification of human splicing
factors SRSF1 and SRSF2 as proteins that also contain such RS-rich domains in addition to
their RRM(s) (Ge and Manley [1990], Krainer et al. [1990], Fu and Maniatis [1992]). The
diverse HNRNPs (∼37 in human, first detailed by the Dreyfuss lab, Piñol Roma et al. [1988])
contain one or more RBDs (typically RRMs, though five contain KH domains) and often
RGG boxes (repeats of Arg-Gly-Gly tripeptides) and glycine-rich, acidic or, proline-rich do-
mains that mediate protein-protein interactions and influence splicing outcomes through a
wide variety of mechanisms (Busch and Hertel [2012], Geuens et al. [2016]).
A major goal of the field is the development of a ‘splicing code’ which could predict the
splicing outcomes of any transcript from its primary sequence. One central feature in such a
splicing code is a ‘parts list’ of splicing factors and the motif(s) they bind. Indeed, position-
and tissue-specific effects of sequence elements that match the motifs of the FOX, NOVA,
MBNL, CELF, TIA, PTB, and QKI protein(s) arose in an early inferred splicing code (Barash
et al. [2010]). An updated splicing code model detected 2080 significant correlations between
RNA-seq Ψ values of 10,689 exons and densities of 98 in vitro RBP binding motifs (Ray et al.
[2013]) in six intronic or exonic regions (Xiong et al. [2015]), and undoubtedly more will arise
with an expanded catalog of RBP binding motifs. Such splicing codes and related efforts
will not only provide greater mechanistic insight into the interplay between trans-factors and
their cis-regulatory elements in splicing regulation but also may provide opportunities for
understanding genetic determinants of human disease and support for casual variants acting
at the level of pre-mRNA splicing.
26
Figure 1-2: cis-acting splicing regulatory elements and trans-acting splicing factors
cis-acting splicing regulatory sequences in the pre-mRNA include ESE/ESS (Exonic Splicing
Enhancer/Silencer) and ISE/ISS (Intronic Splicing Enhancer/Silencer) elements. Typically
4-6 nt in length, they are recognized by trans-acting proteins known as splicing factors, which
promote or inhibit productive assembly of a catalytically active spliceosome that carries out
the splicing reaction. The ‘context-dependent’ nature of cis-regulatory splicing sequences
makes their activity highly reliant on location within the exon and flanking introns as well
as the presence of other synergistic or antagonistic elements nearby. Additionally, different
sets of splicing factors are expressed in different tissues and cell states, resulting in highly
tissue-specific and dynamic alternative splicing programs.
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3’ UTR cis-elements and regulation of mRNA stability and translation
3’ untranslated regions (3’ UTRs) are the noncoding parts of mRNAs following stop codons.
Their length expansion in humans compared to yeast, as well as the increased prevalence of
alternative 3’ UTR isoforms, suggests an important role for 3’ UTRs in the regulation of genes
of higher organisms (Mayr [2017]). Best known to regulate the degradation, translation, and
localization of mRNAs, 3’ UTRs function by recruiting RBPs that bind to cis-elements
and recruit effector proteins such as deadenylases (Rissland [2017]). Though most 3’ UTR
functions are carried out in the cytoplasm, some RBPs are loaded onto the mRNA in the
nucleus and are exported with the message as an mRNP while others are added locally in
the cytoplasm (Mayr [2017]). Co-transcriptional loading of RBPs at promoters can result
in their deposition onto mRNAs with their remained association allowing them to play 3’
UTR regulatory roles in the cytoplasm, enabling crosstalk between the seemingly unrelated
processes of mRNA synthesis in the nucleus and translation or decay in the cytoplasm
(Bregman et al. [2011], Moore and Proudfoot [2009]).
3’ UTRs determine protein output by regulating mRNA stability and translation primar-
ily through the activity of AU-rich elements and miRNAs. Though about half as conserved
as coding sequences on average, 3’ UTRs often contain ‘islands’ that are conserved similarly
to coding sequences and frequently contain binding sites for miRNAs or RBPs (Xie et al.
[2005], Friedman et al. [2009]). AU-rich elements (AREs), characterized by variants of the
pentamer “AUUUA” occurring in variable length repetitions, were one of the first motifs dis-
covered in 3’ UTRs, preferentially found in genes subject to tight expression level regulation
such as immune-regulatory factors, cytokines, and proto-oncogenes (Barreau et al. [2006]).
The mRNA half-lives of these genes are shorter than a half hour compared to a median ∼7
hour half-life across the entire mammalian transcriptome (Sharova et al. [2009]). Effects of
AREs and miRNAs on protein abundance in cell lines is more modest (Baek et al. [2008],
Selbach et al. [2008], Spies et al. [2013]), possibly due to 3’ UTRs not substantially regulating
protein abundance under steady-state growth conditions in cell culture with miRNAs and
RBP-mediated repression more playing important roles in select biological contexts (Mayr
[2017]). Recognized by proteins known as ARE-binding proteins (ARE-BPs), AREs can
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have different effects on mRNA depending on the protein(s) bound to them. Competition
between ARE-BPs and which one(s) ultimately bind to messages can result in either mRNA
stabilization and translational enhancement (commonly observed for the Hu/ELAV family
RBPs) or in mRNA destabilization and translational repression (e.g., HNRNPD, ZFP36,
and TIA1). Consistent with 3’ UTR repressive elements being more prevalent than activat-
ing elements, 3’ UTR length is typically inversely correlated with mRNA stability and gene
expression levels. Furthermore, among genes with alternative polyadenylation sites, those
highly expressed typically prefer the proximal poly(A) site to produce a shorter 3’ UTR
while genes with lower expression levels often use the distal poly(A) site to produce a longer
3’ UTR (Matoulkova et al. [2012]).
In addition to AU-rich elements, other 3’ UTR cis-elements are crucial for post-transcriptional
gene regulation through their interplay with RBPs. GU-rich elements in arrangements of
2-5 overlapping pentamers are contained in at least 5% of human mRNAs. They are present
in the 3’ UTRs of short-lived mRNAs in T-lymphocytes and contribute to additional post-
transcriptional pathways such as deadenylation, mRNA decay, and mRNA splicing (Halees
et al. [2011]). The CELF family of six RBPs have been identified as recognizing GU-rich
elements, with two members almost identical in their RBDs having opposing effects on post-
transcriptional regulation (CELF1 has destabilizing effects on mRNAs with subsequent in-
creased translational efficiency, while CELF2 has stabilizing effects and inhibits translation,
Vlasova et al. [2008]). CA-rich elements, with A/C being the most common dinucleotide
repeat found in the human genome, are located in both coding and noncoding regions.
Thought to be predominantly recognized by HNRNPL, they typically exert stabilizing ef-
fects on mRNA (Hui et al. [2003]). Other 3’ UTR cis-elements include CU-rich elements,
iron responsive elements, and selenocysteine insertion sequence elements (Matoulkova et al.
[2012]).
In addition to being platforms for regulating mRNA stability, 3’ UTRs play a major
role in regulating the translation of an mRNA molecule into protein, and indeed the mecha-
nisms by which trans-acting factors regulate mRNA stability and translation can be coupled.
Translation is initiated when eukaryotic translation initiation factors (eIFs) recruit the small
ribosomal subunit to the 5’ end of the mRNA. The assembly of the eIF4F complex, com-
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posed of the cap-binding protein eIF4E, the scaffold protein eIF4G, and the RNA helicase
eIF4A, is rate-limiting in this process of translation initiation. eIF4G has binding sites for
eIF4E, eIF4A, eIF3, and PABP (poly(A)-binding proteins), making it a hub for regulation of
translation. The eIF4G/PABP interaction stimulates the formation of a closed-loop mRNA
structure, activating cap-dependent translation and facilitating ribosome recruitment to the
mRNA. mRNA translation is thus regulated by the formation of the eIF4F complex and
mRNA circularization induced by eIF4G/PABP, with RBPs and miRNAs promoting or in-
hibiting these processes to affect translational efficiency. Once the small ribosomal subunit
is recruited to the mRNA, this 40S subunit and its associated factors then scan the 5’ UTR,
recognize the start codon, and the large ribosomal subunit finally joins to form a full ribosome
competent for elongation (Fukao and Fujiwara [2017]).
Many proteins, such as ARE-BPs, play roles in regulating translation via 3’ UTR or 5’
UTR binding in addition to possible other roles in regulating mRNA metabolism. For ex-
ample, ZFP36 (also known as TTP) bound to AREs not only directly binds the deadenylase
complex and recruits it to the mRNA (Fabian et al. [2013]), but ZFP36 also inhibits the
translation of target mRNAs by directly interacting with a specific isoform of eIF4E, eIF4E2,
that likely disrupts the assembly of the eIF4F complex (Tao and Gao [2015]). CPEB, the
cytoplasmic polyadenylation element binding protein, binds a U-rich sequence in target 3’
UTRs and regulates the translation of maternally deposited mRNA during oocyte embryo-
genesis as well as later cytoplasmic polyadenylation and activation of translation. CPEB
maintains maternal mRNAs in a dormant state via binding of the protein Maskin, which
contains an eIF4E-binding domain; the CPEB-Maskin complex thus competes with eIF4G
for binding to eIF4E (Stebbins-Boaz et al. [1999]). The Hu family of proteins, composed
of four highly conserved ARE-BPs in vertebrates with one (HuR/ELAVL1) ubiquitously
expressed while the other three (HuB/ELAVL2, HuC/ELAVL3, HuD/ELAVL4) are primar-
ily expressed in neurons, regulate numerous aspects of RNA metabolism including mRNA
stability, poly(A)-tail length, and mRNA translation (Fukao and Fujiwara [2017]). Among
the known translational regulatory roles of these proteins are HuR upregulating p53 protein
levels after UV irradiation by binding the p53 3’ UTR (Mazan-Mamczarz et al. [2003]); HuR
and HuD inhibiting p27 translation by binding to an internal ribosome entry site in the 5’
30
UTR (Kullmann et al. [2002]); HuD inhibiting translation of Ins2 mRNA in pancreatic 𝛽
cells by binding to a 22 nt sequence in its 5’ UTR (Lee et al. [2012]); and HuD enhancing
cap-dependent translation by binding to eIF4A in a poly(A)-dependent manner that is re-
quired for neurite outgrowth in PC12 cells (Fukao et al. [2009]). Together, reminiscent of the
context-dependent RBP regulation of alternative splicing and mRNA stability, these findings
underscore that Hu proteins can regulate translation in a positive or negative manner that
partially depends on which messages and where within the mRNA (5’ or 3’ UTR) they are
bound (Fukao and Fujiwara [2017]).
Although not RBPs themselves, miRNAs recruit RBPs such as Argonaute, the RISC
complex, and deadenylases and TNRC6 to mediate mRNA degradation (discussed above) as
well as an independent role in translational inhibition of initiation through displacement of
PABP from the translation initiation complex to destroy the closed-loop structure (Moretti
et al. [2012]). Yet other RBPs regulate translation at late-initiation or post-initiation steps
(Gebauer and Hentze [2004]). For example, HNRNPK and HNRNPE1 inhibit the translation
of LOX mRNA by binding a CU-rich element in 3’ UTRs known as the differentiation-control
element (DICE), targeting initiation factors that prevent the large ribosomal subunit from
joining the small subunit at the initiation codon (Ostareck et al. [2001]).
In sum, 3’ UTRs regulate gene expression, translation, and protein levels through a com-
plex interplay of RBPs binding to UTR cis-elements to mediate functions via the recruitment
of effector proteins in a dynamic cell state- and context-specific manner.
1.2 Approaches for the study of RNA binding proteins
The following sections contain a brief overview of approaches commonly used to profile RBP-
RNA interactions at the biochemical level in vitro as well as at the systems level in vivo.
Genetic studies of RNA profiling after RBP perturbation as well as the two most common
structural methods to study RBPs and RBP-RNA interactions (X-ray crystallography and
NMR spectroscopy) are also discussed.
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1.2.1 In vitro RNA-RBP profiling techniques
Among the most commonly utilized assays that have been developed to characterize RBP-
RNA biochemical interactions in vitro are:
∙ Systematic evolution of ligands by exponential selection (SELEX) identifies high-affinity
ligands for a protein of interest through sequential cycles of ligand selection from a
pool of variant sequences and amplification of the bound sequences (Tuerk and Gold
[1990]). Multiple rounds of enrichment selection result in the exponential increase of
high-affinity ligands, which can then be clonally isolated and characterized through
electrophoresis and Sanger sequencing. While SELEX typically identifies one or a few
consensus sequences of an RNA binding protein de novo, it is not quantitative and
doesn’t provide information about an RBP’s lower affinity sites.
∙ The RNA electrophoretic mobility shift (EMSA) or ‘gel-shift’ assay allows for the rapid
detection, visualization, and quantification of protein-RNA interactions. In a gel-shift
experiment, unlabeled protein is incubated with in vitro-generated RNA 5’ end-labeled
with [𝛾-32P] ATP. Protein-RNA complexes are separated from unbound (free) RNA
by native, nondenaturing polyacrylamide gel electrophoresis (PAGE). The amount of
bound RNA in the complex as well as the free RNA is measured via phosphorimaging,
with the fraction of bound RNA plotted as a function of protein concentration. From
this curve, the apparent equilibrium binding constant (𝐾𝑑), defined as the concentra-
tion of protein at which 50% of the RNA is bound, can be derived as a measure of
the affinity that the protein has for the particular RNA assayed. An advantage of
the gel-shift assay is that it provides an absolute 𝐾𝑑 for the protein-RNA interaction,
though previous knowledge of a potential RNA substrate for the RBP of interest is
required (Yakhnin et al. [2012]).
∙ Surface plasmon resonance (SPR) is a real-time, label-free optical biosensing technol-
ogy that provides kinetic information about the rates of association and dissociation
of an RBP for an RNA ligand of interest (Katsamba et al. [2002]). The RNA is im-
mobilized to a gold sensor surface and a solution containing the RBP is flowed over
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the surface while a light source shines on the sensor chip and is reflected to a detector.
As the RBP solution is injected into the flow cell and binds to the RNA ligand, a
change in the refractive index causes some of the light to be reflected at a different
angle, with measurement of this index throughout RBP injection and wash out over
the course of minutes at multiple different protein concentrations allowing inference
of the association (𝑘𝐴) and dissociation rates (𝑘𝐷), and thus the dissociation constant
𝐾𝐷 =
𝑘𝐷
𝑘𝐴
. SPR was originally used to study two RRM-containing RBPs and mutants
and individual RBDs thereof (Katsamba et al. [2002]), and has more recently been
utilized to provide absolute dissociation constants for RBFOX2 in a previous RNA
Bind-n-Seq study (Lambert et al. [2014]). While SPR is a powerful method for mea-
suring intermolecular interactions in real time, it requires specific instrumentation and
expensive consumables, making it impractical for profiling hundreds of RBPs.
∙ In RNAcompete, a purified epitope-tagged RBP selects RNA sequences from an RNA
pool of ∼240,000 designed mostly unstructured sequences up to 41 nt in length. Bound
RNAs are identified via microarray hybridization and the 7mer binding profile of an
RBP of interest is determined computationally (Ray et al. [2017]). Originally applied
to nine yeast and human RBPs (Ray et al. [2009]), it has subsequently been applied
to 205 RBPs from 24 diverse eukaryotic species (Ray et al. [2013]), and a more re-
cent adaptation using a sequencing-based approach produced “Sequence and Structure
Models" (SSMs) derived from 40mers for seven yeast and human RBPs performed at
a single protein concentration (RNAcompeteS, Cook et al. [2017]).
∙ In RNA Bind-n-Seq (RBNS), a purified epitope-tagged RBP (consisting minimally of
the RNA binding domains plus 50 flanking amino acids on the N- and C-terminal ends)
is incubated with a pool of random 20 or 40 nt oligonucleotides, and the pulled down
RBP-bound RNA is subjected to high-throughput sequencing (Lambert et al. [2014]).
Typically five separate incubation reactions are performed with differing quantities of
the tagged RBP (5 - 1300 nM), with each of these five libraries as well as the input RNA
sequenced to a depth of ∼15-20 million reads. Computational analysis of the pulldown
reads compared to the input reads provides the full spectrum of bound motifs (including
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high and moderate affinity RNA sequences) as well as their secondary structure and
context preferences. Importantly, because the RBNS oligo pool is random in contrast
to the designed pool of ∼250,000 oligos used in RNAcompete, the RBP is presented
with motifs in a wide variety of sequence and secondary structure contexts, enabling
the fine-tuned dissection of an RBP’s specificity and affinity landscape.
∙ Other in vitro techniques that have been used to profile the specificity and/or affinity
of one or a few RBPs include: SEQRS (Selection, high-throughput sequencing of RNA
and SSLs (sequence specificity landscapes), Campbell et al. [2012]); RNA-MaP (quan-
titative analysis of RNA on aMassively Parallel array, Buenrostro et al. [2014]); HiTS-
RAP (High-Throughput Sequencing -RNAAffinity Profiling, Tome et al. [2014]); and
RNA-MITOMI (RNA-Mechanically Induced Trapping Of Molecular Interactions,
Martin et al. [2012]).
1.2.2 In vivo RNA-RBP profiling techniques
While in vitro techniques reveal the intrinsic specificity an RBP has for RNA sequence(s),
complementary in vivo techniques have been developed to study RBP-RNA interactions in
their endogenous cellular environments, including:
∙ The first genome-wide studies to profile the set of RNAs bound to an RBP of inter-
est employed RNA ImmunoPrecipitation followed by microarray analysis (RIP-chip,
Tenenbaum et al. [2000]) or later high-throughput sequencing (RIP-seq, Zhao et al.
[2010]). These and other initial studies on dozens of RBPs revealed that RBP-RNA
interactions are many-to-many; that is, each RBP typically binds hundreds to thou-
sands of genes while each gene is typically bound by numerous different RBPs (Hogan
et al. [2008]).
∙ Cross-Linking and ImmunoPrecipitation followed by high-throughput sequencing (CLIP-
seq) is the state-of-the-art method to determine an RBP’s RNA targets and specific
binding sites throughout the transcriptome. Though several CLIP-seq variants have
been developed over the past years (see below), most share a general workflow of: sta-
bilization of protein-RNA interactions via UV crosslinking to create covalent bonds
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between amino acid residues and RNA bases in close proximity; RNA shearing; im-
munoprecipitation of the RBP of interest; RNA adapter ligation; reverse transcription
(RT); PCR amplification; high-throughput sequencing; and mapping of reads to the
transcriptome and calling of significant regions of binding. Compared with previous
methods to identify transcriptome-wide protein-RNA interactions such as RIP-chip or
RIP-seq, the crosslinking step of CLIP enables more stringent purification of protein-
RNA complexes, and the RNase digestion step provides binding-site resolution by
creating short RBP-protected fragments of length 20-70 nucleotides (Wheeler et al.
[2017]). Though UV treatment at 254 nm is common due to its simplicity and ability
to crosslink unmodified cells and tissues, this step does introduce known biases includ-
ing: pyrimidines are more photoactivatable than purines (uracil most highly, Sugimoto
et al. [2012], Hauer et al. [2015]); Cys, Lys, Phe, Trp, and Tyr residues crosslink more
efficiently than other amino acids; and RBPs interacting with double-stranded RNA
crosslink poorly due to the deep and narrow groove of A-form RNA helices making
amino acid residues inaccessible to the nucleotides (Wheeler et al. [2017]).
Multiple variants of the CLIP-seq assay have been developed over the past decade, the
most commonly used being:
– Photoactivatable Ribonucleoside CLIP (PAR-CLIP): Metabolic labeling in cell
culture incorporates UV radioactive nucleoside analogs (4-thiouridine, 4sU, or 6-
thioguanosine, 6sG) into RNA, which is subsequently crosslinked at 365 nm UV
irradiation (Maatz et al. [2017]). RNA yield is increased due to the high reac-
tivity compared to traditional UV crosslinking, and the mutation of T to C at
the crosslinking site of 4sU after reverse transcription in up to 70% of reads pro-
vides confidence in identified interaction sites (Hafner et al. [2010]). However, the
method is only applicable to cell culture systems in which the modified nucleoside
can be introduced, and the modified nucleoside may introduce stress responses
(Burger et al. [2013]) and favor RNAs with short half-lives as the nucleoside is
present in a higher proportion of those messages.
– Individual nucleotide CLIP (iCLIP): In first generation CLIP protocols, both 5’
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and 3’ RNA adapters were ligated to the immunoprecipitated RNA fragments
prior to reverse transcription. As the UV-induced amino acid-RNA covalent
adducts often terminate reverse transcriptase, up to 80% of the cDNA products
did not contain the 5’ adapter and were not amplified. iCLIP addressed this by
introducing a single RT primer that contained two cleavable adapter regions, with
circularization after RT followed by digestion producing a linear cDNA molecule
containing both sequencing adapters (König et al. [2010]). Because a number
of reads terminate at the RT stop, a portion of the mapped iCLIP reads mark
crosslink sites with individual nucleotide resolution. However, the circular ligation
is very inefficient and has known biases of preferred nucleotides at the fragment
ends, calling into question the quantitative nature of the assay (Baran-Gale et al.
[2015]).
– enhanced CLIP (eCLIP): modifications to the iCLIP protocol and inclusion of
input controls in the eCLIP protocol has enabled large-scale, robust profiling of
hundreds of diverse RBPs (Fig. 1-3, Van Nostrand et al. [2016]). These im-
provements include omission of radiolabeling and autoradiographic visualization
steps; improved enzymatic reaction efficiencies; ligation of a second 3’ adapter to
the single-stranded DNA after reverse transcription instead of circular ligation to
increase capture efficiency; inclusion of an in-line 5-10 nt randomer in the sec-
ond adapter to distinguish unique molecules from PCR duplicates, making the
number of reads more quantitative and enabling a higher percentage of usable,
nonduplicated reads; and sequencing of a ‘size-matched’ input pre-IP sample that
has the same crosslinking, fragmentation, ligation, and amplification biases as
the IP sample to control for nonspecific background and inherent capture biases.
These improvements reduce the PCR amplification needed by ∼1000-fold (e.g.,
16 eCLIP vs. 28 iCLIP PCR cycles needed for RBFOX2), requiring fewer start-
ing cells (less than a million) and resulting in a sequenced library with a higher
percentage of usable reads and greater library complexity.
The eCLIP method has recently been performed at scale for over 100 different
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RNA binding proteins in two human cell lines through the Encyclopedia of DNA
Elements (ENCODE) project, allowing a consistent comparison of the in vivo
binding preferences of diverse RBPs that is explored in Chapter 3.
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Figure 1-3: The enhanced CLIP (eCLIP) assay
RBP-RNA interactions are covalently stabilized by UV-crosslinking, followed by RNase I
digestion and IP with a validated antibody. After stringent washes, the 3’ adapter with an
in-line random barcode is ligated to RNA, and a region 75 kDa (∼220 nt of RNA) above
the protein size is excised and treated with proteinase K to isolate RNA. After RT and the
second 3’ adapter ligation (this time to cDNA), a library is prepared for high-throughput
sequencing. Reads that were truncated at the RT position result in sequencing reads with
read 2 of the paired-end (PE) sequence beginning just 3’ of the crosslink site (Van Nostrand
et al. [2016]).
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∙ mRNA interactome capture
To assay the global scope of protein-RNA interactions in mammalian cells, ‘mRNA
interactome capture’ methods have been developed that combine UV-crosslinking with
highly stringent oligo(dT) affinity purification to enrich for proteins associated with
polyadenylated RNA (Kastelic and Landthaler [2017]). These methods have uncov-
ered vast repertoires of RBPs with hundreds of novel RBP candidates that were not
predicted to bind RNA based on presence of well-defined, annotated RBDs or previous
RNA-related roles reported in the literature. One pioneering study in HEK cells iden-
tified close to 800 mRNA-bound proteins, nearly one-third of which were previously
unannotated as binding mRNA and 15% of which were not computationally predicted
to interact with RNA (Baltz et al. [2012]). Another study in HeLa cells identified
860 mRNA-bound proteins, only 233 of which contained a classical RBD with intrinsi-
cally disordered regions being highly enriched in the mRNA-bound set (Castello et al.
[2012]). These interactome capture methods will allow changes in protein-mRNA inter-
actions in response to stimuli and disease to be studied in addition to the identification
of the RNA-bound proteome in diverse cell lines and organisms.
Variants of mRNA interactome capture to identify the proteins bound by a specific
RNA of interest include ChIRP-MS (Comprehensive Identification of RNA binding
Proteins by Mass Spectrometry, which utilizes cells grown in standard medium, Chu
et al. [2015]) and RAP-MS (RNA Antisense Purification-Mass Spectrometry, which
utilizes cells grown in SILAC medium, McHugh et al. [2015]), both of which were devel-
oped to determine Xist-interacting proteins that mediate X-chromosome inactivation.
After protein-RNA crosslinking, 20-90 nt long biotinylated DNAs complementary to
the RNA of interest are used to capture RNA-protein complexes, and eluted proteins
are identified through mass spectrometry. The high overlap of 9 out of 10 RAP-MS-
identified RBPs also being pulled down in ChIRP-MS highlights the former’s specificity,
with these two techniques enabling identification of the proteins that interact with any
specific RNA sequence in vivo.
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1.2.3 Genetic studies of RNA profiling after RBP perturbation
To better understand the role(s) than an RBP plays in RNA homeostasis, the RBP can be
perturbed through genetic or other means with resulting effects on RNA processing measured
in a systematic and genome-wide manner through any number of sequencing-based assays.
RBP perturbation can be achieved through transient siRNA-, stably integrated shRNA-, or
more recent CRISPR-Cas13a-mediated (Abudayyeh et al. [2017]) RBP knockdown (KD);
CRISPR-mediated RBP knockout (KO, if the RBP is not essential) or deletion of particular
protein domain(s); or RBP overexpression. The most common assay to profile changes in
the transcriptome after RBP perturbation is traditional steady-state RNA sequencing, which
can reveal changes in alternative splicing and promoter usage; gene expression levels (from
which RBP regulation of mRNA stability can be inferred); and RNA editing in the RBP-
perturbed cells compared to control cells. Alternative assays to probe different aspects of
RNA metabolism after RBP perturbation include ribosome profiling to measure changes
in translation (Ingolia et al. [2009]); RNA-seq on different subcellular fractions to measure
changes in mRNA localization (Lefebvre et al. [2017]); techniques such as 3P-seq (Jan et al.
[2011]) to measure changes in poly(A) site usage and TAIL-seq (Chang et al. [2014]) or
PAL-seq (Subtelny et al. [2014]) to measure changes in poly(A) tail length; and metabolic
labeling or transcriptional inhibition followed by time course measurements to more directly
measure mRNA half-lives (Tani and Akimitsu [2012]). A limitation of RBP perturbation
studies is that it is often difficult to disambiguate direct from indirect changes (e.g., whether
the RBP in question directly affects splice site choice or its perturbation changes the level
of a splicing factor that is responsible for an observed splicing change), though confidence
in identifying directly regulated events can be achieved by integrating binding (e.g., in vivo-
based CLIP or in vitro-based RBNS) data and considering events that have evidence of direct
RBP interaction.
1.2.4 Structural studies of RBPs and RBP-RNA interactions
The two most common methods for determining high-resolution atomic structures of pro-
teins and protein-RNA complexes are nuclear magnetic resonance (NMR) spectroscopy and
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X-ray crystallography. Since the first protein-RNA complex was solved using X-ray crystal-
lography (Chen et al. [1989]), improvements in instrumentation and computational modeling
techniques have led to these structural studies being incredibly influential in revealing infor-
mation about RBP-RNA interactions. Overviews of the two techniques and and differences
between them include:
∙ NMR structures represent an average over semi-random oriented molecules tumbling in
solution over a nanosecond to second time scale (Brünger [1997]). Proteins ≤ 30 kDa
(∼ 270 amino acids) are amenable to NMR spectroscopy. As they occur in solution,
NMR studies of proteins are closer to their physiological state and allow identification
of flexible portions of the protein including interdomain linker sequences commonly
observed in multi-domain RBPs. NMR studies also allow conformational changes to
be observed, such as those that may occur upon RNA binding to a multi-RBD protein
(Afroz et al. [2015], Mackereth et al. [2011]).
∙ X-ray crystallography structures represent an average over molecules arranged in a
regular crystal lattice over a seconds to hours time scale (Brünger [1997]). X-ray
crystallography is also able to provide the position of water molecules in the structure,
allowing prediction of water-mediated hydrogen bonds which may be important in
protein-RNA specificity (Afroz et al. [2015]). It can be applied to proteins or complexes
> 100 kDa, though obtaining a crystal is not guaranteed and is often time-consuming
even when possible.
As of October 2017, there were 230 structures of human RRMs in the Protein Data
Bank (140 solution NMR and 90 X-ray crystallography; 174 RRM(s) alone and 56 in
complex with RNA). There were 58 structures of human KH domains in the PDB, 27
solution NMR and 31 X-ray crystallography, 13 of which are in complex with RNA or
DNA.
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1.3 RNA secondary structure in RBP-RNA interactions
and regulation
Deciphering the structures of complex three-dimensional biomolecules is essential to fully
understand their regulatory capacity and biological function. In contrast to double-stranded
DNA, RNA is single-stranded, permitting it to fold into complex secondary and tertiary
structures that can directly influence RNA regulatory capacity or alter the ability of RBPs
to bind cis-sequence elements. Single nucleotide polymorphisms (SNPs) in UTRs that induce
RNA conformational changes have been associated with six genetic diseases, underscoring the
importance of considering secondary structure in understanding RNA function (Halvorsen
et al. [2010]).
RNA structures can be revealed through three complementary approaches: in silico fold-
ing as well as in vitro or in vivo profiling studies. In silico-folded structures are typically
predicted from dynamic programming algorithms that efficiently search the set of all pos-
sible structures, except for those containing pseudoknots (Eddy [2004]). The prediction(s)
for an RNA can include the minimum free energy (MFE) structure, which is the most prob-
able structure at equilibrium, or a set of structures with associated probabilities based on
the partition function that describes the ensemble thermodynamic properties of the system
(Fig. 1-4). Commonalities at particular RNA bases over the latter set of structures can
provide an estimate of the quality of the prediction and identify highly probable base pairs
(Mathews et al. [2010]). Benchmarking of in silico RNA structure prediction from sequence
alone for rRNAs and other well-studied catalytically active RNAs yielded an ∼70% base pair
accuracy (Hajiaghayi et al. [2012]), with the accuracy dropping for sequences 1 kb or longer
such as full-length mRNAs (Doshi et al. [2004]).
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Figure 1-4: Examples of in silico-folded RNA oligos
(a) Example of an RNA oligo folded in silico with RNAfold (Lorenz et al. [2011]), with the
probability of each RNA base being paired (𝑃paired) in the ensemble of predicted structures
according to their thermodynamic energies.
(b) Example of the RNA bases of the minimum free energy structure of an RNA oligo
classified into five secondary structural elements.
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Improvements to in silico-predicted structures can be made by considering secondary
structures common to homologous RNA sequences. As RNAs whose biological function
depends on their secondary structure (e.g., rRNAs, tRNAs) should be structurally conserved
across related RNAs from different species, covariation with compensatory base pair changes
that preserve not primary sequence but rather secondary structure (e.g., G-C mutating
to A-U) is often observed in such RNAs and is generally more conserved than primary
sequence (Seetin and Mathews [2012]). While covariation sequence analysis is the most
accurate measure of secondary structure prediction with >95% of predicted pairs correct
(Gutell et al. [2002]), multiple homologous sequences, as well as a high quality alignment of
them, are required, which is not always possible for rare RNAs or RNAs with high sequence
variability (Mathews et al. [2010]). Comparative sequence analysis and identification of
covarying sites is often a manual undertaking, though a number of software packages are
available to generate hypotheses, with methods that predict the conserved structure for all
homologous sequences together typically being most accurate (Seetin and Mathews [2012]).
Experimentally, RNA structures and folding have predominantly been studied in dilute in
vitro conditions, leading to fundamental insights. However, in vitro experiments are typically
lacking the biological ions, ligands, proteins, and crowding that affect folding and function
in vivo. Up to 40% of the cytosol is taken up by macromolecules, making crowding a critical
but poorly understood contributor to RNA folding in vivo. While in vivo studies that utilize
structure probing agents are thus desirable due to their biological relevance, they generally
only measure the ensemble structure of each RNA species, do not provide any information
about the kinetics or thermodynamics of folding, and do not disambiguate RNA structure
formed from pairing with itself and inaccessibility due to protein-RNA interactions (Leamy
et al. [2016]).
Major themes from the study of thermodynamic and kinetic studies in vitro over the
past decades include that RNAs fold on rugged pathways in which pathway intermediates
are populated and RNA can form misfolded structures before populating the native sec-
ondary structure state (Leamy et al. [2016]). Additionally, secondary structures form before
tertiary contacts, at least in the context of tRNAs, ribozymes, and riboswitches (Leamy
et al. [2016]). For these RNAs, secondary structures form on a relatively quick timescale
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(on the order of 𝜇s-ms) followed by the slower folding of the tertiary structure (Crothers
et al. [1974]). Quantitative analyses of the melting temperatures of short RNA duplexes led
to improved experimental parameters for RNA base pairs, helices with loops, unpaired ter-
minal nucleotides, and hydrogen bonds known as the “Turner Rules" (Turner et al. [1987]).
This study also demonstrated that the two major fundamental interactions in RNA, base
stacking and hydrogen bonding, contribute roughly similarly to free-energy changes in olig-
oribonucleotide association such that both are likely to be important in three-dimensional
RNA structure prediction and interpretation of RNA-RNA associations. Canonical A-U and
G-C base pairs and the wobble G-U pair engage the canonical Watson-Crick base edges to
form two, three, and two hydrogen bonds, respectively, with the Turner rules and likewise
‘nearest-neighbor’ models assuming the stability of a base pair or other RNA structure is
dependent only on the identity of the adjacent base pairs.
Structure probing chemical and enzymatic methods in vitro and in vivo followed by high-
throughput sequencing readouts have recently been utilized to elucidate the structure of
RNAs with nucleotide resolution. Among the popular chemical probes used to attack and
modify the solvent-accesible RNA bases or sugars to cause reverse transcriptase dropoffs are
DMS (modifies unpaired adenines and cytosines; Structure-seq, Ding et al. [2014]; DMS-
seq, Rouskin et al. [2014]; and Mod-seq, Talkish et al. [2014]) and SHAPE (modifies the
2’-hydroxyl of all unpaired bases, Lucks et al. [2011]). Commonly used enzymatic probes
are the RNases S1 (cleaves single-stranded RNA) and V1 (cleaves double-stranded RNA) in
combination (PARS, Underwood et al. [2010]) or RNase P1 (cleaves single-stranded RNA)
alone along with an untreated sample (FragSeq, Kertesz et al. [2010]). Among the findings
of recent studies using the aforementioned structure probing methods include that there is
significantly more structure in coding regions than in UTRs of yeast RNAs (Kertesz et al.
[2010]) in contrast to humans in which the CDS is slightly more single-stranded than UTRs
(Wan et al. [2014]), and there is less structure at the start and stop codons than at other
transcript areas, facilitating read-through of the ribosome (Ding et al. [2014], Wan et al.
[2014]).
RNA has been shown to be less structured in vivo than in vitro or folded in silico,
likely due to the translocating ribosome, RNA helicases, and other RBPs unwinding the
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RNA (Rouskin et al. [2014]). Upon in vivo ATP depletion, yeast mRNAs become more
structured, implying that ATP-dependent processes unfold RNAs in cells. Integration of a
click-chemistry based SHAPE experiment (icSHAPE) with RBFOX2 iCLIP binding sites in
mouse embryonic stem cells revealed that in vitro vs. in vivo differential icSHAPE signal over
RBFOX2’s UGCAUG motif matched the key RNA residues involved in the RBFOX2-RNA
interaction (Spitale et al. [2015]). Similar analysis identified peaks of structural arrangement
at iCLIP-bound HuR (ELAVL1) binding sites and enabled reasonably accurate HuR binding
site prediction from icSHAPE data alone. Combining structure probing data with an RBP’s
motif occurrences in the transcriptome may thus collectively boost prediction accuracy of
RBP binding sites in the cell type in which the structure probing was performed and provide
insight into RNA structural rearrangements upon RBP binding.
The secondary structure and accessibility of mRNA sites has been shown to affect RBP
binding and post-transcriptional regulation at a transcriptome-wide scale. miRNAs mediate
less repression in the middle of 3’ UTRs than near the end of 3’ UTRs, presumably due to the
decreased accessibility of the middle sites due to occlusive structures (Grimson et al. [2007]).
RNA structure affects recognition of ESEs by SR proteins in the fibronectin EDA exon and
contributes to differential regulation of this exon between human and mouse (Buratti et al.
[2004]), and this finding was generalized in an analysis of experimentally identified SREs
showing they are significantly enriched in single-stranded pre-mRNA regions (Hiller et al.
[2007]). Additionally, a discrepancy arose when examining the effects of 8mer 3’ UTR reg-
ulatory elements determined through a high-throughput cell-based screen versus their effect
when tested within the context of a larger 500 nt endogenous sequence through luciferase
reporters (Wissink et al. [2016]). Five of the seven investigated cis-elements (including both
stabilizing and destabilizing elements) had opposing effects among the 3-5 endogenous 3’
UTR sequences tested, highlighting the importance of sequence context on regulatory ele-
ment function. One likely explanation for the discrepancy is that the endogenous sequence
context puts the regulatory elements within a new local secondary structure that prevents
them from being accessible to RBPs or changes the folding of the isolated 8mers (Mayr
[2017]).
In addition to the general accessibility of RNA sites modulating RBP binding, specific
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RNA structures play an important role in recruiting or inhibiting certain RBPs to effect
biological functions. For example, SLBP (stem-loop binding protein) binds the characteristic
stem-loop structure near the end of replication-dependent histone pre-mRNAs necessary
for efficient 3’-end processing of these messages (Wang et al. [1996]). The selenocysteine
insertion element is an ∼60 nt specific stem-loop structural motif in the 3’ UTRs of particular
mRNAs that causes the UGA stop codon to be translated as selenocysteine (Walczak et al.
[1996]). Long-range RNA duplexes in 3’ UTRs are bound by STAU1 to regulate message
stability (Sugimoto et al. [2015]), and ADAR proteins specifically deaminate adenosines
in duplex RNA to carry out A-to-I editing while leaving other adenosines unmodified (Li
et al. [2009]). Alternative splicing, too, can be modulated through highly regulated and
conserved structures; long-range RNA-RNA base-pairing interactions are necessary for some
RBFOX binding events in distal introns to be recruited to alternative exons to productively
enhance spliceosomal activity (Lovci et al. [2013]). In summary, RNA secondary structure
can greatly influence RBP binding and its consideration is essential in our efforts to more
fully understand RBP-mediated regulation of RNA processing.
1.4 Overview of the thesis
This thesis details the computational methods developed and insights learned from high-
throughput sequencing-based assays applied to in vitro and in vivo RNA-protein interac-
tions. In Chapter 2, I characterize the RNA binding specificities of 78 diverse human RNA
binding proteins assayed through a high-throughput technique, RNA Bind-n-Seq (RBNS),
developed in the Burge laboratory. A resource of the primary sequence, secondary structure,
and other RNA contextual preferences of the RBPs is provided, along with novel integration
of these motifs with functional perturbation data (RBP knockdown followed by RNA-seq)
to infer context-specific maps of RBP regulation of alternative splicing and mRNA stabil-
ity. Additionally, a framework that incorporates these contextual features layered on top
of primary sequence motifs to more fully characterize RBP specificity is presented with
a quantitative comparison of these contextual preferences across RBPs. In Chapter 3, I
present methods for integrating in vitro RBP specificities with the enhanced crosslinking
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and immunoprecipitation (eCLIP) assay that maps RBP binding sites in cells. Further in-
tegrative analysis of five assays, each focused on a distinct aspect of RBP activity (eCLIP;
RBP knockdown/RNA-seq; RBNS; RBP subcellular localization; and RBP association with
chromatin), is presented to expand the catalog of functional RNA elements encoded in the
human genome and understand their processing and regulation by RBPs in cells.
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Chapter 2
Sequence, Structure, and Context
Preferences of Human RNA Binding
Proteins
Under review, posted to bioRxiv on 10/12/17:
D DominguezS, P FreeseS, MS AlexisS, A Su, M Hochman, T Palden, C Bazile, NJ Lam-
bert, EL Van Nostrand, GA Pratt, GW Yeo, B Graveley, CB Burge. “Sequence, Structure
and Context Preferences of Human RNA Binding Proteins”.
https://doi.org/10.1101/201996
My contributions:
Development of RBNS computational pipeline for assay quality control and generation of
enrichment values and sequence motif logos (Fig. 2-1, Fig. 2-S1A, Fig. 2-2A); comparison
to RNAcompete in conjunction with DID (Fig. 2-S1C, D); analysis of RNA motif properties
(Fig. 2-2C, E, F; Fig. 2-S2); generation of RNA maps from RBNS and knockdown/RNA-
seq data and comparison with in vivo binding (Fig. 2-3C, F; Fig. 2-S3A-C, E); overlap
with splicing and stability regulatory 6mers in conjunction with DID and MSA (Fig. 2-3A,
B, D, E); RNA secondary structure analyses (Fig. 2-4; Fig. 2-S1B; Fig. 2-S4; Fig. 2-S6E,
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H, I); comparison of contributions of context features and context feature preferences in vivo
in conjunction with MSA (Fig. 2-6; Fig. 2-S6A-D); tissue specificity of RBP expression
(Fig. 2-S6F); binding similarity among RBPs with similar vs. different RBD types (Fig.
2-S6G); writing of text in conjunction with DID, MSA, and CBB.
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2.1 Abstract
RNA binding proteins (RBPs) orchestrate every step of the production, processing, and
function of mRNAs. Here we present the affinity landscapes of 78 human RBPs using an
unbiased assay that determines the sequence, structure, and context preferences of an RBP
in vitro by deep sequencing of bound RNAs. These data enable construction of “RNA maps”
of RBP activity without requiring crosslinking-based assays. We observed an unexpectedly
low diversity of RNA motifs, implying frequent convergence of binding specificity toward a
relatively small set of RNA motifs, many with low compositional complexity. Offsetting this
trend, we observed extensive preferences for contextual features distinct from short linear
RNA motifs, including spaced ‘bipartite’ motifs, biased flanking nucleotide composition, and
bias away from or towards RNA structure. Our results emphasize the importance of these
contextual features in RNA recognition, which likely enable targeting of distinct subsets of
transcripts by different RBPs that recognize the same linear motif.
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2.2 Introduction
RNA binding proteins (RBPs) control the production, maturation, localization, modifica-
tion, translation, and degradation of cellular RNAs. Many RBPs contain well-defined RNA
binding domains (RBDs) that engage RNA in a sequence- and/or structure-specific manner.
The human genome encodes at least 1500 RBPs that contain established RBDs, the most
prevalent of which include RNA recognition motifs (RRM, ∼240 RBPs), hnRNP K-homology
domains (KH, ∼60 RBPs) and C3H1 zinc-finger domains (ZNFs, ∼50 RBPs) (reviewed by
Gerstberger et al. [2014]). While RBPs containing RRM (Query et al. [1989]) or KH domains
(Siomi et al. [1993]) were first described over two decades ago, the repertoires of RNA se-
quences and cellular targets bound by different members of these and other classes of RBPs
are still largely unknown.
Structural studies have identified conserved residues that enable canonical RBP-RNA
interactions but have also uncovered non-canonical binding modes, making it difficult to
infer RNA target preferences from amino acid sequence alone (reviewed by Cléry and Allain
[2011], Valverde et al. [2008]). For example, RRMs adopt a structure with an antiparallel
four-stranded beta sheet packed onto two alpha helices, with the two central strands (RNP1
and RNP2) typically mediating interactions with RNA (reviewed by Afroz et al. [2015]).
However, crystallography and NMR studies have shown that certain RBPs bind RNA via
the linker regions, loops, or the C- or N- terminal extremities of their RRMs rather than
the canonical RNP1 and RNP2 strands (reviewed by Daubner et al. [2013]). Similarly,
KH domains form a hydrophobic binding cleft that is generally thought to accommodate a
pyrimidine-rich tetranucleotide motif, but specificity is often modulated by hydrogen bonding
or additional interactions with the protein backbone (Grishin [2001],Valverde et al. [2008]).
These variable RNA binding mechanisms in combination with the presence of multiple RBDs
in most RBPs (Lunde et al. [2007]) have motivated efforts to experimentally interrogate the
specificity of individual RBPs (reviewed by Cléry and Allain [2011]).
Several methods exist for determining RBP binding sites in vivo, most notably RNA
immunoprecipitation (RIP, Gilbert and Svejstrup [2006]) and UV crosslinking followed by
immunoprecipitation (CLIP) and sequencing (Ule et al. [2003]). While such techniques cap-
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ture RBP-RNA interactions in their cellular contexts, it is often difficult to derive motifs
from these experiments due to interactions with protein cofactors, high levels of non-specific
background (Friedersdorf and Keene [2014]), and non-random genomic composition. Quan-
titative in vitro assays such as electrophoretic mobility shift assay (EMSA), surface plasmon
resonance (SPR), and isothermal calorimetry (ITC) must be guided by a priori knowledge
of putative RNA substrates, making them unsuitable for high-throughput motif discovery.
Methods such as SELEX (systematic evolution of ligands by exponential selection) typically
select a few high-affinity ‘winner’ sequences, but generally do not reveal the full spectrum of
RNA targets or their associated affinities (reviewed by Cook et al. [2015]). RNAcompete is
a high-throughput in vitro binding assay that captures a more complete specificity profile by
quantifying the relative affinity of an RBP for a pre-defined set of ∼250,000 RNA molecules
(Ray et al. [2013]). One limitation of this approach is that the designed RNAs present motifs
in a relatively small range of predominantly unstructured contexts, restricting the analysis
to short, mostly unpaired motifs. More recent approaches such as RNA Bind-n-Seq (RBNS)
(Lambert et al. [2014]) and RNAcompeteS (Cook et al. [2017]) perform high-throughput
sequencing of bound RNAs selected from a random pool, yielding a more comprehensive
profile of the sequence and RNA secondary structural specificity of an RBP.
The RNA binding specificity of ∼100 human RBPs has been assessed using various unbi-
ased (de novo) methods (Giudice et al. [2016]), though the diversity of techniques employed
hampers comparison of their specificities. To systematically explore the binding specificity
spectrum of humans RBPs at high resolution, we performed RBNS on a diverse set of 78
human RBPs, half of which had previously uncharacterized specificities. RBNS comprehen-
sively and quantitatively maps the RNA binding specificity landscape of an RBP through a
one-step in vitro binding reaction using recombinant RBP incubated with a random pool of
RNA oligonucleotides (Lambert et al. [2014]). The assay was typically carried out for each
RBP at five protein concentrations totaling 400 binding assays. The depth of sequencing
yielded over 6 billion protein-associated reads, enabling detection not only of simple sequence
motifs but also of preferred structural and contextual features (Fig. 2-1A). Analysis of these
data revealed a pattern in which many proteins bind to similar motifs, but differ in their
preferences for additional binding features such as RNA secondary structure, flanking nu-
53
cleotide composition, and bipartite motifs, expanding their ability to distinguish regulatory
targets.
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Figure 2-1: Overview of the high-throughput RNA Bind-n-Seq assay and compu-
tational analysis pipeline
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Figure 2-1
(A) Schematic of RBNS assay and pipeline. Recombinant RBPs are incubated with a pool
of random RNA (black) flanked by adapter sequences (gray). RBP-RNA complexes are
isolated with streptavidin magnetic beads, eluted with biotin, and bound RNA is sequenced.
Computational analysis of pulldown and input reads reveals linear sequence specificities,
secondary structure preferences, and complex binding modes of RBPs.
(B) Number of RBPs with one or more of the three most common RBD types assayed.
(C) Cumulative distribution of the RBD amino acid identity between each RBP and its most
similar analyzed RBP. Distributions are calculated separately for the set of RBPs that has
been assayed by RBNS and all other human RBPs (sampled to match the domain distribution
analyzed by RBNS). Only domains with 5+ RBPs assayed by RBNS are included (RRM,
KH, Zinc finger CCCH-type).
(D) Histogram of Pearson correlations between RBNS assays of the same RBP at different
protein concentrations. Inset: correlation of 5mer 𝑅 values of HNRNPL at 20 nM (most
enriched concentration) and 80 nM.
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2.3 Results
2.3.1 High-throughput RNA Bind-n-Seq Assay
To determine the detailed binding preferences of a large set of human RBPs we developed a
high-throughput version of RNA Bind-n-Seq (RBNS), an in vitro method capable of deter-
mining the sequence, structure, and context preferences of RBPs. In this assay, randomized
RNA oligonucleotides (20 or 40 nt) flanked by constant adapter sequences were synthesized
and incubated with varying concentrations of an SBP-tagged recombinant protein containing
the RBD(s) of an RBP (Fig. 2-1A, constructs listed in Table S1). RNA-protein complexes
were isolated with streptavidin-conjugated affinity resin, washed, and bound RNA was eluted
and prepared for deep sequencing. Protein purification, binding assays, and sequencing li-
brary preparations were carried out in 96-well format increasing scalability and consistency
across experiments (Methods). A typical experiment yielded ∼10-20 million unique reads at
each protein concentration, which were compared to the input RNA pool sequenced to simi-
lar depth (Fig. 2-S1A, Table S2). Inclusion of sequencing adapters flanking the randomized
RNA region simplified library preparation, preventing ligation biases and amplification of
contaminating bacterial RNA carried over from protein purification (Lambert et al. [2014]).
Furthermore, as RBPs bind RNA motifs in a wide range of structural contexts in vivo (Fuku-
naga et al. [2014]), RBNS presents RBPs with motifs spanning a broad spectrum of secondary
structures, exceeding that of similar reported methods (Cook et al. [2015]) (Fig. 2-S1B).
The high sequence complexity of the interrogated libraries enabled the fine dissection of
RNA binding preferences, while use of multiple protein concentrations increased reliability
and enabled detection of lower-affinity motifs.
2.3.2 Binding specificities of a diverse set of human RNA binding
proteins
RBNS was performed on a fairly diverse set of 78 human RBPs containing a variety of types
and numbers of RBDs (Fig. 2-1B). RBPs were chosen based on a combination of criteria,
including: presence of well-established RBDs; evidence of a role in RNA biology (though
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this was not required); and secondary criteria related to expression in ENCODE cell lines
K562 and HepG2 and availability of validated antibodies for complementary eCLIP analysis
(Sundararaman et al. [2016]). Comparing all RBDs in this set, the range of amino acid
identity was similar to that of human RBPs overall (Fig. 2-1C). Together, this set captures
a broad swath of proteins that is reasonably representative of human RBPs.
To assess the sequence specificity of each RBP, we developed a computational pipeline
that calculates enrichment (“𝑅”) values of 𝑘mers (for 𝑘 in the range 3-8 nt), where 𝑅 is defined
as the frequency of a 𝑘mer in protein-bound reads over its frequency in input reads (Fig.
2-1A, top right). In most cases, 𝑅 values of top 𝑘mers exhibited a unimodal profile with
increasing protein concentration consistent with increased signal above noise at moderate
versus low RBP concentrations, and increased binding of lower-affinity motifs at higher
versus moderate concentrations (Lambert et al. [2014]). A mean Pearson correlation across
5mers of 0.96 was observed among experiments performed on the same RBP at different
concentrations, indicating high reproducibility (Fig. 2-1D). A comparison of previously
reported binding specificities for 31 factors also assayed by RNAcompete (Ray et al. [2013])
using an independent array-based assay revealed high correlation with our dataset (Fig.
2-S1C-D, mean Pearson correlation = 0.72), with only four proteins showing correlations
below 0.5.
2.3.3 Overlapping specificities of RNA binding proteins
To visualize and compare the primary sequence specificities of the assayed RBPs, we derived
sequence motif logos for each RBP by aligning enriched 5mers (Z-score ≥ 3, weighted by
enrichment above input using an iterative procedure that avoids overlap issues, Fig. 2-1A
top right, Methods). For more than half of the RBPs (41/78), this yielded multiple sequence
logos, indicating affinity to multiple distinct motifs that may reflect different binding modes
or binding by different RBDs (motif 5mers are listed in Table S3). As expected, the motifs of
closely related paralogs (e.g., PCBP1/2/4, RBFOX2/3) clustered closely together (Conway
et al. [2016], Smith et al. [2013]) (Fig. 2-2A). However, unexpectedly, some completely
unrelated proteins, often containing distinct classes of RBDs, were also grouped together.
Inspection of the dendrogram revealed 15 or so clusters of RBPs with highly similar primary
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motifs (nine with three or more members), leaving 18 RBPs with motifs more distinct from
other profiled RBPs unclustered (Methods). Notably, eight of the 15 clusters contained two
or more proteins with completely different types of RBDs (e.g., cluster 1 contained RRM-,
KH- and ZNF-containing proteins as well as factors with multiple RBD types).
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Figure 2-2: RBPs bind a small subset of the sequence space, characterized by
low-entropy motifs
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Figure 2-2
(A) From left to right: Dendrogram of hierarchical clustering of RBPs by sequence logo
similarity and 15 clusters at indicated branch length cutoff (dashed line); protein name;
colored circles representing nucleotide content of RBP motif (one circle if motif is >66% one
base, two half-circles if motif is >33% two bases); top motif logo for each protein; protein
RBD(s). Each logo represented an average of seven 5mers.
(B) Network map connecting RBPs with overlapping specificities (sharing at least two of
the top 15 RBNS 6mers). Line thickness increases with number of overlapping 6mers as
indicated. Node outline indicates RBD type of each protein.
(C) Number of unique top 6mers among subsamplings of the 78 RBNS experiments versus
randomly selected 6mers.
(D) Edge count between nodes for network maps as shown in B, drawn using groups of 15
6mers with decreasing ranks.
(E) Entropy of nucleotide composition of RBNS motifs vs. simulated motifs (Methods).
𝑃 -value determined by Wilcoxon rank-sum test.
(F) Enrichment of RBNS motifs over simulated motifs among partitions of a 2D simplex of
the motif nucleotide composition (Methods). Significance along margins was determined by
bootstrap Z-score (number of asterisks = Z-score).
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To more rigorously assess the relatedness of RBP binding affinities, we generated a net-
work map with edges connecting RBPs with significantly overlapping sets of top 6mers (at
least two of the top fifteen 6mers, 𝑃 = 0.001, hypergeometric test, Fig. 2-2B). While
RBFOX2 and RBFOX3 (which bind GCAUG) were connected only to each other, many
proteins were members of larger highly connected groups and the network overall was much
more connected than expected (𝑃 < 10−5 relative to null distribution of RBPs binding all
sequences equally, Methods). Indeed, for 27 RBPs the highest ranked 6mer was also the
highest ranked 6mer of at least one other RBP. Given that there are 4096 distinct 6mers,
this large overlap among highest-affinity 6mers was highly significant compared to the ∼1
overlap expected if RBPs bound all sequences equally (Fig. 2-2C). A large excess of overlaps
also occurred when considering the top fifteen 6mers for each RBP. Furthermore, the excess
of overlaps remained when eliminating paralogs and any pairs of proteins containing RBDs
sharing at least 40% amino acid identity (Fig. 2-S2A-B). To explore the network’s connec-
tivity further, we regenerated network maps with sets of 6mers with progressively decreasing
affinities (e.g., 6mers ranked 2-16, 13-17, etc. for each RBP). A monotonic decrease in edges
(overlaps of two or more) was observed with decreasing affinity categories, indicating that
the connectivity of this RBP map is highest for the 6mers with the highest relative affinity
(Fig. 2-2D). Together, these observations indicate that RBPs recognize a much smaller sub-
set of the available sequence space than expected. The pattern of clustering and overlap of
motifs observed in Fig. 2-2A-C, including many clusters of RBPs with distinct RBD types,
suggests that unrelated RBPs have evolved to bind similar RNA sequence motifs many times.
2.3.4 RBPs preferentially bind low-complexity motifs
We noted that most motifs were primarily composed of just one or two distinct bases (Fig.
2-2A). To assess motif composition objectively, we measured the Shannon entropy of the nu-
cleotide composition of each sequence logo, a scale which ranges from 0 bits (homopolymers)
to 2 bits (25% of each base). The entropies of actual RBP motifs were substantially lower
than control simulated motifs made from sampling motif columns across RBPs (𝑃 < 10−4,
Wilcoxon rank-sum test, Methods), indicating that RBP motifs are biased toward lower
compositional complexity (Fig. 2-2E). This trend applied generally to all compositions with
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low complexity, as mapping RBP motif compositions onto a 2-dimensional simplex revealed
increased density at all four mononucleotide ‘corners’, as well as all 6 dinucleotide ‘margins’
(with A/C, A/U, and C/U most significant, Fig. 2-2F, Fig. 2-S2C, all bootstrap 𝑃 <
0.05).
2.3.5 RNA maps from RBNS and knockdown RNA-seq data
Many human RBPs are involved in pre-mRNA splicing. Therefore, it was not unexpected
that ∼35% of the 596 ‘RBNS 6mers’ (union of the top fifteen 6mers for all RBPs) matched
6mer splicing elements identified previously in cell-based reporter screens (Fig. 2-3A, 𝑃 =
1.7×10−4, hypergeometric test) (Ke et al. [2011], Rosenberg et al. [2015], Wang et al. [2012],
Wang et al. [2013]) consistent with common roles of the studied RBPs in splicing. The
RBNS 6mers conferred stronger regulation than non-RBNS 6mers (Fig. 2-3B left, 𝑃 =
6×10−36, Wilcoxon rank-sum test), and higher RBNS enrichment (reflecting higher affinity)
was associated with increased splicing activity (Fig. 2-3B right for binned comparisons,
overall Spearman 𝜌 = 0.08, 𝑃 < 10−12).
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Figure 2-3: RBNS-derived motifs are associated with regulation of mRNA splicing
and stability in vivo
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Figure 2-3
(A) Overlap of RBNS 6mers and 6mers with splicing regulatory activity (𝑃 -value determined
by hypergeometric test).
(B) Comparison of splicing regulatory scores of, left: RBNS 6mers (top 15 of any RBNS,
“RBNS”) and all other 6mers (“non-RBNS”); right: all 6mers binned by their maximum 𝑅
value Z-score across all RBNS experiments (𝑃 -values determined by Wilcoxon rank-sum
test). Overall Spearman correlation between 𝑅 Z-score and splicing regulatory score was
0.08 (𝑃 < 10−12).
(C) Left: Number of alternative exons regulated by RBM25 as determined by RNA-seq after
RBM25 knockdown in HepG2 cells. Right: Proportion of events covered by RBNS 5mers in
exonic and flanking intronic regions near alternative exons excluded upon RBM25 KD (red),
included upon RBM25 KD (blue), and a control set of exons (black). Positions of significant
difference from control exons upon KD determined by Wilcoxon rank-sum test and marked
below the 𝑥-axis.
(D) Overlap of RBNS 6mers and 6mers with 3’ UTR regulatory activity (𝑃 -value determined
by hypergeometric test among 1303 6mers with sufficient coverage for representation).
(E) Comparison of 3’ UTR regulatory scores of, left: RBNS 6mers (top 15 of any RBNS,
“RBNS”) and all other 6mers (“non-RBNS”), 𝑃 -value determined by Wilcoxon rank-sum test;
right: all 6mers binned by their maximum 𝑅 value Z-score across all RBNS experiments.
Overall Spearman correlation between 𝑅 Z-score and 3’ UTR regulatory score was 0.19
(𝑃 < 10−11).
(F) Left: Number of gene expression changes after knockdown of TAF15 in HepG2 cells.
Right: Frequency of TAF15 RBNS 5mers along a meta-3’ UTR of genes whose expression
is decreased (blue), increased (red) or unchanged (black) by TAF15 knockdown. Positions
of significant difference from control genes upon KD determined by Wilcoxon rank-sum test
and marked below the 𝑥-axis.
(G) Pearson correlations of eCLIP densities across 100 nt windows of 3’ UTRs for all pairs
of eCLIP experiments. Pairs of experiments are grouped by category, with all pairs not
belonging to ‘Replicates’, ‘Paralogs’, or ‘Similar motifs’ (sharing two of top 5 5mers) placed in
‘Other’. 𝑃 -values determined by Wilcoxon rank-sum test, ***𝑃 < 5× 10−4, N.S.= 𝑃 > 0.05.
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“RNA maps” for splicing factors have traditionally been built using in vivo binding data
from CLIP-seq combined with genome-wide assays of splicing changes in response to RBP
perturbation (Witten and Ule [2011]). To ask whether in vitro data could be used in place
of CLIP data to derive such maps of inferred splicing activity, we integrated RBNS data
with RNA-seq data from human K562 and HepG2 cells depleted of specific RBPs by shRNA
(Van Nostrand et al. [2017]). For example, depletion of RBM25 resulted predominantly in
exclusion of cassette exons (Fig. 2-3C, left). An RNA map for this factor built by assessing
the frequency of its top RBNS 5mers near significantly altered exons revealed enrichment of
its motif in introns flanking exons that were excluded upon RBM25 knockdown (KD) relative
to control introns (Fig. 2-3C, right). Together, these data support that RBM25 functions
as a splicing activator when it binds intronic motifs near alternative exons. This inference is
consistent with previous studies of RBM25 regulation of specific alternative exons (Carlson
et al. [2017], Gao et al. [2011], Zhou et al. [2008]) and illustrates the potential use of RBNS
and RNAi/RNA-seq to inform splicing maps.
By performing this analysis on all 38 RBNS RBPs for which we had KD data in at least
one cell type, we observed that 27 of the 38 RBPs showed significant enrichment of their
RBNS-derived 5mers in either activated or repressed exons or flanking introns (Fig. 2-S3A,
left). These RNA maps were consistent with previously known patterns of splicing factor
activity in many cases, e.g., splicing activation by DAZAP1 (Choudhury et al. [2014]) and
PUF60 (Page-McCaw et al. [1999]) and repression by HNRNPC (Choi et al. [1986]) and
PTBP1 (Singh et al. [1995]), without use of CLIP. In some cases, RBPs not yet implicated
in splicing regulation exhibited splicing maps strongly suggestive of direct function (e.g.,
ILF2 as a splicing activator). Of note, eight of the nine RBPs with G-rich motifs exhibited
splicing activator activity from at least one region, most commonly from introns (FUS being
the sole exception). This result matches results of an unbiased screen for intronic splicing
enhancers, which identified G-rich cis-regulatory sequences and candidate trans-acting fac-
tors (Wang et al. [2012]). Thus, our approach provides a tool for understanding patterns of
splicing regulatory activity by sequence-specific RBPs that augments existing CLIP-based
RNA splicing maps (Van Nostrand et al. [2017]).
66
2.3.6 Protein-bound sequences are associated with in vivo regulation
of mRNA levels
Besides splicing regulatory activity, we also observed significant overlap between RBNS 6mers
and 6mers previously shown to modulate mRNA levels when inserted into reporter 3’ UTRs
(Oikonomou et al. [2014]) (Fig. 2-3D, 𝑃 = 3 × 10−5, hypergeometric test). As observed
for splicing regulation, 3’ UTR regulatory scores were higher for RBNS motifs (Fig. 2-3E
left, 𝑃 = 4×10−10, Wilcoxon rank-sum test), and regulatory scores increased for 6mers with
higher RBNS enrichment (Fig. 2-3E right for binned comparisons, overall Spearman 𝜌 =
0.19, 𝑃 < 10−11).
Again using RNAi/RNA-seq data, we examined an RBP’s RBNS motif density in 3’
UTRs for genes significantly up- or down-regulated upon KD of that RBP to generate 3’
UTR RNA maps. For example, TAF15 knockdown resulted in decreased levels of many
mRNAs (Fig. 2-3F left), and these mRNAs were enriched for TAF15 motifs in their 3’
UTRs relative to control genes with unchanged expression upon KD (Fig. 2-3F right).
These data suggest that TAF15 stabilizes mRNAs by binding to G-rich sequences in 3’
UTRs, mirroring expression changes observed upon TAF15 depletion in adult mouse brain
and human neural progenitor cells (Kapeli et al. [2016]). Just over half of the RBPs with
corresponding KD data (20/38) had RNA expression maps that were consistent with a
role in regulating mRNA levels (Fig. 2-S3A right), equally split between stabilizing and
destabilizing activity. Interestingly, SRSF5 motifs were highly enriched in 3’ UTRs (and the
end of the upstream ORF) of genes up-regulated upon KD (Fig. 2-S3B). 3’ UTR binding
has been observed in cell types in which SRSF5 undergoes nucleocytoplasmic shuttling (Botti
et al. [2017]), and its role in modulating gene expression levels may be related to its role in
linking alternative mRNA processing to nuclear export (Müller-McNicoll et al. [2016]).
2.3.7 RBPs with similar motifs often bind distinct transcript loca-
tions
As part of a larger analysis of ENCODE RBP data, we compared RBNS motifs to in vivo
motifs enriched in eCLIP peaks (Van Nostrand et al. [2017]). We observed strong agreement
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between eCLIP and RBNS motifs in most cases, with 17 of 26 proteins having significant
overlap between RBNS 5mers and 5mers identified de novo as enriched in eCLIP peaks (Fig.
2-S3C, adapted from (Van Nostrand et al. [2017])). Furthermore, RBNS-enriched 5mers were
more enriched in reproducible eCLIP peaks identified in multiple eCLIP replicates and in
peaks identified in multiple cell types, which likely represent sites of more robust binding
(Fig. 2-S3D). Together, these observations support that RBNS-identified motifs drive the
in vivo RNA binding specificity of most RBPs.
In cells, RBPs appear to bind only a subset of cognate motifs in expressed transcripts
(Taliaferro et al. [2016]). The extent to which RBPs with similar binding motifs bind the
same targets in vivo is incompletely understood. Comparing eCLIP-derived binding sites for
131 RBPs, we observed moderate correlation of binding locations between pairs of paralogs,
which generally bind highly similar motifs in vitro, below that for replicate experiments but
above that for randomly chosen RBP pairs (Fig. 2-3G). However, we observed surprisingly
little correlation between binding locations of other pairs of RBPs that bound similar motifs
in vitro (sharing at least two of their top five RBNS 5mers) (Fig. 2-3G). Their mean
Pearson correlation of 0.20 was not different from random pairs of RBPs, even though in
vivo-enriched motifs generally matched those observed in vitro (Fig. 2-S3C). For example,
while TIA1 and HNRNPC both have high affinity for polyU tracts in vitro and in vivo, they
bind distinct sites in many transcripts (example shown in Fig. 2-S3E).
The low correlation between locations of in vivo binding sites of RBPs with similar
motifs could result from various factors, including: i) differences in subcellular localization
of RBPs resulting in differential access to transcripts; ii) participation of some RBPs in
complexes with other factors that alter RNA specificity (e.g., (Damianov et al. [2016])); iii)
occlusion of sites by one RBP leading to the exclusion of other RBPs (Zong et al. [2014]); iv)
technical differences in efficiency of eCLIP capture of different regions by different RBPs; or
v) differences in binding specificities not well captured by conventional motif representations.
While all of these factors likely contribute to differential binding to some extent, we focused
here on exploring the last possibility, leveraging the depth and sensitivity of the RBNS data
to explore determinants of binding beyond canonical short RNA motifs.
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2.3.8 Most RBPs analyzed prefer less structured RNAs
RNA secondary structure can impact RBP binding and regulation (Warf and Berglund
[2010]), modulate the activity of regulatory RNA sequences (Hiller et al. [2007]), and con-
tribute to improved in vivo RBP binding site prediction when considered (Li et al. [2010]).
Since potential RBP binding sites in the transcriptome exist in a variety of structural con-
formations, we determined RNA secondary structure preferences for each RBP by compu-
tationally folding 5 million input and compositionally-matched protein-bound reads for all
78 RBNS experiments at all concentrations (Methods). To assess RNA secondary structure
preferences, we first computed the base-pairing probabilities (𝑃paired) of occurrences of the
top RBNS 6mer and flanking bases in pulldown libraries (Fig. 2-S4A) and calculated their
ratios to the corresponding 𝑃paired values in the input library (Fig. 2-4A). While the great
majority of RBPs favored less base-pairing of the motif itself, some like NUPL2 and RBM41
did to a large extent while others did more modestly. Just six proteins favored increased
𝑃paired averaged over the 6mer motif, with the strongest preference observed for ZNF326
(23% increase in mean 𝑃paired between input and pulldown, Fig. 2-S4A right). Structural
preferences at flanking positions were more variable, including some proteins within the same
cluster preferring increased base-pairing five or more bases away from the 6mer (e.g., BOLL,
cluster 10 in Fig. 2-4A) while others preferred decreased base-pairing (e.g., PTBP3).
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Figure 2-4: RNA secondary structural preferences of RBPs
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Figure 2-4
(A) The log2(Pulldown 𝑃paired/Input 𝑃paired) for the most enriched pulldown library over
each position of the top 6mer plus 10 flanking positions on each side; RBPs are grouped
by motif clusters in Fig. 2-2A and from greatest to least mean log2(Pulldown 𝑃paired/Input
𝑃paired) over the top 6mer from top to bottom within each cluster.
(B) Mean change (log2) in 𝑃paired over each position of the top 6mer at different concentra-
tions of NUPL2 (top) and PRR3 (bottom) relative to the input library.
(C) Enrichment of the top 6mer of NUPL2 (top) and PRR3 (bottom) in 5 bins into which
all 6mers were assigned based on their average 𝑃paired.
(D) Top: Three types of structural contexts considered and the percentage of all 6mers
and RBNS 6mers (top 6mer for each of 78 RBPs) found in each context in pulldown reads.
Bottom: Log-fold change of the top 6mer’s recalculated 𝑅 among 6mers restricted to each
structural context relative to the original 𝑅.
(E, F) Left: Percentage of each position of the top 6mer found in the four structural ele-
ments for RBM22 (E) and ZNF326 (F) in pulldown reads. Structure logo for top 6mer is
shown above. Right: Representative MFE structures of the top 6mer pairing with the 5’
sequencing adapter (gray) for 6mers found at the most enriched positions within the random
20mer (RBM22, position 5; ZNF326, position 6).
(G) Enrichment of the percentage of pulldown vs. input reads containing hairpin loops of
various lengths, separated by RBPs that contain (𝑛 = 13) vs. do not contain (𝑛 = 65) at
least one KH domain. Lengths with significant differences determined by Wilcoxon rank-sum
test (𝑃 < 0.05).
(H) Average 𝑃paired in random sequence for all 6mers binned by maximum 𝑅 value Z-score
across all RBNS experiments (***𝑃 < 0.0005 by Wilcoxon rank-sum test; overall Spearman
correlation = −0.18, 𝑃 < 10−22).
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Many RBPs showed varying degrees of secondary structure preferences at different posi-
tions within the top 6mer. For example, NUPL2, a protein that binds A6 motifs, strongly
disfavored structure at all positions, a pattern observed consistently at all tested protein
concentrations (Fig. 2-4B, top). By contrast, PRR3 disfavored structure at positions 1-4 of
its AUAAGC motif but actually favored higher 𝑃paired at positions 5 and 6, again consistent
across concentrations (Fig. 2-4B, bottom).
To assess the effect of secondary structure on enrichment, we recomputed 𝑅 values for all
6mers considering only occurrences of the 6mer in five structure bins ranging from unpaired
(average 𝑃paired < 0.2 over the 6 positions) to paired (average 𝑃paired ≥ 0.8) (Fig. 2-4C,
Methods). Consistent with the pattern observed in Fig. 2-4B, PRR3’s top 6mer was most
highly enriched in a moderately structured context (𝑃paired 0.2-0.4, Fig. 2-4C, bottom)
while NUPL2’s top 6mer was most highly enriched in the least structured context (𝑃paired
0-0.2, Fig. 2-4C, top). For PRR3 and NUPL2, the 𝑅 values of the top 6mer were 3- and
4-fold higher, respectively, in the most enriched 𝑃paired bin relative to the least enriched
bin, underscoring the impact of RNA secondary structure on affinity. Similar magnitudes of
enrichment were observed between 𝑃paired bins for many other proteins (full listing in Table
S4).
2.3.9 RNA structural elements influence binding of some RBPs
Specific RNA structures are known to affect RBP binding in pre-mRNA splicing (Warf and
Berglund [2010]), mRNA decay (Goodarzi et al. [2012]), and mRNA localization (Rabani
et al. [2008]). To identify preferences for specific structures, we classified each RNA base
in the analyzed pulldown and input reads as being part of a stem, hairpin loop, interior
loop, or multiloop based on the ensemble of predicted structures (Kerpedjiev et al. [2015]).
Averaging over all 78 proteins in pulldown sequences, we found that within hairpin loops the
top RBNS 6mers were about two-fold overrepresented compared to all 6mers, while within
stems the top RBNS 6mers were about two-fold underrepresented on average (Fig. 2-4D,
top). Correspondingly, the top 6mers of many RBPs were more enriched in a loop context
(Fig. 2-4D, bottom), including RBPs of clusters 7, 8, 11, 14, and almost all members
of cluster 15. Fewer RBP motifs were preferentially enriched in bulged stem (9 RBPs) or
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stem (8 RBPs) contexts, with generally more modest increases in enrichment than seen in
hairpin loops (all enrichments reported in Table S4). Among the strongest bulged stem- and
stem-preferring RBPs were the core spliceosomal protein RBM22 (Fig. 2-4E) - which binds
catalytic RNA structural elements in the spliceosome and makes direct contacts with the
U6 snRNA Internal Stem Loop and intron lariat (Rasche et al. [2012], Zhang et al. [2017]) -
and the zinc-finger protein ZNF326 (Fig. 2-4F). RBM22 favored a structure with two bases
bulged out of a stem while ZNF326 favored a stem within the random region and one base
bulged out of its reverse complement paired sequence in the adapter. Unlike most other
RBPs, the motifs for these two proteins showed uneven distributions along sequence reads,
with increased frequency at the 5’ end of the random sequence (Fig. 2-S4B), and they were
commonly predicted to base-pair with the 5’ adapter. Examining patterns of enrichment
manually, we found evidence that RBM22 prefers AC as the bulged bases, as shown (Fig. 2-
4E), while ZNF326 may simply favor an extended duplex structure independent of sequence.
We also observed a link between RBD type and structural element preference. Large
hairpin loops were strongly preferred by 10/13 KH-containing RBPs (all but the FUBP
family), while non-KH RBPs showed much more modest preferences for hairpin loops (Fig.
2-4G). Given that most (7/10) of these RBPs contain more than one KH domain, it is
possible that relatively large hairpin loops allow binding of multiple KH domains to the
RNA as has been observed in a crystal structure of NOVA1 (Teplova et al. [2011]) and in
SELEX analysis of PCBP2 (Thisted et al. [2001]).
For RBPs for which we had corresponding eCLIP data (𝑛 = 26), we observed a high
correlation between RNA secondary structure preferences in vitro and in vivo (Fig. 2-S4C).
While most RBPs avoided structure in both assays, RBPs that were found to prefer struc-
tured or partially structured motifs in RBNS, such as SFPQ, showed this same preference
in vivo.
A natural question raised by our observation above that human RBPs preferentially
bind a small subset of motifs is why RBPs have evolved to bind this particular subset of
motifs. While various factors may have contributed to this pattern, we noted a difference in
RNA structure. Analyzing RNA folding in random RNAs (Fig. 2-4H) or in fragments of
human introns or exons (see Discussion), we noted that 6mers with higher maximal RBNS
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enrichment amongst the 78 experiments were even less structured than 6mers with lower
maximal enrichment (overall Spearman correlation = −0.18, 𝑃 < 10−22). Given that most
RBPs prefer binding to unstructured motif instances, as observed previously and above
(e.g., Fig. 2-4A), this observation suggests that many RBPs have evolved specificity for
motifs that are intrinsically less structured and therefore have greater numbers of accessible
occurrences in the transcriptome.
2.3.10 Many RBPs favor pairs of short, spaced motifs
Although structural studies have described a variety of ways that RBDs engage RNA, it is
generally thought that a single RBD (e.g., an RRM or KH domain) makes contacts with
3-5 contiguous RNA bases (Auweter et al. [2006]). More than half of the factors in this
study contain multiple RBDs (Fig. 2-1B) and/or multiple types of RBDs, raising the
possibility that these RBPs can interact with pairs of short motifs spaced one or more bases
apart, hereafter referred to as “bipartite motifs”. For example, NMR structures of MSI1’s
individual RRMs 1 and 2 revealed that they bind GUAG and UAG, respectively, leading to a
structural model where both RRMs together bind the sequence UAGN(0−50)GUAG (Iwaoka
et al. [2017]), and several other examples of RBPs binding to bi- or tripartite motifs have
been reported (reviewed in Afroz et al. [2015]), raising the question of how widespread this
pattern is.
RBNS is well-suited for the unbiased identification of bipartite motifs as the complexity
of the RNA sequence space and the depth of sequencing allow sufficient statistical power
to quantify enrichments of longer, spaced 𝑘mers. We computed enrichments for motifs
composed of two 3mer “cores” separated by spacers of 0-10 nt, with spacing 0 representing
a traditional contiguous 6mer motif (Fig. 2-1A, Methods). Since motifs with different
spacings have equal information content (6 positions × 2 bits/position = 12 bits), they
can be readily compared. We identified many RBPs that bound bipartite motifs, including
PCBP2, ELAVL4, and CELF1, which have been previously reported to bind tandem C-rich,
U-rich, and UGU(U/G) sequences, respectively (Teplova et al. [2010], Wang and Tanaka Hall
[2001], Teplova et al. [2010]). We found that DAZAP1, which contains two RRMs, preferred
AUA followed by another AUA-containing core spaced by 1-3 nucleotides, with no particular
74
preference for any of the four bases in the spacer (Fig. 2-5A). RBM45, which contains three
RRMs, bound two AC-containing cores separated by a spacer of 1-3 nucleotides, with a
slight bias against Gs in the spacer (Fig. 2-5B). Analysis of all 78 factors revealed that
almost one-third of RBPs bound bipartite motifs with similar or greater affinity than linear
6mers, with 18 RBPs showing a significant preference for a bipartite over linear motif at a
5% FDR (Fig. 2-5C, Table S5, Methods). A complementary analysis testing the preference
for specific pairs of spaced cores rather than the aggregate profile over multiple pairs of cores
revealed evidence for binding of bipartite motifs for 13 additional RBPs, including several
that have been previously reported to bind tandem short sequences (NOVA1 (Teplova et al.
[2011]), UNK (Murn et al. [2016]), and the PTB family (Oberstrass et al. [2005])) (Fig.
2-S5A).
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Figure 2-5: Many RBPs bind bipartite motifs or prefer flanking nucleotide com-
positions
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Figure 2-5
(A, B) Top: Sequence logos of bipartite motifs for DAZAP1 (A) and RBM45 (B). Bottom:
Nucleotide composition of the spacer between both motif cores (left) and enrichment as a
function of the spacing between cores (right).
(C) Core spacing preferences of all RBPs. Each row indicates the relative enrichment as a
function of the spacing between cores for a given RBP (i.e., enrichments normalized to the
maximum in each row). A box indicates the spacing with maximal enrichment for that RBP,
and * to the right of the RBP name signifies the non-zero spacing is significantly preferred
over the best linear 6mer. RBPs are grouped by motif clusters in Fig. 2-2A.
(D) Pearson correlation between the maximum identity of RBDs of the same type within an
RBP and the similarity between the core motifs of the best bipartite motif. Only RBPs with
a significant preference for spacing greater than 0 in C and those with at least two RBDs of
the same type were used.
(E, F) Flanking nucleotide compositional preferences surrounding the top five NOVA1 (E)
and FUBP3 (F) 5mers. Reads with no secondary motifs were centered around the top 5mer
and the enrichment for each nucleotide in protein-bound reads relative to input reads was
calculated (Methods). Inset: mean enrichments across all positions flanking the motif for
each of the four nucleotides.
(G) Flanking nucleotide compositional preferences of all RBPs. Each row displays the en-
richment or depletion for each nucleotide surrounding the RBP’s top five 5mers. Boxes
indicate significant enrichment (log2(enrichment) > 0.1 and 𝑃 < 0.001, Methods).
(H) Enrichments of HNRNPK’s top 10 linear 6mers (right) and top 10 degenerate sequences
of length 12 with 6 Ns (left).
(I) Filter assay validation of HNRNPK binding to the oligo
UUU(CCUCUCUUUUCC)UUU (blue) and the oligo U12 (black) as a negative control (Meth-
ods). Dot-blot of filter assay shown on top with fraction of RNA bound quantified below.
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As expected, preference for spacing was associated with the presence of more than one
RBD (Fig. 2-S5B, 𝑃 = 0.023, 𝑡−test), although several exceptions were observed. For
example, KHDRBS2 showed the strongest preference for a bipartite motif even though it
contains a single KH domain (Fig. 2-S5B). However, KHDRBS2 also has an N-terminal
QUA1 (Quaking-1) domain, a domain which has been shown to promote homodimerization
of some STAR (Signal Transduction and Activation of RNA) family proteins (Beuck et al.
[2012], Meyer et al. [2010]). Thus, KHDRBS2 may bind bipartite motifs as a homodimer.
We also observed several proteins whose affinity for RNA continuously increased with
longer spacers (e.g., TAF15 and ESRP1 in cluster 15 of Fig. 2-5C), some of which may result
from multimerization. For example, FUS, a factor that displayed increasing enrichments as
a function of spacing, has a C-terminal RG-rich domain that has been shown to promote
cooperative binding to RNA (Schwartz et al. [2013]). Notably, EWSR1, a FUS paralog
that is a member of the FET (FUS, EWSR1, TAF15) family and has a similar domain
composition, displayed the same preference for increased spacing, suggesting it may also
multimerize through low-complexity domains (Schwartz et al. [2015]).
We noted that the two RNA cores bound by MSI1 were nearly identical and that MSI1’s
two RRMs were highly similar at the amino acid level (∼47% identity). In contrast, SFPQ
favored a bipartite motif consisting of two very different RNA cores, and its RBDs were much
less similar (∼22% identical). Expanding this observation to all RBPs that preferred spaced
motifs and contain at least two RRM, KH, or ZNF domains, we observed a strong positive
correlation between the percent identity of sibling RBDs within a protein and the similarity
of the bipartite motif RNA cores (Fig. 2-5D, Pearson correlation = 0.64, 𝑃 < 0.01). These
observations support the model that most binding of bipartite motifs in the set of RBPs
analyzed involves engagement of RNA by more than one RBD. Furthermore, our observation
that many bipartite cores are highly similar to one another is supported by the recent finding
that RRMs within the same protein are often the result of recent RRM duplications and
therefore highly similar to one another (Tsai et al. [2014]).
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2.3.11 RNA sequence context commonly influences RBP binding
It has previously been observed that binding of certain transcription factors may be enhanced
by a particular nucleotide composition adjacent to a high-affinity motif (Jolma et al. [2013])
and that such flanking nucleotide biases are also seen around motifs within ChIP-seq peaks
(Wei et al. [2010]). We hypothesized that adjacent nucleotide context could play a similar
role in modulating RBP specificity by altering local RNA secondary structure or creating
additional interactions with the RBP. One such example is Argonaute-2, which preferentially
binds miRNA target sites in an AU-rich context, a feature often used to predict miRNA
targeting efficacy (Agarwal et al. [2015], Grimson et al. [2007], Nielsen et al. [2007]). For each
RBP, we computed the enrichment of each nucleotide at all positions in reads surrounding
a high-affinity motif, using only those reads containing one of the top five 5mers and no
secondary motifs (Methods).
We found 28 proteins with a significant preference for a particular flanking nucleotide
composition (mean log2(enrichment) > 0.1, 𝑃 < 10−3 by Wilcoxon rank-sum test, Table S5,
Methods). For example, NOVA1 preferred to bind its motif in a C-rich context (Fig. 2-5E)
while FUBP3 preferred to bind its motif in a U-rich context (Fig. 2-5F). We noted an en-
richment for RBPs with KH domains within this set (𝑃 < 10−3, Fisher’s exact test), as seen
for factors that prefer binding to RNAs within hairpin loops (Fig. 2-4G). While particular
flanking nucleotide compositions may be correlated with the presence of large hairpin loops,
we observed a majority of these flanking nucleotide compositional preferences even after con-
trolling for the secondary structure context of the motif, suggesting that nucleotide context
effects and secondary structure can each contribute to binding (Fig. 2-S5C). In most cases,
this nucleotide preference was dependent on the presence of a motif in the read, suggesting
that flanking sequence promotes or stabilizes RBP binding to a primary motif. However,
some RBPs showed these same nucleotide preferences in the absence of a high-affinity mo-
tif (e.g., FUS and IGF2BP1, Fig. 2-S5D), suggesting that these factors have affinity for
degenerate sequences with biased nucleotide content.
To formalize these observations and test cases in which biased sequence composition
may better describe an RBP’s specificity than a linear motif, we calculated enrichments for
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degenerate patterns with biased nucleotide composition. For example, HNRNPK, one of
the RBPs that showed a preference for C bases in the absence of a high-affinity 𝑘mer, was
far more enriched for the degenerate pattern CNCNCNCNNNCC (enriched 2.9-fold) than
the corresponding contiguous 6mer CCCCCC (1.11-fold) with identical information content.
In fact, HNRNPK showed greater or equal enrichments for various permutations of the
above degenerate pattern (6 Cs with 6 interspersed Ns) relative to the most highly enriched
linear 6mers (Fig. 2-5H). We generalized this observation by calculating enrichments for all
degenerate patterns composed of 6 fixed bases and 6 Ns for each RBP (Methods) and found
that HNRNPK had higher enrichment for many C-rich degenerate patterns than for its best
linear motifs of equal information content (Fig. 2-S5E). Most other RBPs such as RBFOX2
strongly preferred specific linear sequences over degenerate patterns (Fig. 2-S5E).
Because binding of RBPs to such degenerate patterns has not been extensively studied,
we sought to confirm the preference of HNRNPK for a degenerate sequence, CCNCNC-
NNNNCC, containing no motif longer than two bases. Substituting U at the N positions
in order to avoid creating RNA secondary structure or other potential motifs, we validated
that HNRNPK specifically bound RNAs containing this pattern using a filter binding assay
(Fig. 2-5I). These degenerate patterns were also enriched more than two-fold relative to
linear 6mers in HNRNPK eCLIP peaks, supporting in vivo binding of such sequences (Fig.
2-S5F). In all, we identified 17 RBPs whose binding was well-described by degenerate pat-
terns, 14 of which bound spaced motifs (Fig. 2-5C) and were often enriched for patterns
similar to their previously identified bipartite motifs (e.g., CELF1, Fig.2-S5G). However, at
least three RBPs showed enrichment for patterns with no more than 2 contiguous specified
bases (e.g., FUBP1, HNRNPK, PUF60; FUBP1 is shown in Fig. 2-S5H). These patterns
may therefore represent degenerate bi- or tripartite motifs, with multiple RBDs each con-
tacting just one or two RNA bases.
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2.3.12 Towards a more complete characterization of RBP specifici-
ties
Our observation of widespread preferences for secondary structure features, bipartite motifs,
and flanking nucleotide composition led us to hypothesize that RBPs favoring similar primary
sequence motifs may differ in their preferences for these secondary contextual features in
order to select different subsets of targets. For example, PCBP2 and RBM23 (cluster 12)
both bind C-rich sequences even though they have distinct RBD composition (3 KH domains
versus 2 RRMs). Our analyses indicated that PCBP2 avoids structure within its motif, is
capable of binding the bipartite motif CCCNNCCC, and is enriched for flanking C bases. In
contrast, RBM23 has no structural preference over its motif and favors a contiguous C-rich
motif with no flanking nucleotide compositional preference. Thus, PCBP2 and RBM23 are
likely to bind distinct C-rich sites in transcripts.
In order to systematically compare the contributions of these features, we computed
“feature-specific” 𝑅 values for the top 6mer of a cluster. These feature-specific 𝑅 values
measured an RBP’s 6mer enrichment as a function of: i) 𝑃paired of the 6mer; ii) the average
base-pairing probability of the sequence flanking the 6mer (𝑃flank); or iii) the nucleotide
frequencies surrounding the 6mer (Methods). Feature-specific 𝑅 values for bipartite motifs
were calculated based on the pattern of preference for spacing between the split motif cores
(analogous to Fig. 2-5C). We then measured a correlation-based distance between feature-
specific 𝑅 value profiles for pairs of RBPs within the same motif cluster (Fig. 2-S6A).
Intra-cluster pairwise distances were significantly higher than distances calculated between
replicate RBNS experiments at different RBP concentrations for 𝑃paired, flanking nucleotide
content, and bipartite motifs. This analysis suggests that RBPs with similar primary motifs
are often differentially affected by contextual features (Fig. 2-6A).
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Figure 2-6: RBPs that bind similar motifs often diverge in sequence context pref-
erences
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Figure 2-6
(A) Pairwise distances (1 - Pearson correlation) of feature-specific 𝑅 values for pairs of RBPs
within a motif cluster (“Intra-cluster”) compared to distances between controls (“Reps”),
where controls are replicate assays of the same RBP performed on different days and at
different protein concentrations. Significance determined by Wilcoxon rank-sum test (*𝑃 <
0.05, **𝑃 < 0.005, ***𝑃 < 0.0005).
(B) Overall dispersal of specificities between cluster 1 RBPs for RNA motif UAAUUA. 𝑥-
and 𝑦- axes represent the degree to which secondary structure over (𝑥) and flanking (𝑦) the
motif affect UAAUUA 𝑅 values. Coloring of circle denotes whether the protein displayed a
significant enrichment for flanking nucleotide composition, with gray denoting none. Split
semicircles indicate whether the protein had significant preference for a bipartite motif over
a linear motif with the distance between the semicircles reflecting the preferred spacing of
the cores, and no separation indicating preference for linear motif.
(C) From left to right: UAAUUA 𝑅 value for each RBP in cluster 1; 𝑅bipartite/𝑅linear 6mer
if a bipartite motif was significantly preferred in Fig. 2-5C; the ratio of maximum 𝑅 to
minimum 𝑅 for feature-specific 𝑅 values over 5 context bins for each of the context features
𝑃paired, 𝑃flank, and flanking nucleotide composition.
(D) Top: Same as B for cluster 9 RBPs relative to RNA motif UUUUUU.
(E) Mean and standard error of the log2 ratio in 𝑃paired over non-overlapping UUUUU occur-
rences and the 5 nucleotides directly up- and downstream in: Top: RBNS pulldown relative
to input; Middle: Intronic eCLIP peaks relative to randomized peak locations; Bottom: 150
nt of intron downstream of exons with increased inclusion upon RBP knockdown relative to
same regions downstream of control exons. Significance determined by Wilcoxon rank-sum
test (*𝑃 < 0.05, **𝑃 < 0.005, ***𝑃 < 0.0005).
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To visualize protein preferences for each of the four features among RBPs within the same
cluster, we placed RBP markers (consisting of paired semicircles) on a coordinate system
according to their structural preferences 𝑃paired and 𝑃flank, colored each RBP marker based
on its flanking nucleotide preferences, and separated the semicircles based on the bipartite
spacer preferences (Methods). This visualization of RBPs within the AU-rich cluster 1
revealed that no two RBPs are superimposed in this multidimensional sequence space (Fig.
2-6B), and divergences were observed within most other clusters as well (Fig. 2-S6B).
Overall, we found that 9/15 clusters diverged significantly in at least one feature, and 5/15
diverged in more than one feature with the most common significant feature being bipartite
motif spacing (Table S6). This analysis therefore divides RBP clusters into those likely to
bind distinct sites and those likely to compete for binding to the same target sites when
coexpressed.
To systematically compare the effects of these contextual features on RBP affinities, we
examined the 𝑅 value differences between the most and least favored motif occurrences for
each feature. As shown in Fig. 2-S6C, the ratio of the most to least favored context for the
structure of the motif, the structure flanking the motif, and the nucleotide context for each
RBP varied from close to 1.0 for features that did not affect an RBP’s motif enrichment
to over 10-fold for the 𝑃paired context of HNRNPH2, which strongly favored unstructured
occurrences of its G6 motif. Considering the AU-binding RBPs of cluster 1 as an example,
KHDRBS2 had an 𝑅 value for its bipartite motif that was ∼20% above that of the top con-
tiguous 6mer. The context features with the greatest effects on binding were the nucleotide
context flanking KHDRBS2 motifs and structure over PRR3 motifs with ∼3.5- and 2.5-fold
increases in 𝑅 for the most versus least favored contexts, respectively (Fig. 2-6C, Fig. 2-
S6D). Overall, structure over the motif typically had the greatest impact on 𝑅 values, with
a mean 2.2-fold difference between the most and least favored 𝑃paired bins, while the 𝑃flank
and flanking nucleotide composition had mean 1.7- and 1.9-fold differences, respectively. To-
gether, these context effects appear to impact the overall specificity and affinity of this and
other RBPs in the cluster significantly (Fig. 2-6C, left; Fig. 2-S6C, bottom). In summary,
we find that the specificity of most RNA binding proteins is conferred not only by primary
sequence elements but also by a variety of contextual properties of the local RNA sequence
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environment.
It is worth emphasizing here that because in our assay binding of an RBP to a specific
𝑘mer pulls down an entire oligo containing many other 𝑘mers, the 𝑅 value greatly underes-
timates the affinity of the RBP for the 𝑘mer relative to background. Applying a formalism
to estimate quantitative differences in affinity from 𝑅 values that we introduced previously
(Lambert et al. [2014]), we have that an 𝑅 value of 1.5 for a 6mer within a 20mer oligo corre-
sponds to ∼7-fold increased affinity above background, while an 𝑅 value of 4 corresponds to
∼45-fold increased affinity. Thus, the ∼1.5- to 3.5-fold increases in 𝑅 value seen for various
context features above generally indicate increases in affinity of severalfold or more.
Finally, we sought to determine if the contextual features observed in vitro could help
proteins discriminate among potential regulatory targets in vivo. We focused on comparison
of HNRNPC and TIA1 as they had the following desirable features: (1) both have well-
established roles in regulating splicing and KD/RNA-seq yields RNA splicing maps consistent
with these roles (Fig. 2-S3A); (2) both have available in vivo binding (eCLIP) data where
the eCLIP-derived motif is identical to the RBNS-derived motif (Fig. 2-S3E); and (3) they
have distinct in vitro context preferences despite sharing the same top 5mer U5 (Fig. 2-
6D). The two context features most divergent between HNRNPC and TIA1 were structure
over the motif (𝑃paired) and flanking it (𝑃flank), with HNRNPC showing a stronger bias
against structure in both locations via RBNS (Fig. 2-6E, top). Examining eCLIP peaks
for each factor, we also observed a stronger bias against structure for HNRNPC than for
TIA1 on and flanking U5 motifs in eCLIP peaks (Fig. 2-6E, middle). Furthermore, we also
observed a stronger bias against structure on and flanking U5 motifs located downstream of
HNRNPC-regulated exons than for TIA1-regulated exons (Fig. 2-6E, bottom). Thus, the
contextual features identified by our in vitro assay appear to help distinguish in vivo binding
and regulatory locations of different factors that recognize the same primary motif.
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2.4 Discussion
2.4.1 Towards an RNA processing parts list of RNA elements and
RBPs
A substantial body of work has aimed to catalog functional RNA elements and their inter-
acting proteins to gain a more complete and mechanistic understanding of RNA processing
in cells. For example, analysis of 𝑘mer frequency and evolutionary conservation in specific
regions of the genome has led to the appreciation that many cis- sequences are associated
with specific types of regulation (Fairbrother et al. [2002], Ke et al. [2011]), even when the
trans-acting RBPs that bind them are not always known. Here, we characterized 78 hu-
man RBPs using a high-throughput version of RBNS, a one-step in vitro binding assay that
assesses the spectrum of RBP primary sequence binding specificities along with contextual
features that influence binding such as secondary structure, bipartite motifs, and flanking
nucleotide content.
2.4.2 RBPs recognize a small subset of the available sequence space
Considering a diverse set of 78 proteins, we found that many RBPs bind a relatively small,
defined subset of primary RNA sequence space rich in low-complexity motifs primarily com-
posed of just one or two bases. This trend was seen independently for RRM and KH domain
proteins that do not share common ancestry, suggesting convergent evolution toward recogni-
tion of these types of motifs. These findings are consistent with previous studies implicating
AU-, U-, and G-rich sequences as functional elements that regulate stability and splicing
(Fu and Ares Jr [2014], Wu and Brewer [2012]). Previous studies have shown certain mono-
and dinucleotide-rich sequences occur in clusters to mediate their effects on RNA processing
(Barreau et al. [2006], Cereda et al. [2014]). These motifs also have lower propensity to form
secondary structures that might block RBP binding, both in random sequences (Fig. 2-4H)
and in sequences from the human transcriptome (Fig. 2-S6E). Thus, greater average acces-
sibility for binding may have favored evolution of RBP specificity towards a set of motifs.
Binding modes involving sliding of RBPs along RNA may also favor low complexity motifs.
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For example, HNRNPC was shown to bind runs of uridines with a potential to slide among
registers within an RNA (Cieniková et al. [2014]). Such a sliding model would be most feasi-
ble for mono- or dinucleotide repeat motifs, while more complex motifs would likely require
the RBDs to completely dissociate from the RNA between specific binding interactions.
A similar analysis of DNA binding proteins and transcription factors (not shown) revealed
that they do not show the same inherent propensity to target low complexity sequences, per-
haps due to differences in the size of the search space and differences in DNA and RNA
structure and the biochemical mechanism of binding (Jolma et al. [2013]). While the over-
lapping specificity across the 78 RBPs is high, we found that 18 of the 78 profiled RBPs have
motifs dissimilar from that of any other RBP assayed (‘Unclustered’ in Fig. 2-2A), suggest-
ing that a subset of RBPs may have evolved to recognize more distinct sets of RNA targets.
These 18 RBPs tended to have broader expression profiles across human tissues than did
RBPs within motif clusters, while RBPs with motifs shared by other RBPs were more often
expressed tissue-specifically (Fig. 2-S6F). Thus, some members of the same clusters may
serve redundant functions in different cell or tissue types. Even so, coexpression of many
members of a cluster appears widespread, and this is likely to provide versatile opportunities
for post-transcriptional gene regulatory networks and evolution (Lapointe et al. [2017]).
2.4.3 RBP binding specificities harbor hidden complexity
Closer analysis of the complexity of RBNS data revealed that linear sequence motifs are
often insufficient to fully capture RBP binding specificities, with sequence features beyond
short motifs contributing to the specificity of most RBPs (Fig. 2-S6C). We find that nearly
all RBPs have strong preferences for or more often against RNA secondary structure, and
about half of RBPs were identified as favoring noncontiguous ‘bipartite’ motifs. While the
most common representation of RBP binding sites is a single position weight matrix (PWM),
our data suggest that in many cases RBP specificity may be better described by pairs of
short motifs with variable spacing, and sometimes by representations describing structural
preferences. We hypothesize that these context preferences may be general features that
allow RBPs with similar motifs to select distinct targets in cells, a paradigm that has been
put forth for pairs of RBPs (Smith et al. [2013]).
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In assaying a number of RBPs containing RRM, KH, and zinc finger domains, we noted
several commonalities across RBPs with similar RBDs. For example, RRMs and ZNFs were
identified that bound to A-, C-, G- and U-rich motifs, while KH domains bound A-, C- and
U-rich but not G-rich motifs, in agreement with previous structural studies showing that
G-recognition by KH domains is rare (reviewed by Nicastro et al. [2015]). Further, while
many motif clusters included RBPs from all three RBD types analyzed (Fig. 2-2A), 5mer
enrichments were more highly correlated among RBPs with the same RBD type relative to
RBPs with different RBD types, even after excluding paralogs (Fig. 2-S6G), suggesting
greater residual similarity in binding preferences.
We also noted domain-specific trends among preferences for contextual features. For ex-
ample, while RBPs overwhelmingly preferred unstructured motifs both in vitro (Fig. 2-4A)
and in vivo (Fig. 2-S4C), ZNFs bound motifs encompassing a wide range of secondary struc-
ture contexts including those with greater stem content (Fig. 2-S6H), and RBPs containing
ZNFs showed greater variability in their 𝑃paired preferences than did other RBPs (Fig. 2-
S6I). These observations are consistent with a recent study finding that more than twenty
ZNF-containing proteins selectively bound highly-structured pre-microRNAs (Treiber et al.
[2017]). Proteins with KH domains also shared numerous properties, including a preference
for binding to large hairpin loops, flanking nucleotide compositional preferences, and com-
mon preference for bipartite motifs. Notably, all but one KH-containing RBP assayed by
RBNS (SF1) had either more than one KH domain or a known homodimerization domain,
suggesting that binding of RNA by pairs of KH domains is very common.
Together, our findings emphasize the complexity of the interactions between proteins and
RNA and motivate future studies of the structural basis of the dependence on the various
contextual features documented here.
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2.5 Supplementary Figures
Figure 2-S1: RBNS assay and comparison to RNAcompete.
(A) Histogram of the number of unique reads sequenced in all RBNS Input and Pulldown
libraries, with the ∼250,000 RNAcompete oligo sequences marked for comparison.
(B) 10th-90th percentile range of the mean base-pairing probability (𝑃paired) for all 5mer
occurrences (averaged over all five positions) in RBNS input libraries and the RNAcompete
custom array. The 1,024 5mers are sorted along the 𝑥-axis by increasing median RBNS
𝑃paired.
(C) Dendrogram of clustered RBNS (red) and RNAcompete (black) experiments for the 31
RBPs that were assayed by both methods. Clustering was performed via the hclust function
in R (with ‘method=average’) on the pairwise Pearson correlations of 5mer 𝑅 Z-scores, for
the set of 306 5mers that were enriched (𝑍 ≥ 3) in any of the 62 experiments.
(D) Histogram of Pearson correlations of RBNS and RNAcompete for the 31 RBPs assayed
by both methods as described in C.
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Figure 2-S2: Overlapping specificities of RBPs
(A) Number of unique top 6mers among random subsamplings of the RBNS experiments
versus randomly selected 6mers (similar to Fig. 2-2C), for the subset of 78 RBNS experi-
ments that excludes any paralogs (left) or any RBPs that share at least 40% identity among
any RBDs (right).
(B) Similar to Fig. 2-2C and Fig. 2-S2A, but for the top 15 6mers of each RBNS experi-
ment instead of just the top 6mer. Black line determined from sets of 15 6mers in which the
top 6mer was chosen at random, with the remaining 14 6mers matching the edit distances
relative to the top 6mer observed among actual RBNS experiments (Methods).
(C) Mapping of the four nucleotide frequencies in motif logos onto a 2D simplex, for both the
actual 78 RBNS motifs (left), simulated RBNS motifs (center), and the resulting enrichment
of RBNS versus simulated motifs in each simplex partition (right) (Methods). Gray boxes
denote that none of the 78 RBNS motif frequencies mapped to that partition. Significance
along margins of the enrichment simplex was determined by bootstrap Z-score (number of
asterisks = Z-score). The data in the top and bottom rows is the same, with the A and C
corners of the simplex switched so that each of the six dinucleotide combinations (AC, AG,
AU, CG, CU, GU) is included along an edge in at least one of the two mappings. Upper
right simplex is the same as Fig. 2-2F.
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Figure 2-S3: RBNS-derived splicing and stability RNA maps and RBP binding in
the transcriptome
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Figure 2-S3
(A) Summary of RBNS-inferred regulatory activity of RBPs in pre-mRNA splicing and
mRNA levels.
Left (Splicing): From left to right: All RBPs assayed by both RBNS and KD/RNA-seq,
ordered from top to bottom by RBNS motif (same ordering as in Fig. 2-2A); a bar denoting
KD in HepG2/K562; the top RBNS motif logo as in Fig. 2-2A; a bar denoting whether
there were significantly more SEs included upon KD (pink) or excluded upon KD (blue); the
inferred RBNS regulatory activity of the RBP over the SE and upstream and downstream
250 nt of flanking intron (Methods), with strength of RBNS splicing regulatory activity of
significant regions noted by green (ESE/ISE) or red (ESS/ISS) heat map; total number of
SEs changing in each direction upon KD.
Right (mRNA levels): Similar to Left (Splicing), but for inferred activity on gene expression
levels based on RBNS motif density in the 3’ UTRs of genes significantly up- or down-
regulated upon KD (Destab.=increased RBNS density in 3’ UTRs of genes up-regulated
upon KD; Stab.=increased RBNS density in 3’ UTRs of genes down-regulated upon KD).
(B) Similar to Fig. 2-3F right, but for SRSF5 KD in K562 (left) and HepG2 (right) cells.
(C) Comparison of RBNS and eCLIP motifs for RBPs assayed by both techniques (repro-
duced with permission from (Van Nostrand et al. [2017])). The top RBNS and eCLIP motifs
are shown for each RBP (Methods), clustered by RBNS motif as in Fig. 2-2A. 17 of the 26
RBPs with significant overlap in the 5mers comprising the RBNS and eCLIP logos (𝑃 < 0.05,
hypergeometric test) marked with a star to the right of the eCLIP logo.
(D) Left: Enrichment of RBNS 5mers (averaged among all RBNS 5mers with Z-score ≥ 3)
in eCLIP peaks that occur in both replicates (peaks overlap by at least 1 position) relative
to peaks that occur in only one replicate. Right: Enrichment of RBNS 5mers (averaged
among all RBNS 5mers with Z-score ≥ 3) in eCLIP peaks that occur in both HepG2 and
K562 (peaks overlap by at least 1 position) relative to peaks that occur in only one cell type.
(E) Genome browser snapshot of a portion of the 3’ UTR of the 𝑆𝑇𝑂𝑀 gene and eCLIP
entropies (log2(IP density/input density)) for TIA1 and HNRNPC bound to two different
locations in this region. Instances of U5 motifs shown in top track (red) and eCLIP peaks
are marked in black below each entropy track. Motifs derived from RBNS and eCLIP peaks
for each RBP shown on the left.
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Figure 2-S4: In vitro and in vivo structural preferences of RBPs and distribution of
enrichments across reads
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Figure 2-S4
(A) Top: 𝑃paired over each position averaged over the 78 RBPs; 95% confidence interval is
shadowed. Bottom: Mean 𝑃paired in the most enriched pulldown library over the top 6mer
plus 10 flanking positions on each side; RBPs are grouped by motif clusters in Fig. 2-2A.
Right: Mean change (log2) in pulldown vs. input 𝑃paired averaged over the top 6mer.
(B) The frequency of the top RBNS 6mer at each position of the random region, relative to
a uniform distribution at all positions (top: RBPs with random 20mers; bottom: random
40mers). Difference from uniform denoted by the green heat map bar to the right, calcu-
lated as the KL-divergence of the observed frequency at each position relative to a uniform
distribution; RBPs are sorted by decreasing difference. RBPs and their top 6mers noted on
left, with ZNF326 and RBM22 marked as the 1st and 3rd most unequal distributions across
20mers, respectively.
(C) Correlation of 𝑅 value profiles of the top 5mer across five bins of increasing 𝑃paired for
RBPs assayed by both RBNS (𝑥-axis) and eCLIP (𝑦-axis). For each assay, 𝑅 was calculated
in each of the 5 𝑃paired bins (as in Fig. 2-4C) and the monotonicity of 𝑅 over the 5 bins was
calculated (-10 monotonicity = 5 bins monotonically decreasing 𝑅 with increasing 𝑃paired; 10
monotonicity = 5 bins monotonically increasing 𝑅 with increasing 𝑃paired).
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Figure 2-S5: Bipartite core spacing, flanking nucleotide composition, and degen-
erate pattern binding preferences
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Figure 2-S5
(A) Enrichment (log2) as a function of the spacing between pairs of cores (3mers) for NOVA1
(top), UNK (middle), and PTBP3 (bottom). Individual 3mer pairs are shown in blue, and
the average across all pairs is shown in gray (analogous to Fig. 2-5A-B).
(B) Relative preference for spacing (Methods) grouped by whether RBPs have a single
RBD, multiple RBDs, or have been shown to multimerize in the literature with the domain
responsible for multimerization included in the RBNS construct. 𝑃 -value determined by
𝑡-test.
(C) Flanking nucleotide compositional preferences for RBPs with KH domains, with and
without controls for RNA secondary structure. “Matched 𝑃paired” contains motif occurrences
that are sampled to have the same mean base-pairing probability in the input and pulldown
libraries. “Motifs in hairpin” contains motif occurrences that have the 5-letter code “HHHHH”
in the minimum free energy structure in both the input and pulldown libraries.
(D) Enrichment for particular nucleotides in reads with no high-affinity motifs for FUS (top)
and IGF2BP1 (bottom).
(E) Enrichments for degenerate patterns of length 12 with 6 fixed bases shown for HNRNPK
(top) and RBFOX2 (bottom). Only the top 5% of degenerate patterns are shown and the
red lines indicate the enrichment of the linear 6mers. For HNRNPK, degenerate patterns
where 5 out of the 6 fixed positions are C are in blue.
(F) Enrichment of HNRNPK motifs in eCLIP data. Linear: top 10 6mers; Bipartite: top 10
spaced 6mers; Degenerate: top 10 degenerate 12mers with 6 Cs (those shown in Fig. 2-5H
left).
(G, H) Enrichments for top 10 degenerate 12mers with 6 Ns for CELF1 (G) and FUBP1
(H).
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Figure 2-S6: Sequence context effects on RBP binding
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Figure 2-S6
(A) Example of the distance between feature-specific 𝑅 value profiles for PCBP2 and RBM23
for 𝑃paired.
(B) Dispersal of specificities as in Fig. 2-6B for all other clusters.
(C) From bottom to top: 𝑅 value for the ‘exemplar’ 6mer for each RBP (6mer denoted to
the left of each cluster), 𝑅bipartite/𝑅linear 6mer if a bipartite motif was significantly preferred
in Fig. 2-5C; the ratio of maximum 𝑅 to minimum 𝑅 for feature-specific 𝑅 values over 5
context bins for each of the context features (𝑃paired, 𝑃flank, and flanking nucleotide compo-
sition).
(D) For cluster 1 RBPs bound to UAAUUA, from left to right: 𝑅 by 𝑃paired bin (as in Fig.
2-4C); 𝑅 by 𝑃flank bin; and 𝑅 by nucleotide context bin.
(E) Mean average 𝑃paired over 6mers in RBNS input 20mers and human transcript regions (5’
UTR, 3’ UTR, CDS, Intron), separated by whether the 6mer is a homopolymer (‘1 base’),
contains two distinct bases (‘2 bases’), or contains three or four distinct bases (‘Complex’).
(F) Tissue specificity of gene expression profile in 40 human tissues from the GTEx con-
sortium for RBPs within a motif cluster versus those unclustered. 𝑃 -value determined by
Wilcoxon rank-sum test.
(G) Distribution of Pearson correlations of the 𝑅 Z-scores of top 5mers for RBPs within
the same motif cluster, separated by RBP pairs that have different RBD types (left) or the
same RBD type (right: all RBPs; center: no paralogs). The 𝑅 Z-scores of the top 18 5mers
(i.e., the median number of enriched 5mers over all RBPs) for each RBP pair were used, and
RBPs with only 1 RBD type were included. **𝑃 < 0.05 by Wilcoxon rank-sum test.
(H) Change in stem content (= 𝑓stem,PD× log2(𝑓stem,PD/𝑓stem,IN), where 𝑓stem,PD is shown for
RBM22 and ZNF326 in Fig. 2-4E-F) averaged over the top 6mer of each RBP, separated
by RBPs that do vs. do not contain a ZNF. 𝑃 -value determined by Wilcoxon rank-sum test.
(I) Comparison of differences in 𝑃paired preferences among pairs of RBPs (|𝑃paired ratioRBP1
- 𝑃paired ratioRBP2|, where 𝑃paired ratio is 𝑃paired,PD/𝑃paired,IN averaged over the top 6mer as
shown in the right bar of Fig. 2-S4A), separated by RBPs that do vs. do not contain a
ZNF. 𝑃 -value determined by Wilcoxon rank-sum test.
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2.6 Methods
2.6.1 Cloning of RNA binding protein domains
In most cases, RBPs were selected from a curated set of high-confidence annotations consist-
ing of factors with well-defined RNA binding domains or with previous experimental evidence
of RNA binding (Van Nostrand et al. [2017]). Regions of each protein containing all RBDs
plus ∼50 amino acids flanking the RBD were cloned into the pGEX6 bacterial expression
construct (GE Healthcare). A list of all constructs generated and primer sequences used is
given in Table S1.
2.6.2 Bacterial expression and protein purification
Transformed Rosetta Cells (Novagen) were cultured in SuperBroth until optical density
reached 0.6, cultures were transferred to 4∘C and allowed to cool. Protein expression was in-
duced for 14-20 hrs with IPTG at 15∘C. Cells were pelleted, lysed (Qproteome Bacterial Pro-
tein Prep Kit, Qiagen) for 30 min in the presence of protease inhibitor cocktail (Roche), son-
icated and clarified by centrifuging at >8,000 rpm, passed through a .45 𝜇M filter (GE), and
purified using GST-sepharose in either column format (GST-trap FF, GE) or 96-well format
(GSTrap 96-well Protein Purification Kit, GE). Generally, 250 mL bacterial cultures used for
column purifications and 50 mL for 96-well plate purifications (note: 8 wells of a 96-well plate
were used per protein so that up to 12 proteins were purified per plate at a time). Eluted
proteins were concentrated by centrifugation (Amicon Ultra-4 Centrifugal Filter Units) and
subjected to buffer exchange (Zeba Spin Desalting Columns, 7K MWCO, Life Technologies)
into Final Buffer (20 mM Tris pH 7, 300 mM KCl, 1 M DTT, 5 mM EDTA, 10% glycerol).
Proteins were quantified using Bradford Reagent (Life Technologies), and purity and quality
of protein was assessed by PAGE followed by Coomassie staining (all gels are available
at https://www.encodeproject.org/search/?type=Experiment&assay_title=RNA+Bind-N-
Seq&assay_title=RNA+Bind-n-Seq).
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2.6.3 Production of random RNAs by in vitro transcription
Single-stranded DNA oligonucleotide and random template were synthesized (Integrated
DNA Technologies) and gel-purified as previously described (Lambert et al. [2014]). Synthe-
sis of random region of the template DNA oligo was hand-mixed to achieve balanced base
composition. An oligo matching the T7 promoter sequence was annealed to the random
template oligo by mixing in equal parts, bringing it to 70∘C for 2 min, and allowing it to
cool by placing at room temperature.
T7 Template:
CCTTGACACCCGAGAATTCCA(N)20GATCGTCGGACTGTAGAACTCCCTATAGTGAGTCGTA
T7 oligo: TAATACGACTCACTATAGGG
RNA was synthesized by transcribing 6 𝜇L of 25 𝜇M annealed template and T7 oligo in a 100
𝜇L reaction (Hi-Scribe T7 transcription kit (NEB) according to manufacturer’s protocol) or
with a custom protocol using T7 polymerase (NEB) for larger-scale preps. RNAs were then
DNase-treated with RQ1 (Promega) and subjected to phenol-chloroform extraction. RNA
was suspended in nuclease free water and resolved on a 6% TBE-Urea gel (Life Technologies).
RNA was excised and gel-extracted as previously reported (Lambert et al. [2014]). RNA was
aliquoted and stored at -80∘C.
Final transcribed RNA with sequencing adapters:
GGGGAGUUCUACAGUCCGACGAUC(N)20UGGAAUUCUCGGGUGUCAAGG
2.6.4 RNA Bind-n-Seq Assay
All steps of the following binding assay were carried out at 4∘C. Dynabeads MyOne Strep-
tavidin T1 (Thermo) were washed 3X in binding buffer (25 mM tris pH 7.5, 150 mM KCl,
3 mM MgCl2, 0.01% tween, 500 𝜇g/mL BSA, 1 mM DTT). 60 𝜇L of beads per individual
protein reaction were used. 60 𝜇L RBP diluted (see below for protein concentrations used)
in binding buffer were allowed to equilibrate for 30 minutes at 4∘C in the presence of 60 𝜇L
of washed Dynabeads MyOne Streptavidin T1. After 30 min of incubation, 60 𝜇L of random
RNA diluted in binding buffer was added, bringing the total reaction volume to 180 𝜇L. The
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final concentration per reaction of each of the components was 1 𝜇M RNA; 5, 20, 80, 320
or 1300 nM of RBP; and 60 𝜇L of Dynabeads MyOne Streptavidin T1 stock slurry washed
and prepared in binding buffer. Each reaction was carried out in a single well of a 96-well
plate. After 1 hr, RBP-RNA complexes were isolated by placing 96-well plate on a magnetic
stand for 2 min. Unbound RNA was removed from each well and the bound RNA complexes
were washed with 100 𝜇L of wash buffer (25 mM tris pH 7.5, 150 mM KCl, 0.5 mM EDTA,
0.01% tween). Immediately after adding wash buffer the plate was placed on the magnet
and wash was removed after ∼1 minute. This procedure was repeated 3 times. RBP-RNA
complexes were eluted from Dynabeads MyOne Streptavidin T1 by incubating reaction at
room temperature for 15 minutes in 25 𝜇L of elution buffer (4 mM biotin, 1x PBS), the elu-
ate was collected, the elution step was repeated, and eluates were pooled. RNA was purified
from elution mixture by adding 40 𝜇L AMPure Beads RNAClean XP (Agencourt) beads and
90 𝜇L of isopropanol and incubating for 5 minutes. 96-well plate was placed on a magnetic
stand and supernatant was discarded. Beads were washed twice with 80% ethanol, dried, and
RNA was eluted in 15 𝜇L of nuclease-free water. The extracted RNA was reverse transcribed
into cDNA with Superscript III (Invitrogen) according to manufacturer’s instructions using
the RBNS RT primer. To prepare the input random library for sequencing, 0.5 pmol of the
RBNS input RNA pool was also reverse transcribed. To make Illumina sequencing libraries,
primers with Illumina adapters and sequencing barcodes were used to amplify the cDNA by
PCR using Phusion DNA Polymerase (NEB) with 10-14 PCR cycles. PCR primers always
included RNA PCR 1 (RP1) and one of the indexed primers as previously reported (Lambert
et al. [2014]). PCR products were then gel-purified from 3% agarose gels and quantified and
assessed for quality on the Bioanalyzer (Agilent). Sequencing libraries for all concentrations
of the RBP as well as the input library were pooled in a single lane and sequenced on an
Illumina HiSeq 2000 instrument.
2.6.5 RNA Bind-n-Seq data processing and motif logo generation
RBNS 𝑘mer enrichments (𝑅 values) were calculated as the frequency of each 𝑘mer in the
pulldown library reads divided by its frequency in the input library; enrichments from the
pulldown library with the greatest enrichment were used for all analyses of each respective
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RBP. Mean and standard deviation of 𝑅 values were calculated across all 4𝑘 𝑘mers for a
given 𝑘 to calculate the RBNS Z-score for each 𝑘mer.
RBNS motif logos were made from following iterative procedure on the most enriched
pulldown library for 𝑘 = 5: the most enriched 𝑘mer was given a weight equal to its enrichment
over the input library (=𝑅-1), and all occurrences of that 𝑘mer were masked in both the
pulldown and input libraries so that stepwise enrichments of subsequent 𝑘mers could be used
to eliminate subsequent double counting of lower-affinity ‘shadow’ 𝑘mers (e.g., only GGGGA
occurrences not overlapping a higher-affinity GGGGG would count towards its stepwise
enrichment). All enrichments were then recalculated on the masked read sets to obtain
the resulting most enriched kmer and its corresponding weight (=stepwise 𝑅-1), with this
process continuing until the enrichment Z-score (calculated from the original 𝑅 values) was
less than 3. All 𝑘mers determined from this procedure were aligned to minimize mismatches
to the most enriched 𝑘mer, with a new motif started if the 𝑘mer could not be aligned to the
most enriched 𝑘mer in one of the following 4 ways: one offset w/ 0 mismatches (among the
4 overlapping positions); 1 offset w/ 1 mismatch; no offset w/ 1 mismatch; 2 offsets w/ 0
mismatches. The frequencies of each nucleotide in the position weight matrix, as well as the
overall percentage of each motif, were determined from the weights of the individual aligned
𝑘mers that went into that motif; empty unaligned positions before or after each aligned 𝑘mer
were given pseudocounts of 25% each nucleotide, and outermost positions of the motif logo
were trimmed if they had had unaligned total weight >75%. To improve the robustness
of the motif logos, the pulldown and input reads were each divided in half and the above
procedure was performed independently on each half; only 𝑘mers identified in corresponding
motif logos from both halves were included in the alignments to make the final motif logo
(weight of each 𝑘mer averaged between the two halves). In Fig. 2-2A, only the top RBNS
motif logo is shown if there were multiple (all motifs displayed on the ENCODE portal within
the “Documents” box of each experiment, with the proportion of each motif logo determined
by computing the relative proportion of each motif’s composite 𝑘mer weights). Motif logos
were made from the resulting PWMs with Weblogo 2.0 (Crooks et al. [2004]). In addition to
those displayed for 5mers with a Z-score=3 cutoff, for comparison motif logos were also made
using: 5mers with Z-score=2 cutoff, 6mers with Z-score=2 cutoff, and 6mers with Z-score=3
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cutoff; additionally, different rules of when to start a new logo vs. add to an existing one
were tried. Logos for 5mers with Z-score=3 cutoff and the rules for starting a new motif
described above appeared to strike the best balance of capturing a sufficient number of 𝑘mers
to accurately represent the full spectrum of the RBP’s binding specificity but did not create
a number of secondary, largely similar motifs, and thus these parameters were used across
all 78 RBPs.
The RBNS pipeline is available at: https://bitbucket.org/pfreese/rbns_pipeline. More
specialized software is being prepared for release to coincide with publication.
2.6.6 Clustering of RBNS motifs
A Jensen-Shannon divergence (JSD)-based similarity score between each pair of top RBNS
motif logos was computed by summing the score of the 𝑗 overlapping positions between RBP
A and RBP B:
∑︁
aligned pos. 𝑖=1,...,𝑗
infoA,i × infoB,i ×
(︂
1−
√︁
JSD[
#             »
𝐴𝐶𝐺𝑈A,i|| #             »𝐴𝐶𝐺𝑈B,i]
)︂
where infoA,i is the information content in bits of motif A at position 𝑖 and
#             »
𝐴𝐶𝐺𝑈A,i is
the vector of motif A frequencies at position 𝑖 (vectors sum to 1).
This score rewards positions with higher information content (scaled from positions po-
sitions with 100% one nucleotide given maximum weight to degenerate positions with 25%
each nucleotide given zero weight) and more aligned positions (more positions 𝑗 contributing
to the summed score).
This similarity score was computed for each possible overlap of the two logos (subject
to at least four positions overlapping, i.e., 𝑗 ≥ 4), and the top score with its corresponding
alignment offset was used. The matrix of these scores were normalized to the maximum
score over all RBP pairs and clustered using the linkage function with centroid method in
scipy.cluster.hierarchy to obtain the dendrogram shown in Fig. 2-2A, with the 15 RBP
groupings derived from a manually-set branch length cutoff.
This branch length cutoff was chosen to balance the competing interests of maximizing
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the number of paralogous proteins within the same cluster (more stringent cutoffs elim-
inated PCBP4 from the cluster containing PCBP1 and PCBP2; it also did not include
RBM4 and RBM4B to be in a cluster) and minimizing differences between primary mo-
tifs within the same cluster (less stringent cutoffs included the distinct UAG- containing
MSI1/UNK/HNRNPA0 motifs within the same cluster as the AU-rich RBPs, for example).
2.6.7 Comparison with RNAcompete
5mer scores were derived from publicly available 7mer Z-scores by computing the mean
across all 7mers containing a given 5mer (http://hugheslab.ccbr.utoronto.ca/supplementary-
data/RNAcompete_eukarya/). Correlations between RBNS and RNA-compete experiments
were computed by taking the Pearson correlation of Z-scores for all 5mers which had a Z-score
≥ 3 for at least one of the 31 RBPs in common between both assays.
2.6.8 Overlap of RBNS 6mers with splicing and stability regulatory
elements
Splicing regulatory elements were taken from: ESS and ESE: Ke et al. [2011] and Rosenberg
et al. [2015]; ISE: Wang et al. [2012]; ISS: Wang et al. [2013]. 3’ UTR regulatory 6mers
were derived from Oikonomou et al. [2014]. Only 6mers with ≥100 occurrences across all
designed sequences were used (totaling 1303 6mers) in order to derive a mean 6mer score with
sufficient coverage in different contexts. 6mer repressor and activator scores were obtained
by averaging scores (log2(frequency) as described in the original manuscript) across all oligos
containing that 6mer in the low (L10) and high (H10) Dual-reporter Intensity Ratio bins,
respectively. Activator and repressor scores were averaged across both replicates (Libraries A
and B). 6mers with an overall score ≥ 0.25 were used, where regulatory score=|log2(repressor
score)-log2(activator score)|.
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2.6.9 Analysis of eCLIP for motif discovery, regulation and over-
lapping targets
eCLIP datasets were produced by the Yeo Lab through the ENCODE RBP Project and are
available at:
https://www.encodeproject.org/search/?type=Experiment&assay_title=eCLIP.
For all analyses, only eCLIP peaks with an enrichment over input ≥ 2 were used. Peaks
were also extended 50 nucleotides in the 5’ direction as the 5’ start of the peak is predicted
to correspond to the site of crosslink between the RBP and the RNA.
To produce eCLIP logos in a similar manner for comparison with RBNS logos, an anal-
ogous procedure to creating the RBNS motif logos was carried out on the eCLIP peak
sequences: the two halves of the RBNS pulldown reads were replaced with the two eCLIP
replicate peak sequences, and the input RBNS sequences were replaced by random regions
within the same gene for each peak that preserved peak length and transcript region (5’
and 3’ UTR peaks were chosen randomly within that region; intronic and CDS peaks were
shuffled to a position within the same gene that preserved the peak start’s distance to the
closest intron/exon boundary to match sequence biases resulting from CDS and splice site
constraints). The enrichment Z-score threshold for 5mers included in eCLIP logos was 2.8,
as this threshold produced eCLIP logos containing the most similar number of 5mers to that
of the Z=3 5mer RBNS logos. Each eCLIP motif logo was filtered to include only 5mers
that occurred in both corresponding eCLIP replicate logos. eCLIP motif logos were made
separately for all eCLIP peaks, only 3’ UTR peaks, only CDS peaks, and only intronic peaks,
with the eCLIP logo of those 4 (or 8 if CLIP was performed in both cell types) with highest
similarity score to the RBNS logo shown in Fig. 2-S3C, where the similarity score was the
same as previously described to cluster RBNS logos. To determine overlap significance of
RBNS and eCLIP, a hypergeometric test was performed with the 5mers in all (not just the
top) logos for: RBNS logo 5mers, eCLIP logo 5mers (for peaks in the region with highest
similiarity score to the RBNS logo), and 5mers in their intersection among the background
of all 1,024 5mers; overlap was deemed significant if 𝑃<0.05.
All eCLIP/RBNS comparisons were for the same RBP with the following exceptions in
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which the eCLIP RBP was compared to its paralogous RBNS protein: KHDRBS2 (KHDRBS1
RBNS); PABPN1 (PABPN1L RBNS); PTBP1 (PTBP3 RBNS); PUM2 (PUM1 RBNS); and
RBM15 (RBM15B RBNS).
For Fig. 2-3G, the Pearson correlation between eCLIP experiments was assessed by
computing the mean eCLIP coverage across 3’ UTRs of all genes. 3’ UTRs were split into
windows of ∼100 nucleotides and the mean base-wise coverage (eCLIP coverage divided by
input coverage) was calculated in each window. Pairs of RBPs were assigned as paralogs
according to their classification in Ensembl. Pairs of RBPs were assigned as having overlap-
ping motifs if at least 2 of their 5 top 5mers overlapped; RBPs with specificities determined
from RBNS and RNAcompete (Ray et al. [2013]) were pooled.
2.6.10 Analysis of RNA-seq datasets for regulation and RBNS Ex-
pression & Splicing Maps
RNA-seq after shRNA knockdowns of individual RBPs in HepG2 and K562 cells (two KD
and two control RNA-seq samples per RBP) were produced by the Graveley Lab as part of
the ENCODE RBP Project and are available at:
https://www.encodeproject.org/search/?type=Experiment&assay_title=shRNA+RNA-seq.
Splicing changes upon KD were quantified with MATS (Shen et al. [2012]), considering
only skipped exons (SEs) with at least 10 inclusion + exclusion junction-spanning reads and
a Ψ between 0.05 and 0.95 in the averaged control and/or KD samples. SEs that shared a
5’ or 3’ splice site with another SE (i.e., those that are part of an annotated A3’SS, A5’SS,
or Retained Intron) were eliminated. If multiple pairs of upstream & downstream flanking
exons were quantified for an SE, only the event with the greatest number of junction-spanning
reads was used. SEs significantly excluded or included upon KD were defined as those with
a 𝑃 -value < 0.05 and |∆Ψ| ≥ 0.05. Control SEs upon KD were those with a 𝑃 -value=1 and
|∆Ψ| ≤ 0.02.
Differentially expressed genes upon KD were called from DEseq2 (Love et al. [2014]),
considering genes that had a ‘baseMean’ coverage of at least 1.0 and an adjusted 𝑃 -value <
0.05 and | log2(FC)| ≥ 0.58 (1.5-fold up or down upon KD). Candidate control genes upon
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KD were taken from those with a 𝑃 -value > 0.5 and | log2(FC)| ≤ 0.15; from this set of
genes, a subset matched to the deciles of native (i.e., before KD) gene expression levels of
the differentially expressed genes was used. The last 50 nt of each gene’s ORF and 3’ UTR
sequence were taken from the Gencode version 19 transcript with the highest expression in
the relevant cell type (HepG2 or K562).
‘RBNS splicing maps’ were made by taking the three sets of SEs included, excluded,
or control upon KD and extracting their exonic and upstream/downstream flanking 250 nt
sequences. At each position of each event, it was determined whether the position overlapped
with one of the top 10 RBNS 5mers for that RBP in any of the five registers overlapping
the position. Then to determine if the RBNS density was significantly higher or lower for
included/excluded SEs at a position relative to control SEs at that position, the number
of positions in a 20 bp window on each side (total 41 positions) covered by RBNS motifs
was determined for each of the events, with significance determined by 𝑃 -value<0.05 in a
Wilcoxon rank-sum test on the control vs. changed events in the desired direction upon KD.
Exonic regions were deemed to have ESE or ESS RBNS regulatory activity if 20 of the 100
exonic positions among SEs excluded or included upon KD, respectively, had significantly
higher RBNS motif coverage than control SEs. The upstream and downstream intronic
regions were each individually deemed as ISE or ISS regions if 50 of the 250 intronic positions
had significantly higher RBNS motif coverage. For each significant region for each RBP,
the ratios of log2(RBNS density over changing SEs/RBNS density over control SEs) of all
significant positions in that region were summed, and the maximum value was normalized
to 1 over all RBPs.
‘RBNS stability maps’ were made in an analogous manner, but for genes up- or down-
regulated compared to control genes upon KD. The 3’ UTR sequence was divided into 100
segments of roughly equal length and the proportion of positions covered by RBNS motifs
in each segment were used for each bin of the meta-3’ UTR. An RBP was deemed to have
significant RBNS regulatory activity if 10 of the 100 positions of the meta-3’ UTR for up-
or down-regulated genes had increased RBNS density relative to control genes.
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2.6.11 Generation of random sets of ranked 6mer lists with edit
distances to top 6mer matching RBNS
Because the ranked lists of top enriched 𝑘mers (e.g., the top 15 6mers) are highly constrained
depending on what the most enriched 𝑘mer is (e.g., 6mers 2-15 are typically Hamming
distance of 1 and/or shifted by 1 from the top 6mer), as background sets for comparison
to actual RBNS 6mer lists we sought to create groups of 6mers that matched the observed
RBNS patterns of Hamming distances and shifts from the top 6mer for any given randomly
selected 𝑘mer. To do this, for each of the 78 RBNS experiments we first calculated the edit
distance from 6mer𝑖 to 6mer1, where 6mer1 is the most enriched 6mer and 𝑖=2, ..., 15 is the
𝑖th enriched 6mer (e.g., 6mer8 might have a mismatch at position two compared to 6mer1
and then be shifted to the right by 1 position). Then, for all 4,096 starting 6mers, we created
78 ranked lists of 15 6mers, each of which matched the observed edit distances to the top 15
list of an actual RBNS experiment. The expected number of network edges in Fig. 2-2B,
and the ‘random’ number of edges in Fig. 2-2D were performed by selecting random lists
from these 4,096×78 possibilities.
2.6.12 RBNS RBP groups without paralogs or RBPs with any RBD
pair sharing 40% identity
∙ No Paralogs (𝑛 =52):
A1CF, BOLL, CELF1, CNOT4, CPEB1, DAZ3, EIF4G2, ELAVL4, ESRP1, EWSR1,
FUBP1, HNRNPA2B1, HNRNPC, HNRNPK, HNRNPL, IGF2BP1, ILF2, MBNL1,
NUPL2, PABPN1L, PRR3, PTBP3, PUM1, RBFOX2, RBM15B, RBM22, RBM23,
RBM24, RBM25, RBM4, RBM41, RBM45, RBM47, RBM6, RBMS2, RC3H1, SF1,
SFPQ, SNRPA, SRSF10, SRSF11, SRSF2, SRSF4, SRSF8, TARDBP, TIA1, TRA2A,
TRNAU1AP, UNK, ZCRB1, ZFP36, ZNF326
∙ No RBPs sharing >40% identity among any RBDs (𝑛 =47):
A1CF, BOLL, CELF1, CNOT4, CPEB1, EIF4G2, ELAVL4, EWSR1, FUBP3, HN-
RNPA0, HNRNPCL1, HNRNPDL, HNRNPH2, HNRNPL, IGF2BP1, ILF2, KHDRBS3,
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MBNL1, NOVA1, NUPL2, PABPN1L, PCBP2, PRR3, PTBP3, PUF60, PUM1, RB-
FOX3, RBM15B, RBM22, RBM24, RBM25, RBM41, RBM45, RBM4B, RBM6, RBMS2,
SFPQ, SNRPA, SRSF11, SRSF8, SRSF9, TARDBP, TIA1, TRA2A, TRNAU1AP,
ZFP36, ZNF326
Pairwise RBD alignments were performed using ClustalW2 (Larkin et al. [2007]) and
percent identities (as shown in Fig. 2-1C and Fig. 2-5D) were calculated as the percentage
of identical positions relative to the number of ungapped positions in the alignments.
2.6.13 Network map of overlapping affinities
The lists of top 15 6mers for each RBP were intersected to get the number in common
- those with 2 or more were deemed significant and connected by an edge (𝑃 < 0.05 by
hypergeometric test, as well as by simulations based on the empirical distribution from
random sets of ranked 6mer lists with edit distances to top 6mer matching RBNS as described
above). The resulting network was visualized with Cytoscape (Shannon et al. [2003]).
2.6.14 Motif entropy analysis
To construct a set of ‘simulated’ motifs that matches the overall nucleotide composition
of the 78 RBNS motifs but removes any positional correlations within a motif, individual
columns of each RBNS motif (including all motifs for an RBP if there was more than one)
were pooled to be sampled from. A ‘simulated’ motif was constructed by randomly sampling
5 or 6 columns (with probability 2/3 and 1/3, respectively, to roughly match the lengths of
RBNS motifs) from this pool and concatenating them, repeated to construct 100,000 shuffled
motifs.
The frequency of the four bases in each logo was calculated by averaging over all positions
in the motif. This frequency vector (=[f𝐴, f𝐶 , f𝐺, f𝑈 ], f𝐴+f𝐶+f𝐺+f𝑈=1) was mapped onto a
square containing corners at [+/-1, +/-1] using two different orderings of the 4 corners, which
together contain all 6 dinucleotide combinations (AC, AG, AU, CG, CU, GU) as edges:
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1. Purine/Pyrimidine diagonals:
A U
C G
?⃗? =
⎡⎣−1
1
⎤⎦
?⃗? =
⎡⎣−1
−1
⎤⎦
?⃗? =
⎡⎣ 1
−1
⎤⎦
?⃗? =
⎡⎣1
1
⎤⎦
2. Purine/Pyrimidine edges:
C U
A G
?⃗? =
⎡⎣−1
−1
⎤⎦
?⃗? =
⎡⎣−1
1
⎤⎦
?⃗? =
⎡⎣ 1
−1
⎤⎦
?⃗? =
⎡⎣1
1
⎤⎦
To map the frequency vector to its coordinates (𝑢, 𝑣) within the unit circle, the frequency
vector was normalized to the largest component:
𝐹 = [𝐹𝐴, 𝐹𝐶 , 𝐹𝐺, 𝐹𝑈 ] = [𝑓𝐴/𝑓max, 𝑓𝐶/𝑓max, 𝑓𝐺/𝑓max, 𝑓𝑈/𝑓max],
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where 𝑓max = max(𝑓𝐴, 𝑓𝐶 , 𝑓𝐺, 𝑓𝑈), and (𝑢, 𝑣) was computed as:
|𝐹 | =
√︁
𝐹 2𝐴 + 𝐹
2
𝐶 + 𝐹
2
𝐺 + 𝐹
2
𝑈⎡⎣𝑢
𝑣
⎤⎦ = 𝐹𝐴?⃗? + 𝐹𝐶?⃗? + 𝐹𝐺?⃗? + 𝐹𝑈 ?⃗?√
2× |𝐹 |
The elliptical grid mapping was used to convert the (𝑢, 𝑣) coordinates within the unit
circle to the corresponding position (𝑥, 𝑦) within a square containing corners at [+/-1, +/-1]:
⎡⎣𝑥
𝑦
⎤⎦ =
⎡⎣12 (︁√︀2 + 𝑢2 − 𝑣2 + 2√2𝑢−√︀2 + 𝑢2 − 𝑣2 − 2√2𝑢)︁
1
2
(︁√︀
2− 𝑢2 + 𝑣2 + 2√2𝑣 −
√︀
2− 𝑢2 + 𝑣2 − 2√2𝑣
)︁
⎤⎦
The simplex grid shown was divided into 11 equal parts along both dimensions, and the
density in each of the 121 squares was computed for the 78 RBNS motifs and 100,000
shuffled motifs to get enrichments.
To determine significance via bootstrapping, 1,000 different shuffled motif distributions
over the grid were computed. In each of the 1,000 bootstraps, the 100,000 shuffled motifs
were drawn from a different starting pool of motif columns: rather than all 78 RBPs’ motifs
contributing once to the pool, a random sampling (with replacement) of the 78 RBPs was
performed, and those motifs’ columns served as the starting pool for the 100,000 shuffled
motifs. The mean and standard deviation of these 1,000 bootstraps were computed for each
margin, and margins for which the density of the 78 RBNS motif logos had a Z-score greater
than 2 were marked significant (number of asterisks = Z-score, rounded down).
2.6.15 RNA secondary structure analysis
The RNA base-pairing probability was extracted from the partition function of RNAfold:
“RNAfold -p –temp=X”, where X was 4∘C or 21∘C depending on what temperature the
binding reaction was conducted at (See Table S3) (Lorenz et al. [2011]). For each pulldown
library, reads were randomly selected to match the distribution of C+G content among input
reads; all enrichments were recalculated for these C+G-matched pulldown reads for Fig. 2-4,
Fig. 2-S4, Fig. 2-6, and Fig. 2-S6. Reads were folded with the 5’ and 3’ adapters (24 and
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21 nt, respectively), resulting in folded sequences of length 65 and 85 for 20mer and 40mer
RBNS experiments, respectively.
Secondary structural element analyses were performed by using the forgi software pack-
age (Kerpedjiev et al. [2015]). For each read, to mirror the partition function rather than
relying solely on the Minimum Free Energy structure, 20 random suboptimal structures with
probabilities equal to their Boltzmann weights were sampled and averaged over (“RNAsub-
opt –temp=X –stochBT=20”). In Fig. 2-4D, 6mers counting toward: ‘loop’ were: H6, M6,
I6; ‘stem’ was S6; ‘bulged stem’ were 6mers matching the pattern SXXXXS, where XXXX
contained 1-3 S.
For Fig. 2-6A, Fig. 2-6C, Fig. 2-S6C, Fig. 2-S6D, bin limits for the motif structure
analyses (𝑃paired) were: 0-0.2 (bin 1); 0.2-0.4 (bin 2); 0.4-0.6 (bin 3); 0.6-0.8 (bin 4); and
0.8-1.0 (bin 5). Bin limits for flanking structure analyses (𝑃flank) were: 0-0.3 (bin 1); 0.3-
0.45 (bin 2); 0.45-0.6 (bin 3); 0.6-0.75 (bin 4); 0.75-1.0 (bin 5). 𝑃paired was calculated as
the average over the six positions of the 6mer; 𝑃flank was calculated as the average over all
other positions in the read. The continuous measures of preference for motif and flanking
preference for the 𝑥- and 𝑦-axes in Fig. 2-6B, Fig. 2-6D, Fig. 2-S6B were computed as:⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
−2
−1
0
1
2
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
·
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
𝑙𝑜𝑔2(𝑅bin 1/𝑅original)
𝑙𝑜𝑔2(𝑅bin 2/𝑅original)
𝑙𝑜𝑔2(𝑅bin 3/𝑅original)
𝑙𝑜𝑔2(𝑅bin 4/𝑅original)
𝑙𝑜𝑔2(𝑅bin 5/𝑅original)
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
RBNS structure profiles were compared to eCLIP structure profiles in the region with
the greatest number of eCLIP peaks. Bound RBNS motifs were selected from the tran-
scriptome region that showed the highest enrichment for the number of peaks (5’ UTR/3’
UTR/introns/CDS). Motifs that were not bound were selected from the same gene regions
as bound motifs and matched for the same genes. Motifs were folded with 50 nucleotides of
flanking sequence on both sides using RNAfold. Motifs (both bound and not bound) were
then binned by their mean base-pairing probability (same bins as RBNS), and the fraction of
bound motifs in each bin was computed. The monotonicity of 𝑅 over 𝑃paired bins for RBNS
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and eCLIP was computed by taking all 10 comparisons over the 5 bins, adding 1 if 𝑅 was
greater in the higher 𝑃paired bin or subtracting 1 if it was lower in the higher 𝑃paired bin.
The structure of 6mers in random sequences (Fig. 2-4H) was calculated by creating ran-
dom 65mers, folding them at 4∘C, and computing the mean 𝑃paired over each of the 15 6mers
within the region corresponding to the random RBNS 20mer positions (i.e., positions 25-44
of the 65mer, inclusive). The structure of 6mers in human Gencode version 19 transcript
regions (Fig. 2-S6E) was calculated by taking all consecutive 65 nt sequences (the length
of the RBNS 20mer + adapter sequences) fully within one of the four respective transcript
regions. Each 65 nt sequence was folded at 37∘C, and the mean 𝑃paired over each of the 15
6mers within the region corresponding to the random RBNS 20mer positions was calculated.
The mean 𝑃paired for each 6mer was then computed over all occurrences of that 6mer within
the given transcript region, and the 6mer was classified as being composed of “1 base” (e.g.,
GGGGGG), “2 bases” (e.g., GAGGAA), or “Complex” (3+ unique bases, e.g., UGGAGU).
2.6.16 Determination of bipartite motifs
Enrichments were computed for all pairs of the top 10 enriched 3mers, with a spacer of
length 𝑖 = 0 − 10 (in total: 10 × 10 × (𝑖 + 1) combinations), where the enrichment was
defined as the fraction of pulldown reads with a motif relative to the fraction of input reads
with a motif. The enrichment for each spacing was computed as the mean enrichment of
the 10 most enriched combinations of that particular spacing (Fig. 2-5A-B). Nucleotide
composition of the spacer (as shown in Fig. 2-5A-B) was the mean nucleotide frequency
across positions between both motif cores, relative to the corresponding nucleotide frequency
between the same motif cores the input libraries. Preference for spacing (Fig. 2-S5B) was
computed as the change in the mean enrichment for the top 10 spaced combinations (𝑖 > 0)
relative to the mean enrichment of the top 10 non-spaced combinations (𝑖 = 0, i.e., top
10 6mers): log2(enrichmentspaced/enrichmentlinear). Significance was determined by setting
a False Discovery Rate (FDR) using 0 nM control libraries as follows: samples of 10 3mer
cores were repeatedly drawn and the observed relative enrichments were used to set an FDR
at each spacing 𝑠. Motif cores were sampled such that the relationships between sampled
3mers were the same as the relationship observed for that particular protein’s enriched cores.
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2.6.17 Assessment of flanking nucleotide compositional preferences
For a given RBP, we only considered (protein-bound and input) reads that: a) contained one
of the top 5 enriched 5mers; b) contained no additional secondary motifs, where secondary
motifs were the top 50 enriched 5mers or all 5mers with 𝑅 ≥ 2, whichever set was larger. The
remaining protein-bound and input reads were then subsampled to match the distribution of
motifs and the positions of those motifs along a read. These reads were further subsampled
to match the distribution of mean base-pairing probabilities over the motif (bins used were
[0- 0.1),[0.1-0.2),...,[0.9,1.0]). For the analysis in Fig. 2-S5C, protein-bound and input reads
were instead subsetted only to reads where the motif was in a hairpin configuration (H5 in the
MFE). The flanking nucleotide enrichment was then determined by centering these reads on
the motif and computing the relative enrichment (= log2(𝑓PD,NT/𝑓IN,NT)) for each nucleotide
at each position relative to the motif. We excluded the two nucleotides immediately adjacent
to the motif on either side (to avoid capturing the extension of a core motif) as well as the
first and last position of the random region in order to avoid certain nucleotide biases that
can occur due to the presence of adaptor sequences. The overall enrichment (Fig. 2-5G) is
the mean enrichment across all assessed positions, with significance assessed by a Wilcoxon
rank-sum test.
Binding to mono- or dinucleotide rich sequence (e.g., Fig. 2-S5E) in absence of a motif
was done analogously, except only using reads that did not contain any of the top 50 5mers
or any 5mer with 𝑅 ≥ 2. Enrichments for degenerate patterns were calculated as the mean
of the 10 best degenerate 𝑘mers matching that pattern (e.g., mean of top 10/4096 12mers
matching CCNNNCCNNNCC in the example in Fig. 2-5H, 2-S5H). We first calculated
enrichments for patterns where the fixed positions (e.g., CCCCCC in the previous example)
contained only one or two nucleotides to assess which RBPs were biased towards binding
to degenerate nucleotide-rich sequences, but later performed exhaustive searches where the
fixed 𝑘mer was allowed to cover the entire sequence space (i.e., 4096 possible sequences in
fixed positions × 210=(10 choose 4) patterns with 6 fixed positions and 6 internal Ns).
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2.6.18 Filter binding assay
Filter binding assay was performed with the oligo UUU(CCUCUCUUUUCC)UUU, i.e., the
pattern CCNCNCNNNNCC flanked by Us and with Ns substituted with Us to avoid creat-
ing high-affinity motifs and ensure the oligo was void of secondary structure. The negative
control oligo used was U12. Custom RNA oligonucleotides were synthesized by IDT (Inte-
grated DNA Technologies) and RBPs were purified as described earlier (see Cloning of RNA
binding protein domains). RNA was end-labeled with 32P by incubating with Polynucleotide
Kinase (NEB) according to manufacturer protocol. The assay was done following the pro-
tocol described in (Rio [2012]) for use with a 96-well dot-blot apparatus (Biorad). RBP and
radio-labelled RNA were incubated in 50 𝜇L binding buffer (500 𝜇L 2M KCl, 10 𝜇L 1M
DTT, 400 𝜇L 40% glycerol, 200 𝜇L 1M Tris in 10 mL) for 1 hour at room temperature.
Final concentration of RNA was 1 nM and protein concentration ranged from 10 nM-10 𝜇M
(three-fold serial dilutions spanning this range).
2.6.19 Calculation of feature-specific 𝑅 values and relative entropy
of context features
Feature-specific 𝑅 values were calculated by assigning all 6mers into their respective bin for
the feature under consideration for both the pulldown and input libraries, converting the
counts into frequencies within each bin for both libraries, and computing the 𝑅 value for the
6mer under consideration using the pulldown and input bin frequencies.
For Fig. 2-6A, bins used to compute feature-specific 𝑅 values for each feature were the
following:
∙ 𝑃paired: bin 1=0-0.2; bin 2=0.2-0.4; bin 3=0.4-0.6; bin 4=0.6-0.8; bin 5=0.8-1.0
∙ 𝑃flank: bin 1=0-0.3; bin 2=0.3-0.45; bin 3=0.45-0.6; bin 4=0.6-0.75; bin 5=0.75-1.0
∙ Core spacing: bin 1 = 0 nt spacing; bin 2 = 1 nt spacing; ... ; bin 11 = 10 nt spacing,
where the spacing corresponds to the spacing between the two cores of a bipartite
motif.
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∙ Nucleotide context: 16 bins, where the first four bins are quartiles of the percentage of
A content flanking a 6mer based on the composition of input reads (bins 5-8, 9-12, and
13-16 are analogous for C, G, and U content, respectively). Each 6mer occurrence was
therefore counted 4 times, into the corresponding bin for each of the four nucleotides.
Feature-specific 𝑅 values within each bin were compared to the overall 𝑅 value of the
6mer without binning (i.e., log2(𝑅bin/𝑅original) ) to create the feature-specific enrichment
profile for a particular context feature (example for 𝑃paired for two RBPs in Fig. 2-S6A).
For Fig. 2-6C and Fig. 2-S6C-D, feature-specific 𝑅 values were computed for the
‘exemplar’ 6mer for each group (i.e., the 6mer with the lowest summed ranks among all cluster
members). The enrichments of the exemplar 6mer over five context bins were calculated for
𝑃paired and 𝑃flank as described above; the ratio of the maximum to minimum 𝑅 values over
these 5 bins for each feature was then computed. Nucleotide context bins were created using
the empirical distribution of nucleotide flanking contents for reads with the same 6mer in the
input according to: bin 1) ‘high A’ (flanking A content in the 75th percentile of input reads);
bins 2), 3) and 4) ‘high C’, ‘high G’, and ‘high U’ (analogous to high A for the respective
nucleotides); bin 5) ‘other’ (all other reads). As was done in Fig. 2-5E-G, only reads with
one exemplar 6mer and no additional high affinity 6mers (top 100 6mers) were used.
For Fig. 2-6E, RNA folding was done as described above. To determine the log2 ratio of
base-pairing probabilities, control U5 occurrences were determined as previously described for
each datatype (RBNS reads, eCLIP peaks, control exons in knockdown data). Log2(𝑃paired
ratio) values were then bootstrapped from the 𝑃paired distributions in pulldown relative to
input for each datatype, with significance assessed by a Wilcoxon rank-sum test.
2.6.20 Tissue specificity of RBP gene expression
Tissue specificity was measured as the information content deviation from a uniform distri-
bution among all tissues as in (Gerstberger et al. [2014]). For each RBP, the log2(TPM+1)
was calculated for each of the 40 GTEx tissues (GTEx Consortium [2015]), and the tissue
specificity was computed as the difference between the logarithm of the total number of
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samples (𝑁 = 40) and the Shannon entropy of the expression values for an RBP:
𝑆 = 𝐻max −𝐻obs = log2(𝑁)−
∑︁
𝑖=1,...,𝑁
[𝑝𝑖 × log2(𝑝𝑖)] ,
Where 𝑝𝑖 = 𝑥𝑖 /
(︁∑︀
𝑖=1,...,𝑁 𝑥𝑖
)︁
for 𝑥𝑖 = log2(TPM𝑖 + 1) in sample 𝑖.
The data used for the analyses were obtained from dbGaP accession number phs000424.v2.p1
in Jan. 2015. TPMs were measured using kallisto (Bray et al. [2016]) on the follow-
ing samples: Adipose-Subcutaneous: SRR1081567; AdrenalGland: SRR1120913; Artery-
Tibial: SRR817094; Bladder: SRR1086236; Brain-Amygdala: SRR1085015; Brain- Anteri-
orCingulateCortex: SRR814989; Brain-CaudateBasalGanglia: SRR657731; Brain- Cerebel-
larHemisphere: SRR1098519; Brain-Cerebellum: SRR627299; Brain-Cortex: SRR816770;
Brain-FrontalCortex: SRR657777; Brain-Hippocampus: SRR614814; Brain- Hypothalamus:
SRR661179; Brain-NucleusAccumben: SRR602808; Brain-SpinalCord: SRR613807; Brain-
SubstantiaNigra: SRR662138; Breast-MammaryTissue: SRR1084674; Cervix: SRR1096057;
Colon: SRR1091524; Esophagus: SRR1085211; FallopianTube: SRR1082520; Heart-LeftVentricle:
SRR815517; Kidney-Cortex: SRR809943; Liver: SRR1090556; Lung: SRR1081283; Mi-
norSalivaryGland: SRR1081589; Muscle-Skeletal: SRR820907; Nerve-Tibial: SRR612911;
Ovary: SRR1102005; Pancreas: SRR1081259; Pituitary: SRR1077968; Prostate: SRR1099402;
Skin: SRR807775; SmallIntestine: SRR1093314; Spleen: SRR1085087; Stomach: SRR814268;
Testis: SRR1081449; Thyroid: SRR808886; Uterus: SRR820026; Vagina: SRR1095599.
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Chapter 3
A Large-Scale Binding and Functional
Map of Human RNA Binding Proteins
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My contributions:
Analysis of comparison of in vitro and in vivo binding specificities and relationship be-
tween sequence-specific binding and regulation (Fig. 3-3, Fig. 3-S3, and Fig. 3-S4);
association between TIA1 binding and RNA expression upon KD (Fig. 3-S5e-g); methods
development of RNA splicing maps pipeline in conjunction with ELVN, GAP, and BAY
(Fig. 3-5, Fig. 3-S6, and Fig. 3-S8); integrative analysis of RBP data types in cryptic
exon suppression (Fig. 3-S1); tissue specificity of RBP expression (Fig. 3-8e, Fig. 3-S11);
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writing of text section “In vivo binding is largely determined by in vitro binding specificity”
with CBB as well as editing remainder of text.
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3.1 Abstract
Genomes encompass all the information necessary to specify the development and function
of an organism. In addition to genes, genomes also contain a myriad of functional elements
that control various steps in gene expression. A major class of these elements function only
when transcribed into RNA as they serve as the binding sites for RNA binding proteins
(RBPs) which act to control post-transcriptional processes including splicing, cleavage and
polyadenylation, RNA editing, RNA localization, translation, and RNA stability. Despite
the importance of these functional RNA elements encoded in the genome, they have been
much less studied than genes and DNA elements. Here, we describe the mapping and
characterization of RNA elements recognized by a large collection of human RBPs in K562
and HepG2 cells. These data expand the catalog of functional elements encoded in the
human genome by addition of a large set of elements that function at the RNA level through
interaction with RBPs.
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3.2 Introduction
RBPs have emerged as critical players in regulating gene expression, controlling when, where,
and at what rate RNAs are processed, trafficked, translated, and degraded within the cell.
They represent a diverse class of proteins involved in co- and post-transcriptional gene reg-
ulation (Gerstberger et al. [2014], Glisovic et al. [2008]). RBPs interact with RNA to form
ribonucleoprotein complexes (RNPs), governing the maturation and fate of their target RNA
substrates. Indeed, they regulate numerous aspects of gene expression including pre-mRNA
splicing, cleavage and polyadenylation, RNA stability, RNA localization, RNA editing, and
translation. In fact, many RBPs participate in more than one of these processes. For exam-
ple, studies on the mammalian RBP Nova using a combination of crosslinking and immuno-
preciptation (CLIP)-seq and functional studies revealed that Nova not only regulates alter-
native splicing, but also modulates poly(A) site usage (Licatalosi et al. [2008]). Moreover, in
contrast to regulation at the transcriptional level, post-transcriptional regulatory steps are
often carried out in different subcellular compartments of the nucleus (e.g. nucleoli, nuclear
speckles, paraspeckles, coiled bodies, etc.) and/or cytoplasm (e.g. P-bodies, endoplasmic
reticulum, etc.) by RBPs that are enriched within these compartments. These regulatory
roles are essential for normal human physiology, as defects in RBP function are associated
with diverse genetic and somatic disorders, such as neurodegeneration, auto-immune defects,
and cancer (Kao et al. [2010], King et al. [2012], Lagier-Tourenne et al. [2010], Nussbacher
et al. [2015], Paronetto et al. [2007], Lukong et al. [2008], Martini et al. [2002]).
Traditionally, RBPs were identified by affinity purification of single proteins (Sonenberg
et al. [1979a], Sonenberg et al. [1979b]). However, several groups have recently used mass
spectrometry-based methods to identify hundreds of proteins bound to RNA in human and
mouse cells (Baltz et al. [2012], Castello et al. [2012], Kwon et al. [2013], Brannan et al.
[2016]). Recent censuses conducted by us and others indicate that the human genome may
contain between 1,072 (Sundararaman et al. [2016]) and 1,542 (Castello et al. [2012]) RBP-
encoding genes. This large repertoire of RBPs likely underlies the high complexity of post-
transcriptional regulation, motivating concerted efforts to systematically dissect the binding
properties, RNA targets, and functional roles of these proteins.
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The dissection of RBP-RNA regulatory networks therefore requires the integration of
multiple data types, each viewing the RBP through a different lens. In vivo binding assays
such as CLIP-seq provide a set of candidate functional elements directly bound by each
RBP. Assessments of in vitro binding affinity help understand the mechanism driving these
interactions, and (as we show) improve identification of functional associations. Functional
assays that identify targets whose expression or alternative splicing is responsive to RBP
perturbation can then fortify evidence of function. For example, observation of protein
binding by CLIP-seq within introns flanking exons whose splicing is sensitive to RBP levels in
RNA-seq provides support for the RBP as a splicing factor and for the binding sites as splicing
regulatory elements. In vivo interactions of RBPs with chromatin can also be assayed to
provide insight into roles of some RBPs as transcription regulators and can provide evidence
for co-transcriptional deposition of RBPs on target RNA substrates. The regulatory roles of
RBPs are also informed by the subcellular localization properties of RBPs and of their RNA
substrates. Furthermore, these data resources comprised of multiple RBPs profiled using the
same methodology may be integrated to enable the identification of factor-specific regulatory
modules, as well as a factor’s integration into broader cellular regulatory networks, through
novel integrated analyses.
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3.3 Results
3.3.1 Overview of data and processing
To develop a comprehensive understanding of the binding and function of the human RBP
repertoire, we used five assays to produce 1,076 replicated datasets for 352 RBPs (Fig. 3-1,
Supplementary Table 1). The RBPs characterized by these assays have a wide diversity of
sequence and structural characteristics and participate in diverse aspects of RNA biology
(Fig. 3-1). Functionally, these RBPs are most commonly known to play roles in the regula-
tion of RNA splicing (96 RBPs, 27%), RNA stability and decay (70, 20%), and translation
(69, 20%), with 161 RBPs (46%) having more than one function reported in the literature.
However, 82 (23%) of the characterized RBPs have no known function in RNA biology other
than being annotated as involved in RNA binding (Fig. 3-1). Although 57% of the RBPs
surveyed contain well-characterized RNA binding domains (RNA recognition motif (RRM),
hnRNP K homology (KH), zinc finger, RNA helicase, ribonuclease, double-stranded RNA
binding (dsRBD), or pumilio/FBF domain (PUM-HD)), the remainder possess either less
well studied domains or lack known RNA binding domains altogether (Fig. 3-1). Each of
the five assays used focused on a distinct aspect of RBP activity:
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Figure 3-1: Overview of experiments and data types
The 352 RNA binding proteins (RBPs) profiled by at least one ENCODE experiment (or-
ange/red) are shown, with localization by immunofluorescence (green), essential genes from
CRISPR screening (maroon), manually annotated RBP functions (blue/purple), and anno-
tated protein domains (pink). Histograms for each category are shown on bottom, and select
RBPs highlighted in this study are indicated on left.
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∙ Transcriptome-wide RNA binding sites of RBPs: We identified and validated hundreds
of immunoprecipitation-grade antibodies that recognize human RBPs (Sundararaman
et al. [2016]) and developed enhanced CLIP (eCLIP) followed by sequencing to effi-
ciently identify RNA targets bound by these RBPs at scale (Van Nostrand et al. [2016]).
We performed eCLIP to profile 97 RBPs in K562 cells and 84 RBPs in HepG2 cells,
for a total of 126 RBPs (of which 55 were characterized in both cell types). This effort
identified 717,765 significantly enriched peaks (relative to size-matched input controls
for each RBP) that cover 16.5% of the annotated mRNA transcriptome and 2.4% of
the pre-mRNA transcriptome (Fig. 3-2d, Fig. 3-S2d).
∙ RBP-responsive genes and alternative splicing events: To obtain insight into the func-
tions of the RBP binding sites identified by eCLIP, we used shRNA- or CRISPR-
mediated depletion followed by RNA-seq of 224 RBPs in K562 and 228 RBPs in
HepG2 cells, for a total of 251 RBPs (of which 200 were characterized in both cell
types). This effort identified 223,118 instances of RBP-mediated differential gene ex-
pression involving 14,281 genes affected upon knockdown of at least one RBP as well
as 205,919 cases of RBP-mediated alternative splicing events involving 37,829 alterna-
tively spliced events impacted upon knockdown of at least one RBP.
∙ In vitro RBP binding motifs: To identify the in vitro RNA sequence and structural
binding preferences of RBPs, we developed a high-throughput version of RNA Bind-
N-Seq (RBNS, Lambert et al. [2014]) that assays binding of purified RBPs to pools
of random RNA oligonucleotides. This effort identified the binding specificities of 78
RBPs. Short oligonucleotides of length 𝑘=5 (𝑘mers) with high RBNS affinity clustered
into a single motif for about half of the RBPs assayed (37/78). The remaining RBPs
had more complex patterns of binding, best described by two motifs (32/78), or even
three or more motifs (9 RBPs). These data also indicate that many RBPs are sensitive
to the sequence and RNA structural context in which motifs are embedded.
∙ RBP subcellular localization: Post-transcriptional gene regulation occurs in different
intracellular compartments. For instance, rRNA maturation and pre-mRNA splicing
primarily occur in sub-regions of the nucleus, whereas mRNA translation and default
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mRNA decay pathways operate in the cytoplasm. To illuminate functional properties
of RBPs in intracellular space, we took advantage of our validated antibody resource
(Sundararaman et al. [2016]) to conduct systematic immunofluorescence (IF) imaging
of 274 RBPs in HepG2 cells and 268 RBPs in HeLa cells, in conjunction with a dozen
markers for specific organelles and subcellular structures. These data, encompassing
230,000 images and controlled vocabulary localization descriptors, have been organized
within the RBP Image Database (http://rnabiology.ircm.qc.ca/RBPImage).
∙ RBP association with chromatin: Recent work has suggested that RBP association
with chromatin may play roles in transcription and co-transcriptional splicing (Naftel-
berg et al. [2015], Ji et al. [2013]). To generate a large-scale resource of chromatin
association properties for RBPs, we identified the DNA elements associated with 58
RBPs in HepG2 cells and 45 RBPs in K562 cells by ChIP-seq, for a total of 63 RBPs
(of which 34 RBPs were characterized in both cell types). These experiments identified
622,443 binding locations covering 3.1% of the genome.
To facilitate integrated analyses, all data for each data type were processed by the same
data processing pipeline, and consistent, stringent quality control metrics and data standards
were uniformly applied to all experiments. Although only 8 RBPs were investigated using all
five assays, 249 of the 352 RBPs (71%) were studied using at least two different assays and 129
(37%) were subjected to at least three different assays, providing opportunities for integrated
analysis using multiple datasets. As an example of how these complementary datasets pro-
vide distinct insights into RNA processing regulation, we considered the Vascular Endothelial
Growth Factor A gene (VEGFA) (Fig. 3-2a). Although the RBPs IGF2BP1 and IGF2BP3
both showed significant binding to the VEGFA 3’ UTR, knockdown of IGF2BP1 increased
VEGFA mRNA levels, while knockdown of IGF2BP2 decreased them, pointing to opposing
regulatory effects. Knockdown of HNRNPK also yielded decreased VEGF mRNA, as well
as a significant decrease in inclusion of exon 6. This splicing event is likely directly regu-
lated by HNRNPK, as the flanking introns contain multiple HNRNPK eCLIP peaks, some
of which contain the preferred binding motif for HNRNPK (GCCCA) identified in RBNS
experiments. Similar integrated analysis can provide insight into mechanisms of cryptic exon
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repression, illustrated by HNRNPL binding to a region downstream of a GTPBP2 cryptic
exon that contains repeats of HNRNPL’s top RBNS motif, contributing to production of
GTPBP2 mRNA with a full-length open reading frame (Fig. 3-S1).
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Figure 3-2: Integrative analysis of RBP binding and function
(a) Combinatorial expression and splicing regulation of VEGFA. Tracks indicate RNA-seq
read density (as reads per million, RPM) and eCLIP relative information (in IP versus
input). Asterisk indicates significant expression changes (|log2(fold-change)| > 1 and 𝑝-value
< 0.05), and percent spliced in (Ψ) is indicated.
(b) Lines indicate the number of genes that are (green) differentially expressed upon RBP
knockdown in RNA-seq (FDR < 0.05, 𝑝-value < 0.05, and |log2(fold-change)| > 1), (blue)
bound in eCLIP, or (orange) both bound and differentially expressed in the same cell type.
The ordering of each data type was randomly shuffled 100 times, with the shaded region
indicating the tenth and ninetieth percentiles. Grey line indicates the number of genes
expressed with TPM > 1 in either K562 or HepG2.
(c-d) Lines indicate the mean of (c) the cumulative total number of bases covered by peaks,
or (d) the cumulative fraction of bases covered by peaks for 100 random orderings of the 181
eCLIP datasets, separated by transcript regions as indicated. Shaded region indicates tenth
through ninetieth percentiles.
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The scale of data available enabled us to query the degree to which we have saturated
the discovery of RBP binding sites on RNA and RBP-associated RNA processing events. In
total, 14,281 genes were differentially expressed in at least one knockdown experiment (Fig.
3-2b), including 72.8% of genes expressed in both cell types and 71.2% of those expressed in
at least one of the two (Fig. 3-S2a-b). Similarly, 11,211 genes were bound in at least one
eCLIP dataset, representing 86.1% of genes expressed in both cell types and 75.6% of those
expressed in at least one (Fig. 3-2b, Fig. 3-S2a-b). However, only 2,827 genes were both
bound by and responsive to knockdown of the same RBP, suggesting that a large fraction of
knockdown-responsive expression changes result from indirect effects and that many binding
events do not directly affect gene expression levels in the conditions assayed here (Fig. 3-2b,
Fig. 3-S2a-b). Similar analysis of alternative splicing changes revealed that differentially
spliced events were saturated to a lesser degree than differentially expressed genes. (Greater
variability in the cumulative number of unique events resulted from the large number of
splicing changes in one knockdown dataset, the RNA helicase and spliceosomal protein AQR
(Zhang et al. [2017]) (Fig. 3-S2c).)
Considering RBP binding, we observed a total of 23.4 Mb of annotated pre-mRNA tran-
scripts covered by at least one reproducible RBP binding site, representing 9.1 Mb of exonic
and 13.4 Mb of intronic sequence (Fig. 3-2c). This total represents only 1.5% of annotated
intronic sequence (1.1% of distal intronic, 2.5% of proximal intronic, and 8.9% of splice site),
but 16.5% of annotated exonic sequences (22.9% of 5’ UTR, 19.3% of CDS, and 11.4% of 3’
UTR, respectively) were covered by at least one peak (Fig. 3-2d). Restricting our analysis
to only genes expressed (TPM≥1) in both cell types resulted in substantial increases in these
percentages (Fig. 3-S2d). We found that profiling a new RBP often resulted in greater in-
creases in covered bases of the transcriptome than did re-profiling the same RBP in another
cell line, with the marginal 181st dataset averaging a 0.38% (for newly profiled RBPs) or
0.32% (for RBPs profiled in a second cell type) increase (Fig. 3-S2e-g). We additionally
observed an average 1.4% increase in covered bases when we added eCLIP datasets from H1
and H9 embryonic stem cells for RBFOX2 and IGF2BP1-3 (all of which were also profiled
in either K562 or HepG2), suggesting that substantial numbers of additional RBP binding
sites remain to be detected in cell types distinct from K562 and HepG2 (Fig. 3-S2g).
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Although these results correspond well with previous work suggesting that RNAs are
often densely coated by RBPs (Silverman et al. [2014]), it remains to be seen what fraction
of these peaks mark alternative regulatory interactions versus constitutive RNA processing.
Indeed, many may mark relative association of proteins which coat or broadly interact with
RNAs as part of their basic function (such as association of RNA Polymerase II component
POLR2G with pre-mRNAs, or spliceosomal component association with splice sites).
3.3.2 In vivo binding is largely determined by in vitro binding speci-
ficity
Binding of an RBP to RNA in vivo is determined by the combination of the protein’s
intrinsic RNA binding specificity and other influences such as RNA structure and protein
cofactors. To compare the binding specificities of RBPs in vitro and in vivo, we calculated
the enrichment or 𝑅 value of each 5mer in RBNS-bound sequences relative to input sequences
and compared it to the corresponding enrichment of the 5mer in eCLIP peaks relative to
randomized locations in the same genes (𝑅eCLIP). Significantly enriched 5mers in vitro and
in vivo were mostly in agreement, with 17 of the 26 RBPs having significant overlap in the
5mers that comprise their motif logos (Fig. 3-3a, left). The top RBNS 5mer for an RBP
was almost always enriched in eCLIP peaks (Fig. 3-3a, center). In most cases, similar
degrees of enrichment and similar motif logos were observed in eCLIP peaks located in
coding, intronic or UTR regions, suggesting that RBPs have similar binding determinants
in each of these transcript regions (Fig. 3-3a, center; Fig. 3-S3a). Strikingly, the single
most enriched RBNS 5mer occurred in 30% or more of the peaks for several RBPs including
SRSF9, TRA2A, RBFOX2, PTBP3, TIA1, and HNRNPC. For most RBPs, at least half of
eCLIP peaks contained one of the top five RBNS 5mers. Therefore, instances of these 5mers
provide candidate nucleotide-resolution binding locations for the RBP (Fig. 3-3a, right).
Such precise binding locations have a number of applications, e.g., they can be intersected
with databases of genetic variants to identify those likely to alter function at the RNA
level. When two or more distinct motifs were enriched in both RBNS and eCLIP, the most
enriched motif in vitro was usually also the most enriched in vivo (5 out of 7 cases). These
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observations are consistent with the idea that intrinsic binding specificity observed in vitro
explains a substantial portion of in vivo binding preferences for most RBPs studied to date.
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Figure 3-3: Sequence-specific binding in vivo is determined predominantly by in-
trinsic RNA affinity of RBPs
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Figure 3-3
(a) Left: Top sequence motif of RBNS versus eCLIP-derived enriched 5mers clustered by
similarity of RBNS motifs. Filled circles to the right of the eCLIP logo indicate if the groups
of 5mers comprising the RBNS and eCLIP motifs overlap significantly (hypergeometric 𝑝 <
0.05). Center: Enrichment of the top RBNS 5mer in eCLIP peaks (𝑅eCLIP) within different
genomic regions. Right: The proportion of eCLIP peaks attributed to each of the 10 highest
affinity RBNS 5mers, as well as the #11-24 RBNS 5mers combined. The black line indicates
the number of top RBNS 5mers required to explain >50% of eCLIP peaks for each RBP
(maximum, 24 5mers).
(b) Comparison of PCBP2 in vivo vs. in vitro 6mer enrichments, with 6mers containing
CCCC and GGGG highlighted. Significance was determined by Wilcoxon rank-sum test
and indicated if 𝑝 < 0.05. 𝑥- and 𝑦-axes are plotted on an arcsinh scale.
(c) Comparison of the magnitude of splicing change upon RBP knockdown for SEs containing
eCLIP peaks with vs. without the top RBNS 5mer, separated by the direction of SE change
upon KD and location of the eCLIP peak relative to the SE. Significance was determined by
Wilcoxon rank-sum test and indicated if 𝑝 < 0.05.
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For a minority of RBPs (12/26), the top five RBNS 5mers explained less than half of
eCLIP peaks. Some of these factors appear to have affinities to RNA structural features or
to more extended RNA sequence elements not well represented by 5mers (Dominguez et al.
[2017]), while the sequence-specific binding of others may be driven to a large extent by
cofactors. In some cases, RBNS revealed affinity to a subset of the motifs that were enriched
in eCLIP peaks. For example, C-rich 6mers were most enriched in RBNS data for PCBP2
and also in PCBP2 eCLIP peaks (Fig. 3-3b). In this example, and in several others, a
subset of similar eCLIP-enriched 𝑘mers were not enriched at all by RBNS (e.g., the G-rich
6mers in Fig. 3-3b). Such ‘eCLIP-only’ motifs, which were often G-, GC-, or GU-rich
(Fig. 3-S3b), may represent RNA binding of cofactors in complex with the targeted RBP
(e.g., G-rich motifs enriched near RBFOX2 peaks may represent sites bound by HNRNPF,
HNRNPH and HNRNPM in complex with RBFOX2, Mauger et al. [2008], Damianov et al.
[2016]) or could represent biases in crosslinking or in genomic sequences near eCLIP peaks
(Sugimoto et al. [2012], Hauer et al. [2015]).
The extent to which strength and mode of binding correlates with eCLIP read density
and regulatory activity is not well understood. We focused on regulation of splicing because
a large proportion of the available cell type/RBP combinations that included KD, eCLIP,
and RBNS data involved RBPs with known roles in splicing, and splicing changes could
be readily detected in the KD/RNA-seq data. For most datasets involving KD of known
splicing RBPs (18/28), eCLIP binding to one or more specific regions near alternative exons
was associated with increased splicing changes upon KD of the RBP. In contrast, this asso-
ciation was observed for only one of the seven datasets involving RBPs that lacked known
splicing functions (Fisher exact 𝑝<0.05, Fig. 3-S4a). To explore the relationship between
sequence-specific binding and regulation, we classified eCLIP peaks as RBNS+ or RBNS-
depending on whether they contained the highest-affinity RBNS motif (Methods). We then
asked whether these classes of peaks differed in their association with splicing regulation.
Examining exon-proximal regions commonly associated with splicing regulation, we found
that RBNS+ eCLIP peaks conferred stronger regulation of exon skipping - with an average
∼25% increase in |∆Ψ| than did RBNS- peaks (Fig. 3-3c). Thus, sequence-specific binding
appears to confer stronger regulation than non-sequence-specific binding, and RBNS motifs
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can be used to distinguish a subset of eCLIP peaks that has greater regulatory activity. The
in vitro data were needed to make this distinction, because a similar analysis of eCLIP peaks
classified by presence/absence of the top eCLIP-only 5mer exhibited minimal differences in
splicing regulatory activity (Fig. 3-S4b). In general, RNA binding directed by intrinsic RNA
affinity may involve longer-duration interactions that more consistently impact recruitment
of splicing machinery.
3.3.3 Functional Characterization of the RBP Map
Analysis of the knockdown/RNA-seq data enables inference of the function of some RNA
elements identified by eCLIP and RBNS. Regulation of RNA stability, which alters steady-
state mRNA levels, can be observed by an increase or decrease in mRNA expression upon
knockdown of an RBP. We compared differentially expressed genes upon RBP knockdown
with eCLIP binding to three regions of mRNAs: 5’ UTR, CDS, and 3’ UTR. We observed
that binding of 17 RBPs correlated with increased expression upon knockdown, including
RBPs with previously identified roles in induction of RNA decay (such as UPF1, XRN2,
and DDX6) (Fig. 3-4a, Fig. 3-S5a) as well as previously unknown candidates including
METAP2, a methionyl aminopeptidase which has been co-purified with poly(A)-selected
RNA but has no previously known RNA processing roles (Castello et al. [2012]). Although
METAP2 was highly bound throughout the transcriptome, CDS regions were on average 3.4-
fold enriched in METAP2 eCLIP, well above the 2.4-fold average enrichment of 3’ UTR and
1.4-fold depletion of intronic regions (Fig. 3-S5b-c). We further observed a trend in which
increasing METAP2 eCLIP fold-enrichment correlated with progressively stronger increases
in RNA expression upon knockdown, supporting an RNA regulatory role (Fig. 3-4b).
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Figure 3-4: Association between RBP binding and RNA expression upon knock-
down
(a) Heatmap indicates significance of overlap between genes significantly bound (𝑝 < 10−5
and > 4-fold enriched in eCLIP versus input) and genes significantly (top) increased or (bot-
tom) decreased (𝑝 < 0.05 and FDR < 0.05) in RBP knockdown RNA-seq experiments. Sig-
nificance was determined by Fisher’s Exact test or Yates’ Chi-Square approximation where
appropriate; * indicates 𝑝 < 0.05 and ** indicates 𝑝 < 10−5 after Bonferroni correction.
Shown are all overlaps meeting a 𝑝 < 0.05 threshold.
(b-c) Lines indicate cumulative distribution plots of gene expression fold-change (knockdown
versus control) for indicated categories of eCLIP binding of (b) METAP2 in K562 and (c)
TIA1 in K562.
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Additionally, we observed 11 RBPs for which binding correlated with decreased RNA
levels following knockdown (Fig. 3-4a), including the stress granule component TIA1. Sur-
prisingly, although our transcriptome-wide analysis indicated that transcripts with 3’ UTR
binding of TIA1 decreased upon knockdown in K562 cells (suggesting a globally stabilizing
role for TIA1) (Fig. 3-4c), little to no stabilization activity was observed for 3’ UTR-bound
mRNAs in HepG2 cells (Fig. 3-S5d). Using TIA1 RBNS motif content in 3’ UTRs rather
than eCLIP binding sites, we additionally observed cell type-specific enrichment of TIA1
motifs in destabilized transcripts upon KD in K562, with no significant effect (though a
slight motif enrichment in stabilized genes upon KD) in HepG2 (Fig. 3-S5e-g). This dis-
tinction is reminiscent of previous studies, which indicate that TIA1 can either induce RNA
decay when tethered to a 3’ UTR (Yamasaki et al. [2007]), or stabilize target mRNA levels
through competition with other RBPs including HuR (Wigington et al. [2015]). Thus, our
results provide further evidence that TIA1 can regulate mRNA stability through dynamic
cell type-specific interactions.
3.3.4 RBP association with splicing regulation
Next, we considered how localized RBP binding was associated with splicing regulation. To
do this, we generated a ‘splicing map’ for each RBP (Ule et al. [2006]), which depicts the
average RBP binding at relative positions in the regulated exon and flanking introns of exons
that show RBP-responsive splicing changes, relative to binding at non-responsive alternative
exons (Fig. 3-5a, Fig. 3-S6). Considering 57 RBPs with eCLIP and knockdown/RNA-seq
performed in the same cell line, we observed a wide variety of RNA maps (Fig. 3-5b).
Binding of SR proteins typically correlated with decreased inclusion upon knockdown and
hnRNP protein binding correlated with increased inclusion upon knockdown, consistent with
classical models of antagonistic effects of SR and hnRNP proteins on splicing (Erkelenz et al.
[2013]) (Fig. 3-S7a-b).
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Figure 3-5: Integration of eCLIP and RNA-seq identifies splicing regulatory pat-
terns
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Figure 3-5
(a) Normalized splicing maps of RBFOX2, SRSF1, and PTBP1 for cassette exons excluded
(left) and included (right) upon knockdown, relative to a set of ‘native’ cassette exons with
0.05 < Ψ < 0.95 in controls. Lines indicate average eCLIP read density in IP versus input
for indicated exon categories, with standard error shown by the shaded area. The displayed
region shown extends 50 nt into exons and 300 nt into introns.
(b) Heatmap indicates the difference between normalized eCLIP read density at cassette
exons excluded (left) or included (right) upon RBP knockdown versus native cassette exons.
Shown are all RBPs with eCLIP and knockdown RNA-seq data, with dashed lines indicating
datasets with fewer than 100 significantly altered events.
(c) As in (b), shown for alternative 3’ splice site events. Dashed lines indicate datasets
with fewer than 50 significantly altered events. The displayed regions include the upstream
common 5’ splice site (grey box), the extended alternative 3’ splice site (orange box), and
the distal alternative 3’ splice site (purple box).
(d) Lines indicate mean normalized eCLIP enrichment in IP versus input for SF3B4 and
SF3A3 at (red/purple/green) alternative 3’ splice site extensions in RBP knockdown or
(black) alternative 3’ splice site events in control HepG2 or K562 cells.
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Surprisingly, in addition to canonical alternative splicing regulators such as RBFOX2 and
PTBP1, we observed significant differential association of spliceosomal components near
knockdown-sensitive alternative splice sites (Fig. 3-5b, Fig. 3-S7c-d). For example, we
observed that comparing cassette exons to constitutive exons revealed strikingly different
binding patterns, with cassette exons characterized by increased association of 5’ splice
site machinery such as PRPF8, EFTUD2, and RBM22 at the upstream 5’ splice site but
depletion at the cassette exon 5’ splice site (Fig. 3-S7c). Branch point recognition factors
such as SF3B4 and SF3A3 showed similar depletion for the cassette exon branch point and
enrichment at the downstream branch point, leading to a distinctive pattern of spliceosomal
association at the cassette exon (Fig. 3-S7c). Moreover, when considering non-spliceosomal
RBPs we similarly observed that while RBP association was higher at cassette-bordering
proximal intron regions relative to constitutive exons, the upstream 5’ splice site and proximal
intron showed an even greater enrichment (Fig. 3-S7d). Together, these observations for
non-spliceosomal RBPs suggest that the upstream 5’ splice site of alternative exons represent
a greater source of regulatory RBP binding than previously believed.
Splicing maps were also constructed for alternative 5’ (A5SS) and alternative 3’ splice
site (A3SS) events (Fig. 3-5c). Again, we noticed differential association of spliceosomal
components (Fig. 3-5c, Fig. 3-S8a). Focusing on A3SS events, we noted a particularly
prominent pattern of association for branch point factors SF3B4 and SF3A3, which typically
bind to the branch point region ∼50 nt upstream of the 3’ splice site. For both, we observed
that enrichment was shifted downstream towards the 3’ splice site for the set of A3SS events
where the distal (downstream) 3’ splice site is preferred upon knockdown (Fig. 3-5c-d, Fig.
3-S8b). These genome-level results generalize previous mini-gene studies showing that 3’
splice site scanning and recognition originates from the branch point and can be blocked if
the branch point is moved close to the 3’ splice site AG (Bradley et al. [2012]), and suggest
that regulated branch point recognition plays a key role in A3SS regulation by restricting
recognition by the 3’ splice site machinery (Smith et al. [1993]) (Fig. 3-S8c).
In summary, the RBPs we have surveyed that participate in alternative splicing display a
wide diversity of regulatory modes. Moreover, although the target splicing events differ, the
splicing map of a given RBP is highly consistent between cell types (Fig. 3-5b-c, Fig. 3-
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S7a-b, Fig. 3-S8a). Thus, performing eCLIP and KD/RNA-seq in a single cell type may be
sufficient to elucidate the splicing map for an RBP, but multiple cell types must be surveyed
to identify the full repertoire of direct regulatory events.
3.3.5 RBP Association with Chromatin
Increasing evidence suggests that regulatory RNAs, both coding and non-coding, are broadly
involved in gene expression through their interaction with chromatin (Engreitz et al. [2016],
Skalska et al. [2017]). Based on the expectation that these regulatory events must enlist
specific RBPs participating in co-transcriptional RNA processing, we surveyed 58 RBPs in
HepG2 and 45 RBPs in K562 cells for their association with chromatin by ChIP-seq (Sup-
plementary Table 1). We selected RBPs for analysis based on their complete or partial
localization in the nucleus and on the availability of antibodies that could efficiently im-
munoprecipitate each factor. These RBPs belong to a wide range of functional categories,
including SR and hnRNP proteins, spliceosomal components, and RBPs that have been
generally considered to function as transcription factors, such as POLR2G and GTF2F1.
Interestingly, 30 of 58 RBPs (52%) in HepG2 cells and 29 of 45 RBPs (64%) in K562 cells
showed specific interactions with chromatin, with several hundred to more than ten thousand
specific binding peaks identified for each RBP.
We next characterized the RBP-chromatin interactions with respect to established chro-
matin activities, including DNase I hypersensitive sites and various histone marks (Fig.
3-6a). This analysis revealed a general preference of RBPs for euchromatic relative to het-
erochromatic regions, especially gene promoters, although individual RBPs showed distinct
preferences. Collectively, even this moderately sized set of RBPs occupied ∼30% of all DNase
hypersensitive or open chromatin regions and ∼70% of annotated gene promoters, which was
similar between the two cell types, suggesting broad involvement of RBPs in chromatin ac-
tivities in the human genome. These data provide a foundation for future investigation of
direct roles of specific RBPs in transcriptional control, exemplified by recent studies on SR
proteins (Ji et al. [2013]) and RBFOX2 (Wei et al. [2016]).
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Figure 3-6: Chromatin-association of RBPs and overlap with RNA binding
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Figure 3-6
(a) Collective RBP binding activities on specific chromatin regions, including DNase I hy-
persensitive sites and various histone marks in HepG2 and K562 cells.
(b) Percentage of RBP eCLIP peaks overlapped with corresponding ChIP-seq peaks (pink)
or percentage of RBP ChIP-seq peaks overlapped with corresponding eCLIP peaks (green).
RBPs are sorted by decreasing level of overlapped ChIP-seq peaks.
(c) Distributions of overall chromatin binding activities (green) and overlapped chromatin
and RNA binding activities (pink) of representative RBPs.
(d) Clustering of overlapped chromatin and RNA binding activities of different RBPs in
non-promoter regions. Color key indicates the degree of ChIP enrichment at eCLIP peaks
relative to surrounding regions with significance as True (𝑝 < 0.001) or False (𝑝 > 0.001)
indicating the significance of the enrichment.
(e) Cross-RBP comparison of chromatin and RNA binding activities. Top: ChIP-seq density
of indicated RBPs around PCBP2 or HNRNPK eCLIP peaks. Bottom: eCLIP density of
indicated RBPs around PCBP2 or HNRNPK eCLIP peaks.
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It is well established that a variety of RNA processing events are co-transcriptionally
coupled (Naftelberg et al. [2015]). It is therefore possible that some RBP-chromatin associ-
ation events are coupled with their direct RNA binding activities in cells. To explore this
possibility, we intersected ChIP-seq peaks with eCLIP peaks for individual RBPs in HepG2
cells, revealing specific RBPs with relatively high degrees of overlap in these two types of in-
teractions (Fig. 3-6b). Interestingly, the distribution of the overlapped regions varies among
individual RBPs. For example, the chromatin and RNA binding activities of SR proteins, as
exemplified by SRSF1, are predominantly coincident near gene promoters, while most other
RBPs show such overlapping activities further into the gene body (Fig. 3-6c). These data
revealed coordinated actions of RBPs at the chromatin and RNA levels, suggesting that a
fraction of their RNA binding events are chromatin-associated. We next sought to quantify
the similarity of each RBP pair’s chromatin and RNA binding activities by computing the
overlap in ChIP-seq and eCLIP-seq signal in non-promoter regions (Fig. 3-6d). Clustering
of the data indicated that many RBPs might function in conjunction with other RBP(s) to
coordinate their chromatin and RNA binding activities (red signals in Fig. 3-6d). Partic-
ularly interesting is the high correlation between poly(rC) binding proteins HNRNPK and
PCBP1/2, which share a common evolutionary history and domain composition yet perform
diverse functions (Makeyev and Liebhaber [2002]) (red box in Fig. 3-6d). To illustrate the
relationship between RNA and chromatin interactions, we plotted the ChIP-seq density of
these three RBPs relative to PCBP2 and HNRNPK eCLIP peaks in non-promoter regions.
We found that chromatin binding signals were typically centered around eCLIP peaks, al-
though HNRNPK and PCBP1 (to a lesser degree) were slightly biased for chromatin binding
upstream of RNA binding, indicative of a specific topological arrangement of these potential
RBP complexes on chromatin in a manner dependent on the direction of transcription (Fig.
3-6e, top panels). We next asked whether the signal overlapping eCLIP peaks was specific to
the DNA binding activity of these RBPs or if it also held for related RNA binding activities.
For this purpose, we plotted the eCLIP density of multiple RBPs relative to another RBP’s
eCLIP peaks. This analysis revealed a significant degree of overlap among the RNA binding
activities of HNRNPK and PCBP2, which contrasts to a randomly selected RBP for com-
parison (Fig. 3-6e, bottom panels). Combined, these data strongly reinforce coordinated
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chromatin and RNA binding activities of specific RBPs.
To investigate whether there is correlation between gene expression and RBP association,
we clustered the probability of each RBP’s association with genes binned by increasing
expression levels, revealing a pervasive positive correlation between gene expression and
RBP association for the majority of RBPs, with the exception of SAFB2 and SFPQ which
have only a few binding sites (Fig. 3-6f, left panels). These data implicated regulatory
roles of RBPs in gene expression through chromatin association. To pursue this point,
we compared the frequency that a gene is differentially expressed upon RBP knockdown
depending on whether or not the RBP was chromatin-associated at that gene, controlling
for the different expression levels of these two groups. We found that chromatin association
of HNRNPLL, HNRNPL, HNRNPK, and AGO1 correlated with a significantly increased
chance of gene expression change upon knockdown (Fig. 3-6f, right panels). To explore
the connection between alternative splicing regulation and RBP-chromatin association, we
calculated similar ratios for each RBP and found that RBM22 chromatin association was
associated with a significant increase in alternative splicing changes upon knockdown (Fig.
3-6f, right panels). Together, these data suggest that chromatin-association of RBPs affects
RNA processing and gene expression.
3.3.6 RBP regulatory features in subcellular space
The systematic imaging screen revealed that RBPs display a broad diversity of localization
patterns (Fig. 3-7a), with most factors exhibiting targeting to multiple structures in the
nucleus and cytoplasm (Fig. 3-7b). Next, we integrated RBP localization data with other
datasets generated here. First, we considered the nuclear relative to cytoplasmic ratios
for each RBP. As expected, we observed a significant shift towards increased binding to
unspliced transcripts for nuclear RBPs, whereas cytoplasmic RBPs were enriched for binding
to spliced transcripts (Fig. 3-S9a-b). Next, we identified a collection of 80 RBPs that
exhibit robust localization to SC35 (SRSF2)-labeled nuclear speckles, a class of subnuclear
structures enriched for proteins involved in pre-mRNA splicing (Spector and Lamond [2011]).
Consistent with the established function of speckles in splicing, analysis of splicing changes
associated with RBP depletion revealed that speckle-localized RBPs impact larger numbers
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of splicing events compared to non-speckle proteins (Fig. 3-7c). Notably, the top 12 (and 19
of the top 20) RBP knockdowns with the strongest impact on splicing (in terms of number
of altered splicing events) corresponded to speckle-localized RBPs, including spliceosomal
components U2AF1, U2AF2, SF3B4, and SF3A1 as well as splicing regulators HNRNPK
and SRSF1 (Fig. 3-7c). By contrast, nucleolar RBPs had significantly less impact on pre-
mRNA splicing than non-nucleolar RBPs, as expected (Fig. 3-7c). Furthermore, when we
queried the enrichment for RNA binding modalities in eCLIP data, we observed similarly
striking enrichment for speckle-localized RBPs binding to proximal introns as well as snRNAs
(notably RNU2 and RNU6) (Fig. 3-S9c), again consistent with nuclear speckles playing a
key role in pre-mRNA splicing.
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Figure 3-7: RBP subcellular localization, binding, and regulation
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Figure 3-7
(a) Example RBPs (green) co-localized with twelve interrogated markers (red).
(b) Circos plot with lines indicating co-observed localization patterns (red: within cytoplasm;
purple: within nucleus; orange: between cytoplasm/nucleus).
(c) Points indicate the number of differential splicing events observed upon knockdown of
each RBP, separated by the presence or absence of localization in nuclear speckles (center) or
the nucleolus (right). * indicates 𝑝 < 0.05 and ** indicates 𝑝 < 10−4 by Wilcoxon rank-sum
test.
(d) Points indicate eCLIP relative information content (IP versus input) for mitochondria
H-strand (𝑥-axis) or L-strand (𝑦-axis) for RBPs with mitochondrial localization by IF (red,
with specific RBPs noted) and all other RBPs (black).
(e) IF images of mitochondrial localization of GRSF and DHX30.
(f) Genome browser tracks indicate binding (as eCLIP relative information content) along
(top) the mitochondrial genome or (bottom) a ∼300 nt region for indicated RBPs. (right)
Inset shows RNA secondary structure prediction (RNAfold) for the indicated region in blue.
(g) Heatmap indicates gene expression change upon DHX30 knockdown for all mitochondrial
protein-coding and rRNA transcripts. * indicates significant expression changes (𝑝 < 0.05
and FDR< 0.05 from DEseq2 analysis).
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Focusing on localization to specific cytoplasmic organelles, we noted that 42 RBPs ex-
hibited localization to mitochondria, an organelle with unique transcriptional and RNA
processing regulation (Rackham et al. [2002]). We observed numerous RBPs with significant
binding to the mitochondrial genome in either Heavy (H)-strand (TBRG4), Light (L)-strand
(GRSF1), or both (FASTKD2, DHX30) (Fig. 3-7d-e). Validating these observations, mi-
tochondrial localization by immunofluorescence was associated with significantly increased
eCLIP binding to mitochondrial RNA (Fig. 3-S9d). DHX30 is essential for proper mi-
tochondrial ribosome assembly and oxidative phosphorylation (Antonicka and Shoubridge
[2015]). Intriguingly, in addition to widespread association with many mitochondrial genes
that was consistent with previous RIP-seq findings (Antonicka and Shoubridge [2015]) (Fig.
3-S9e), we observed dramatic enrichment at an unannotated region on the mitochondrial
H-strand downstream of all annotated genes and just upstream of the replication D loop,
which has strong potential to form a stem-loop structure (Fig. 3-7f). We further observed
that DHX30 knockdown resulted in increased expression of nearly all H-strand transcripts,
but decreased expression of L-strand transcript ND6 (Fig. 3-7g). Identification of the termi-
nation signal for mitochondrial H-strand transcription has remained elusive; it is tempting to
speculate this site of DHX30 association could mark such signal. These examples illustrate
how intracellular localization of RBPs can be used synergistically with binding and loss-
of-function studies to infer aspects of post-transcriptional regulation that occur in different
cellular compartments and organelles.
3.3.7 Preservation of RBP regulation across cell types
Next we evaluated whether RBP regulation is preserved across cell types. Analyzing the 55
RBPs profiled by eCLIP in both K562 and HepG2 cell lines, we found that only a small
portion (averaging 11.0%) of peaks were found in genes with cell type-specific expression
(TPM ≥ 1 in one cell type and TPM < 0.1 in the other) (Fig. 3-8a, Fig. 3-S10a). An
average of 70.6% of peaks were located within genes expressed in both cell types (TPM ≥
1 in both), although only 10.3% were present in genes that were unchanged between K562
and HepG2 (defined as fold-difference ≤ 1.2), and 31.6% of peaks were within genes that
changed by at least two-fold (Fig. 3-8a, Fig. 3-S10a). To illustrate, we observed that
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RBFOX2 eCLIP peaks at least 8-fold enriched in HepG2 were typically also enriched in
K562 (average enrichment of 6.1-fold) if the bound gene was expressed within five-fold of
the level in HepG2 cells (Covering the ‘Unchanged’, ‘Weakly differential’, and ‘Moderately
differential’ classes in Fig. 3-8a). In contrast, 89.8% of HepG2 peaks in genes with cell type-
specific expression were not enriched in K562 (Fig. 3-8a). Indeed, 49.7% of RBFOX2 HepG2
peaks that were not enriched in K562 occurred in genes with cell type-specific expression
whereas only 5.5% occurred in genes within a two-fold change.
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Figure 3-8: Preservation of RBP binding and regulation across cell types
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Figure 3-8
(a) Each point indicates the fold-enrichment in K562 eCLIP of RBFOX2 for a reproducible
RBFOX2 eCLIP peak in HepG2, with underlaid black histogram. Peaks are separated based
on the relative expression difference of the bound gene between K562 and HepG2: unchanged
(fold-difference ≤ 1.2), weakly (1.2 < fold-difference ≤ 2), moderately (2 < fold-difference
≤ 5) or strongly (fold-difference > 5) differential (each of which required expression TPM
≥ 1 in both K562 and HepG2), or cell type-specific genes (TPM < 0.1 in one cell type and
TPM ≥ 1 in the other). Mean is indicated by red lines, with significance determined by
Kolmogorov-Smirnov test.
(b) For each RBP profiled in both K562 and HepG2, points indicate the fraction of peaks in
the first cell type associated with a given gene class that are (blue) at least four-fold enriched,
or (red) not enriched (fold-enrichment ≤ 1) in the second cell type. Boxes indicate quartiles,
with median indicated by red lines. (left) Stacked bar indicates the average fraction of peaks
per RBP (see Fig. 3-S10a for per-RBP distributions).
(c) Cassette exon splicing maps for HNRNPL and SRSF1 in both K562 and HepG2 cells.
(d) Heatmap indicates correlation (Pearson 𝑅) between splicing maps for all RBPs profiled
in both K562 and HepG2, hierarchically clustered at the RBP level.
(e) Expression of the 10 RBPs with the highest and lowest tissue specificity across the two
ENCODE cell lines and 40 human tissues.
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Expanding this analysis to all RBPs profiled in both cell types, we observed similar
results: an average of 84.3% of peaks in genes with cell type-specific expression were not
enriched in the other cell type, whereas 68.0%, 65.5%, and 67.6% of peaks in unchanging,
weakly, or moderately differentially expressed genes were enriched by at least 4-fold in the
second cell type, respectively (Fig. 3-8b). Requiring the strict IDR thresholds for peak
identification, an average of 44.1% of peaks in genes with similar expression were preserved
across cell types (Fig. 3-S10c). 48.9% of all peaks that showed no enrichment in the
second cell type occurred in genes with cell type-specific expression (a 4.4-fold enrichment),
whereas only 21.0% occurred in unchanging, weakly, or moderately differentially expressed
genes, respectively (a 3-fold depletion) (Fig. 3-S10c). Thus, these results suggest that most
RBP binding is preserved across cell types for similarly expressed genes, and that much of
differential eCLIP signal between HepG2 and K562 likely reflects underlying gene expression
differences more than differential binding.
Next, we asked whether an RBP’s positional pattern of splicing regulation tended to be
conserved across cell types. Considering splicing maps of cassette exons, we observed that
binding of many RBPs had highly similar correlations with either inclusion or exclusion upon
knockdown, including alternative splicing regulators HNRNPL and SRSF1 (Fig. 3-8c-d).
We observed that the splicing maps for the same RBP across cell types had significantly
higher correlation than random pairings of RBPs, when comparing across all 16 RBPs with
both eCLIP and RNA-seq datasets (with sufficient splicing changes) in both K562 and HepG2
(Fig. 3-8d, Fig. 3-S10d).
Cell type-specific regulation of RNAs may also be achieved through differential modula-
tion of RBP levels. To assess which RBPs confer regulation in such a manner, we calculated
the expression of each RBP in HepG2 and K562 cells in addition to 40 diverse human tissues
from the GTEx Project (Fig. 3-S11). Many RBPs had high expression in ENCODE cell lines
and across a broad range of human tissues, including ribosomal proteins (RPL23A, RPS11,
RPS24), translation factors (EIF4H, EEF2), and ubiquitously expressed splicing factors
(HNRNPC, HNRNPA2B1) among the 10 least tissue-specific RBPs (Fig. 3-8e). However,
several other RBPs had highly tissue-specific expression exhibiting either a pattern of high
expression in one or a small number of human tissues (e.g., LIN28B, IGF2BP1/3) or were
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differentially expressed by orders of magnitude across several human tissues (e.g., IGF2BP2
and APOBEC3C), indicating that the RNA targets and regulatory activity of these RBPs
are likely modulated through cell type-specific gene expression programs. Of course, even
RBPs with similar mRNA levels across tissues may have different protein levels or activity
because of post-translational modifications, which are widespread among RBPs.
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3.4 Discussion
Our study represents the largest effort to date to systematically study the roles of human
RBPs by integrative approaches. The resulting catalog of functional RNA elements sub-
stantially expands the repertoire of regulatory components encoded in the human genome.
While the impact of DNA binding proteins mostly culminates in effects on gene expres-
sion levels, RBP function encompasses a broader range of activities. RBP functions extend
outside the nucleus and into the cytoplasm and organelles, and consist of multiple paths
by which RNA substrates are altered (splicing, RNA editing/modification, RNA stability,
localization, translation), expanding transcriptome and proteome complexity. We demon-
strate the effectiveness of combining in vivo maps of RNA binding sites using eCLIP with
orthogonal approaches, such as in vitro evaluation of RNA affinity for the same RBPs, chro-
matin association by ChIP-seq, and functional assessment of RNA variation by depletion
experiments and RNA-seq. At the molecular level, we confirm that in vivo and in vitro
preferences are highly correlated for RBPs interrogated here, and show that CLIP peaks
containing motifs reflective of intrinsic RNA affinity are more predictive of regulation. We
confirm using unbiased genome-wide analyses that SR and hnRNP proteins have broadly
antagonistic effects on alternative splicing. Moreover, we extend genome-wide previous find-
ings that alternative 3’ splice site choice results from an “AG” scanning process initiating
with branch point recognition, and implicate the upstream 5’ splice sites of cassette exons
in splicing regulation. We also implicate RNA structures bound by an RBP in processing
of mitochondrial transcripts, and elucidate new RNA splicing maps for many RBPs. Fur-
thermore, our data provide the first systematic investigation of chromatin-associated gene
regulation and RNA processing at the level of RBP-nucleic acid interactions. At the cellular
level, immunohistochemical analysis with our extensive repository of RBP-specific antibod-
ies place these molecular interactions within subcellular contexts. We confirm localization
of many RBPs to nuclear speckles, mitochondria, and other compartments, and identify
many new proteins resident to these sites, emphasizing the necessity of localization data for
interpreting RBP-RNA regulatory networks.
Here, we have surveyed the in vivo binding patterns of 126 RBPs, comprising roughly
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10% of the human genes predicted to encode proteins that interact directly with RNA. Our
observation that additional mapping of new RBPs leads to a greater increase in the func-
tional RNA element coverage than mapping of the same RBPs in additional cell lines argues
that expansion of these approaches to additional RBPs will be particularly informative. Ad-
ditionally, the binding modes in vivo are highly preserved across genes expressed similarly in
our two cell lines assayed (K562 and HepG2). Nevertheless, mapping of previously charac-
terized RBPs in drastically different cell types (embryonic stem cells, post-mitotic cells such
as neurons and muscle cells) and human tissues, with highly distinct transcriptomes, will
undoubtedly yield new discoveries. Additionally, RNA processing is highly dynamically reg-
ulated during acute or chronic environmental influences such as stress, as new binding sites
may arise from both environmental changes in RBP or RNA concentrations as well as from
changes in post-translational modifications, binding partners, or subcellular distribution of
RBPs. Thus, studying RBP subcellular localization and RBP-RNA substrate regulation
under these conditions has potential to reveal new biology.
We expect that the data generated here will provide a useful framework upon which to
build analyses of other aspects of RNA regulation, such as microRNA levels, RNA editing
and modifications such as pseudouridylation and m6A methylation, translation efficiency,
and mRNA half-life measurements. We have yet to integrate in vivo RNA structure probing
data to evaluate how RBP-mediated RNA processing are influenced by local (Singh et al.
[2007]) and long-range RNA structures (Lovci et al. [2013]). As we continue to embark on
comprehensively characterizing all functional RNA elements, genome-scale CRISPR/Cas9-
inspired genome-editing (Doudna and Charpentier [2014]) and RNA modulation (Nelles et al.
[2016]) technologies will ultimately provide opportunities to study the impact on cellular and
organismal phenotypes resulting from disruption of these RNA elements.
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3.5 Supplementary Figures
Figure 3-S1: Integrative analysis of RBP data types in cryptic exon suppression
Shown is RNA-seq read density (reads per million), eCLIP read density (reads per million),
and RBNS motif presence proximal to a 73 nt cryptic exon expected to induce nonsense-
mediated decay (NMD) of GTP Binding Protein 2, a ribosome rescue factor whose loss
induces neurodegeneration in certain genetic backgrounds (Ishimura et al. [2014]). eCLIP
indicates that HNRNPL binds over the cryptic exon 5’ splice site in a sequence-specific
manner to a region rich in the top RBNS 5mer, ACACA.
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Figure 3-S2: Saturation of RBP binding and regulation in the transcriptome
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Figure 3-S2
(a-b) Lines indicate the mean of 100 random orderings of each data type for the number of
genes that are (green) differentially expressed upon RBP knockdown and RNA-seq (requiring
FDR < 0.05, 𝑝-value < 0.05, and |fold-change| > 1), (blue) bound in eCLIP (overlapped
by a IDR-reproducible peak with 𝑝 < 10−3 and fold-enrichment ≥ 8 in IP versus input),
or (orange) both bound and differentially expressed in the same cell type. Grey dotted line
indicates the total number of genes considered, either (a) with TPM > 1 in both HepG2 and
K562, or (b) TPM > 1 in either K562 or HepG2. Shaded regions indicate tenth to ninetieth
percentile.
(c) Lines indicate the mean of 100 random orderings of datasets for the number of (red)
differential splicing events upon RBP knockdown (including cassette exons, alternative 5’
and 3’ splice sites, retained introns, and mutually exclusive exons; requiring FDR < 0.05,
𝑝-value < 0.05, and |∆Ψ| > 0.05), and (blue) exons both bound by an RBP and differentially
spliced upon RBP knockdown in the same cell type (with binding defined as a peak located
anywhere between the upstream intron 5’ splice site and downstream intron 3’ splice site).
Shaded regions indicate tenth to ninetieth percentile.
(d) Lines indicate the mean cumulative fraction of bases covered by peaks for 100 random
orderings of the 181 eCLIP datasets, separated by transcript regions as indicated, with
shaded region indicating tenth and ninetieth percentiles, only considering genes expressed
(with TPM > 1) in both K562 and HepG2.
(e) Data and colors as in (d), represented as fold-increase in mean bases covered by peaks
from 𝑛 to 𝑛 + 1 eCLIP datasets.
(f). Points indicate the fold-increase in bases covered by peaks between sampling one or
two datasets, separated by whether the second is the same RBP in a new cell type (K𝐴 →
H𝐴 or H𝐴 → K𝐴 for RBP A profiled in K562 and then HepG2 or HepG2 and then K562,
respectively) or a different RBP in the same cell type (K𝐴 → K𝐵 or H𝐴 → H𝐵 for RBP A
followed by RBP B in either K562 or HepG2, respectively), with kernel smoothed density
indicated by the shaded area. Red line indicates mean.
(g) Points indicate the fold-increase in bases covered by peaks between sampling all versus
leaving one dataset out, separated by whether the RBP is (left) a newly profiled RBP or
(center) a previously profiled RBP profiled in a second cell type (of either K562 or HepG2).
(right) The fold-increase observed if an independent eCLIP experiment performed in H1 or
H9 human embryonic stem cells is added (including RBFOX2, IGF2BP3, and two replicates
each for IGF2BP1 and IGF2BP2). Red line indicates mean.
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Figure 3-S3: Comparison of in vitro RBNS-derived motifs with in vivo eCLIP-
derived motifs 161
Figure 3-S3
(a) Top motif derived from all eCLIP peaks as well as eCLIP peaks within intronic, CDS,
and 3’ UTR regions. Motifs were only derived if there were at least 5,000 peaks or 5% of
total peaks in that region, averaged over the two eCLIP replicates. Dashed lines indicate
eCLIP was not performed in that cell line. Filled circles indicate significant overlap (𝑝 < 0.05
by hypergeometric test) between RBNS and eCLIP motifs.
(b) The top eCLIP motif that does not match RBNS for the corresponding RBP (if any).
The eCLIP motif was considered as matching RBNS if any of its constituent 5mers were
among the RBNS Z≥3 5mers (always using at least 10 RBNS 5mers if there were fewer
with Z≥3). Dashed lines indicate eCLIP was not performed in that cell line. (right) The
percentage of eCLIP experiments aggregated over all RBP/cell types in each category of
agreement with RBNS. Horizontal line indicates a significant difference in the proportion of
a particular eCLIP/RBNS agreement category between eCLIP analysis of all peaks versus
eCLIP analysis of intron, CDS, or 3’ UTR peaks (𝑝 < 0.05 by Fisher’s Exact Test).
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Figure 3-S4: Splicing regulatory activity of RBNS+ and RBNS- eCLIP peaks
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Figure 3-S4
(a) Left: The distribution of |∆Ψ| changes upon KD in each of the 6 eCLIP+ peak region/SE
splicing change types compared to that of eCLIP- SEs for KHSRP in HepG2 (significant if
𝑝 < 0.05 byWilcoxon rank-sum test). Center: Regions of significance for eCLIP+ vs. eCLIP-
SEs for each eCLIP experiment. Right: Proportion of SEs in each of the six eCLIP+ types
for each eCLIP experiment. Bottom: Classification of eCLIP+ peaks into RBNS+ and
RBNS- based on the presence of the top RBNS 5mer, shown here for two of the KHSRP
peaks in HepG2.
(b) Same set of RBPs and corresponding eCLIP+ peak region/SE splicing change types as
used in Fig. 3-3c, but separating eCLIP peaks on whether they contain the top ‘eCLIP-only’
5mer (based on the motifs from Fig. 3-S3b) instead of the top RBNS 5mer.
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Figure 3-S5: Association between RBP binding and RNA expression upon knock-
down
165
Figure 3-S5
(a) Lines indicate cumulative distribution plots of gene expression fold-change (UPF1 knock-
down versus control) for indicated categories of UPF1 eCLIP binding in K562 cells.
(b-c) METAP2 K562 eCLIP region-level binding at 3’ UTR, CDS, intronic, and non-coding
exonic regions. (b) Points indicate read density in input (𝑥-axis) versus fold-enrichment in
METAP2 eCLIP (𝑦-axis) for indicated transcript regions of all GENCODE v19 genes. Sig-
nificantly enriched regions (𝑝 < 10−5 and fold-enrichment > 4) are indicated by open circles.
(c) Histogram of METAP2 eCLIP fold-enrichment for the indicated transcript regions.
(d) Cumulative distribution plots of gene expression fold-change (TIA1 HepG2 knockdown
versus control) for indicated categories of 3’ UTR TIA eCLIP binding.
(e) Enrichment or depletion of the top 15 TIA1 RBNS 5mers in 3’ UTRs of genes that
are up- and down-regulated upon TIA1 knockdown in K562 and HepG2, relative to their
frequency in control gene 3’ UTRs (green lines indicate an enrichment of 1 (equal frequency
in regulated gene 3’ UTRs and control gene 3’ UTRs)). All 1,024 5mers are ordered from
lowest to highest enrichment from left to right in each row.
(f-g) Position-specific frequency of the top 10 TIA1 RBNS 5mers in the last 50 positions of
the CDS and in a meta-3’ UTR of (red) up-regulated, (blue) down-regulated, and (black)
control genes upon TIA1 knockdown in (f) K562 and (g) HepG2 cells. Positions of motif
density significantly different in up- or down-regulated genes relative to control genes are
indicated below the 𝑥-axis (calculated using a binomial test comparing the number of regu-
lated genes that do versus do not have one of the top 10 RBNS 5mers at that position versus
the frequency observed in control genes).
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Figure 3-S6: Generation of splicing maps for RBFOX2
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Figure 3-S6
(a) First, individual RBP-regulated splicing events are identified from significant changes in
knockdown RNA-seq. Genome browser tracks indicate RNA-seq read density (as reads per
million (RPM)) and eCLIP read density (RPM) of RBFOX2 in the same cell type, as well
as its paired size-matched input.
(b) Next, each exon is normalized between IP versus input to obtain ‘Normalized eCLIP
enrichment’. The heatmap indicates normalized eCLIP enrichment for all exons significantly
excluded upon RBFOX2 knockdown.
(c) Next, a ‘splicing map’ is created by calculating the mean and standard error of the mean
of normalized eCLIP enrichment for each position across the region, removing the top and
bottom 5% outlier values at each position. Lines in splicing map indicate ‘Average eCLIP
enrichment’, defined as the mean normalized eCLIP enrichment for exons (red) included
or (blue) excluded upon RBFOX2 knockdown. Also plotted are (purple) a control set of
cassette exons (referred to as ‘native’ cassette exons) in wildtype HepG2 cells and (black)
constitutive exons.
(d) A final simplified splicing map vector was calculated by subtracting the normalized
eCLIP enrichment of control native cassette exons from that of either included or excluded
exons at each position to calculate ‘Enrichment relative to control events’.
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Figure 3-S7: Splicing regulatory patterns of SR, HNRNP, and spliceosomal pro-
teins
(a) Relative splicing maps for cassette exons included (left) and excluded (right) upon knock-
down (as described in Fig. 3-5b) are shown for all profiled SR and HNRNP proteins.
Datasets were hierarchically clustered at the RBP level, and datasets with fewer than 100
events are indicated by slashed lines.
(b) Heatmap indicates the Pearson correlation (𝑅) between splicing maps shown in (a),
calculated across both included and excluded exon maps. Datasets are ordered identically
to (a).
(c) Average binding patterns for indicated spliceosome-associated RBPs in 50 nt exonic and
500 nt intronic regions flanking splice sites. Lines indicate the difference in average binding
for native cassette exons minus the average at constitutive exons.
(d) Lines indicate the average number of RBPs bound (out of 181 total datasets) in 50 nt
exonic and 500 nt intronic regions flanking splice sites, separated by (top) core spliceosomal
RBPs or (bottom) all other RBPs.
169
Figure 3-S8: RNA maps for alternative 5’ and 3’ splice sites
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Figure 3-S8
(a) Heatmap indicates enrichment relative to control events at alternative 5’ splice site
events, for all RBPs with eCLIP and knockdown RNA-seq data (requiring a minimum of 50
significantly changing events upon knockdown). The region shown extends 50 nt into exons
and 300 nt into introns.
(b) Heatmap indicates normalized eCLIP signal for SF3B4 in HepG2 at alternative 3’ splice
site events either (top) alternatively spliced in wildtype cells or (bottom) events with in-
creased usage of the extended 3’ splice site upon SF3B4 knockdown. The region shown
extends 50 nt into exons and 100 nt into introns.
(c) Model for SF3B4 and SF3A3 blockage of 3’ splice site recognition by U2AF.
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Figure 3-S9: eCLIP binding patterns in subcellular space
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Figure 3-S9
(a) Points indicate nuclear versus cytoplasmic ratio from immunoflourescence (IF) imaging
(𝑥-axis) versus ratio of spliced versus unspliced exon junction reads, normalized to paired
input (𝑦-axis). RBPs profiled by eCLIP and IF in HepG2 are indicated in blue, and RBPs
profiled by eCLIP in K562 (in purple) were paired with IF experiments performed in HeLa
cells.
(b) Points indicate values as in (a), with RBPs separated into nuclear (nuclear / cytoplasmic
ratio > 2) and cytoplasmic (nuclear / cytoplasmic ratio < 0.5). Significance was determined
by Kolmogorov-Smirnov test, and red line indicates mean.
(c) Points indicate eCLIP relative information for all profiled RBPs for the indicated snRNA
or pre-mRNA region, separated by the observation of co-localization at nuclear speckles. Sig-
nificance was determined by Wilcoxon rank-sum test.
(d) Cumulative distribution curves indicate total relative information content for the mito-
chondrial genome for RBPs with mitochondrial localization by IF (red) and all other RBPs
(black). Significance was determined by Kolmogorov-Smirnov test.
(e) Heatmap indicates DHX30 eCLIP binding across all exons for all mitochondrial protein-
coding and rRNA transcripts. * indicates significant eCLIP binding (fold-enrichment > 4
and 𝑝 < 0.00001 in IP versus input).
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Figure 3-S10: Preservation of binding across cell types
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Figure 3-S10
(a) Bars indicate the fraction of peaks observed for each RBP within sets of genes separated
by their relative expression change between K562 and HepG2: unchanged (fold-difference ≤
1.2), weakly (1.2 < fold-difference ≤ 2), moderately (2 < fold-difference ≤ 5) or strongly
(fold-difference > 5) differential, or cell type-specific genes (TPM < 0.1 in one cell type and
TPM ≥ 1 in the other). 𝑛 indicates the number of genes meeting each criteria. For each
RBP, the results shown are for the cell type with fewer total peaks.
(b) Each point represents one eCLIP dataset compared with the same RBP profiled in the
second cell type. For the set of peaks from the first cell type that are not enriched (fold-
enrichment < 1) in the second cell type, red points indicate the fraction occurring in genes
with the indicated expression difference between HepG2 and K562. Blue points similarly
indicate the gene distribution of peaks four-fold enriched in the opposite cell type. Boxes
indicate quartiles, with median indicated by the central red line.
(c) Points indicate the fraction of overlapping peaks between K562 and HepG2 for RBPs
profiled in both cell types (blue or red), or between one RBP in K562 and a second in HepG2
(black), for sets of genes separated by their relative expression change between K562 and
HepG2 as in (a).
(d) Plot represents the distribution of Pearson correlations between splicing maps as shown in
Fig. 3-8d, separated by whether the comparison is between the same RBP or different RBPs
profiled in two different cell types. Different RBPs are shown as smoothed histogram using
a Normal kernel, and red line indicates mean. Significance was determined by Kolmogorov-
Smirnov test.
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Figure 3-S11: Expression of RBPs across tissues and cell types
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Figure 3-S11
Expression of the 352 RBPs (in Transcripts Per Million) investigated in this study in EN-
CODE cell lines HepG2 and K562 as well as 40 human tissues measured by the GTEx
project. RBPs sorted by decreasing expression in HepG2.
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3.6 Methods
3.6.1 RNA binding protein annotations and domains
RBPs were chosen from a previously described list of 1072 known RBPs, proteins containing
RNA binding domains, and proteins characterized as associated with polyadenylated RNA,
based on the availability of high quality antibodies (Sundararaman et al. [2016]). Annotation
of RBP function was performed by integration of published literature, with manual inspec-
tion of references for less well-established annotations. Annotation of RNA binding domain
presence was determined by UniProt Domain Descriptions, and a database of cell-essential
genes was obtained from published high-throughput CRISPR screening efforts (Wang et al.
[2015]).
3.6.2 eCLIP - experimental methods
Antibodies for eCLIP were pre-screened using a set of defined metrics (Sundararaman et al.
[2016]). A ‘biosample’ of HepG2 or K562 cells was defined as a batch of cells starting from
a single unfrozen stock, passaged for less than 30 days under standard ENCODE reference
conditions, and validated for high viability and non-confluence at the time of crosslinking.
All cells within a biosample were pooled and UV crosslinked on ice at 400 mJoules/cm2
with 254 nm radiation. The biosample was then split into 20 million cell aliquots for eCLIP
experiments.
eCLIP experiments were performed as previously described in a detailed Standard Oper-
ating Procedure (Van Nostrand et al. [2016]), which is provided as associated documentation
with each eCLIP experiment on the ENCODE portal (
https://www.encodeproject.org/documents/fa2a3246-6039-46ba-b960-17fe06e7876a/
@@download/attachment/CLIP_SOP_v1.0.pdf). Briefly, 20 million crosslinked cells were
lysed and sonicated, followed by treatment with RNase I (Thermo Fisher) to fragment RNA.
Antibodies were pre-coupled to species-specific (anti-Rabbit IgG or anti-Mouse IgG) Dyn-
abeads (Thermo Fisher), added to lysate, and incubated overnight at 4∘C. Prior to immuno-
precipitation (IP) washes, 2% of sample was removed to serve as the paired input sample.
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For IP samples, high- and low-salt washes were performed, after which RNA was dephos-
phorylated with FastAP (Thermo Fisher) and T4 PNK (NEB) at low pH, and a 3’ RNA
adapter was ligated with T4 RNA Ligase (NEB). 10% of IP and input samples were run on
an analytical PAGE Bis-Tris protein gel, transferred to PVDF membrane, blocked in 5% dry
milk in TBST, incubated with the same primary antibody used for IP (typically at 1:4000
dilution), washed, incubated with secondary HRP-conjugated species-specific TrueBlot an-
tibody (Rockland), and visualized with standard enhanced chemiluminescence imaging to
validate successful IP. 90% of IP and input samples were run on an analytical PAGE Bis-
Tris protein gel and transferred to nitrocellulose membranes, after which the region from
the protein size to 75 kDa above protein size was excised from the membrane, treated with
Proteinase K (NEB) to release RNA, and concentrated by column purification (Zymo). In-
put samples were then dephosphorylated with FastAP (Thermo Fisher) and T4 PNK (NEB)
at low pH, and a 3’ RNA adapter was ligated with T4 RNA Ligase (NEB) to synchronize
with IP samples. Reverse transcription was then performed with AffinityScript (Agilent),
followed by ExoSAP-IT (Affymetrix) treatment to remove unincorporated primer. RNA was
then degraded by alkaline hydrolysis, and a 3’ DNA adapter was ligated with T4 RNA Ligase
(NEB). qPCR was then used to determine required amplification, followed by PCR with Q5
(NEB) and gel electrophoresis to size-select the final library. Libraries were sequenced on
either the HiSeq 2000, 2500, or 4000 platform (Illumina). Each ENCODE eCLIP experiment
consisted of IP from two independent biosamples, along with one paired size-matched input
(sampled from one of the two IP lysates prior to IP washes).
3.6.3 eCLIP - data processing and peak identification
Data processing - including adapter trimming, repetitive element removal, unique genomic
mapping, PCR duplicate removal, and peak calling versus paired size-matched input - were
performed as previously described in a detailed Standard Operating Procedure (Van Nos-
trand et al. [2016]). Unless otherwise noted, reproducible and significant peaks were identified
by merging peaks identified in each replicate, requiring that the peak meet an irreproducible
discovery rate cutoff of 0.01 as well as 𝑝-value ≤ 0.001 and fold-enrichment ≥ 8 (using the
geometric mean of log2(fold-enrichment) and -log10(𝑝-value) between the two biological repli-
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cates). For submission to the ENCODE portal, eCLIP datasets were required to pass several
quality metrics, including minimum read depth, reproducibility, and peak saturation metrics.
To quantify binding to snRNA and other multi-copy elements, a separate pipeline was de-
veloped to require unique mapping to element families instead of unique genomic positions.
All analyses described in this manuscript used mapping to GRCh37 and GENCODE v19
annotations, but mapping to GRCh38 and GENCODE v24 annotations were also deposited
at the ENCODE portal.
For analyses using binding considered at the level of regions (e.g. 3’ UTR, CDS, or
proximal intronic), read density was counted for the indicated region for both IP and paired
input, and significance was determined by Fisher Exact test (or Yates’ Chi-Square test if all
observed and expected values were above 5). Only regions with at least 10 reads in one of
IP or input, and where at least 10 reads would be expected in the comparison dataset given
the total number of usable reads, were considered, and significant regions were defined as
those with fold-enrichment ≥ 4 and 𝑝-value ≤ 0.00001.
To summarize relative enrichment between IP and input, information was defined as the
Kullback-Leibler divergence (relative entropy): 𝑝𝑖 × log2 (𝑝𝑖/𝑞𝑖), where 𝑝𝑖 is the fraction of
total reads in IP that map to a queried element 𝑖 (peak, gene, or repetitive element), and 𝑞𝑖
is the fraction of total reads in input for the same element.
3.6.4 Knockdown followed by RNA-seq (KD/RNAseq) - experi-
mental methods
Individual RBPs were depleted from HepG2 or K562 cells by either RNA interference or
CRISPR-mediated gene disruption. RNA interference was performed by transducing cells
with lentiviruses expressing shRNAs (TRC collection) targeting an RBP of interest followed
by puromycin selection for 5 days. CRISPR-mediated gene disruption was performed by
transfecting cells with a plasmid expressing Cas9 and a gRNA targeting the RBP of interest,
followed by puromycin selection for 5 days. In each case, depletions were performed in
biological duplicate along with a pair of control depletions using a scrambled shRNA or
gRNA. RNA was extracted from half of each sample and used to perform qRT-PCR to
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confirm depletion of the targeted RBP transcript and to prepare RNA-seq libraries using
the Illumina Tru-seq stranded mRNA library preparation kit. Protein was extracted from
the other half of each sample and used to confirm depletion of the target RBP by Western
blotting. Paired-end 100 bp reads were generated from the RNA-seq libraries to an average
depth of 63 million reads per replicate.
3.6.5 KD/RNA-seq - data processing
Reads were aligned to both the hg19 assembly of the genome using the Gencode v19 anno-
tation, respectively, using both TopHat2 (Kim et al. [2013]) and STAR (Dobin et al. [2013]).
Gene expression levels were quantitated using RSEM (Li and Dewey [2011]) and Cufflinks
(Trapnell et al. [2012]) and differential expression levels determined using DESeq2 (Anders
and Huber [2010]) and Cuffdiff2 (Trapnell et al. [2013]). Alternative splicing was quantitated
using rMATS (Shen et al. [2014]) and alternative poly(A) site use quantitated with MISO
(Katz et al. [2010]). All analyses described in this manuscript used mapping to GRCh37
and GENCODE v19 annotations, but mapping to GRCh38 and GENCODE v24 annotations
were also deposited at the ENCODE portal.
3.6.6 RNA Bind-N-Seq (RBNS) - experimental methods
RBNS experiments were performed as indicated in the protocol included on each exper-
iment at the ENCODE portal. Briefly, randomized RNA oligonucleotides (20 or 40 nt)
flanked by constant adapter sequences were synthesized and incubated with an SBP-tagged
recombinant RBP (consisting minimally of all annotated RNA binding domains) at sev-
eral concentrations (typically five, ranging from 5-1300 nM). RNA-protein complexes were
isolated with streptavidin-conjugated affinity resin and eluted RNA was prepared for deep
sequencing, resulting in 15-20 million reads per RBP pulldown concentration with a similar
number of input reads sequenced per in vitro transcription reaction.
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3.6.7 RBNS - data processing
RBNS 𝑘mer enrichments (𝑅 values) were calculated as the frequency of each 𝑘mer in the
pulldown library reads divided by its frequency in the input library; enrichments from the
pulldown library with the highest individual 𝑘mer 𝑅 value were used for each RBP. Mean
and SD of 𝑅 values were calculated across all 𝑘mers for a given 𝑘 to calculate the RBNS
Z-score for each 𝑘mer. RBNS pipeline source code is available at:
https://bitbucket.org/pfreese/rbns_pipeline.
RBNS motif logos were made using the following iterative procedure for 𝑘=5: the most
enriched 5mer was given a weight equal to its excess enrichment over the input library (=𝑅-
1), and all occurrences of that 5mer were masked in both the pulldown and input libraries
to eliminate subsequent counting of lower-affinity ‘shadow’ 5mers (e.g., GGGGA shifted by
1 from GGGGG). All enrichments were then recalculated on the masked read sets to obtain
the resulting most enriched 5mer and its corresponding weight, with this process continuing
until the enrichment Z-score (calculated from the original 𝑅 values) was less than 3. All
5mers determined from this procedure were aligned to minimize mismatches to the most
enriched 5mer, with a new motif initiated if the number of mismatches + offsets exceeds
2. The frequencies of each nucleotide in the position weight matrix, as well as the overall
percentage of each motif, were determined from the weights of the individual aligned 5mers
that went into that motif; empty unaligned positions before or after each aligned 5mer were
given pseudocounts of 25% each nucleotide, and outermost positions of the motif logo were
trimmed if they had >75% unaligned positions. To improve the robustness of the motif
logos, the pulldown and input read sets were each divided in half and the above procedure
was performed independently on each half; only 5mers identified in corresponding motif logos
from both halves were included in the alignments to make the final motif logo. In Fig. 3-3a,
only the top RBNS motif logo is shown if there were multiple (all motifs displayed on the
ENCODE portal within the “Documents” box of each experiment).
The RBPs’ top RBNS logos were clustered using Jensen-Shannon divergence (JSD)-based
similarities computed by summing the score of the 𝑗 overlapping positions between the motifs
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of RBP A and RBP B:
∑︁
aligned pos. 𝑖=1,...,𝑗
infoA,i × infoB,i ×
(︂
1−
√︁
JSD[
−−−−→
𝐴𝐶𝐺𝑈A,i||−−−−→𝐴𝐶𝐺𝑈B,i]
)︂
where infoA,i and infoB,i are the information content of motifs A and B at aligned position
i, and Ai and Bi are the vectors of base frequencies at aligned position i in motifs A and
B, respectively (with each Ai and Bi vector summing to 1). This score weights similarity
more heavily at positions with higher information content and greater numbers of aligned
positions. This similarity score was computed for each possible overlap of the two logos (with
at least four positions overlapping, i.e., 𝑗 ≥4), and the top score with its corresponding
alignment offset was used. The matrix of these scores was normalized to the maximum
score over all RBP pairs and clustered using the linkage function with centroid method in
scipy.cluster.hierarchy to obtain the dendrogram shown in Fig. 3-3a.
3.6.8 Immuno-Fluorescence, Microscopy Imaging and Data Pro-
cessing
HepG2 cells were seeded in Poly-L-Lysine coated 96-well clear bottom plates (Corning Inc;
plate number 3882 half-area microplates), at a concentration of 2,000 cells per well in DMEM
+ 10% FBS. After 72 hr in standard growth conditions (i.e. 37∘C and 5% CO2), cells were
fixed with 3.7% formaldehyde, permeabilized in PBS + 0.5% Triton X-100 and blocked in
PBS + 0.2% Tween-20 + 2% BSA (PBTB), all conducted for 20 min at room temperature.
Primary antibodies directed against specific RBPs (all rabbit antibodies) and marker proteins
were subsequently applied to the cells at a final concentration of 2 𝜇g/mL in PBTB and
incubated overnight at 4∘C. The cells were next washed 3 times for 10 min each in PBST
and incubated with secondary antibodies (Alexa647 donkey anti-rabbit and Alexa488 donkey
anti-mouse, both diluted 1:500 in PBTB) for 90 min at room temperature. After 3 PBTB
washes, the cells were counter-stained with DAPI for 5 min, washed 3 times in PBS and stored
in PBS at 4∘C. Subcellular marker antibodies and dilutions used are as follows: rat anti-Alpha
Tubulin, MCA78G, 1:200 (Serotec, Bio-Rad); mouse anti-CD63, ab8219, 1:200 (Abcam);
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mouse anti-Coilin, GTX11822, 1:100 (GeneTex Inc); mouse anti-DCP1a, sc100706, 1:200
(Santa Cruz Biotechnology); mouse anti-Fibrillarin, ab4566, 1:200 dilution (Abcam); mouse
anti-GM130, #610822, 1:200 (Becton Dickinson); mouse anti-KDEL, ENZSPA827D, 1:200
(Enzo Life Sciences); mouse anti-Phospho Tyrosine, #9411S, 1:200 (NEB); mouse anti-PML,
sc-966, 1:50 (Santa Cruz Biotechnology); mouse anti-SC35, GTX11826, 1:200 (GeneTex Inc).
For staining with Mitotracker (Molecular Probes, M22426), cells were incubated with 100
nM of dye in tissue culture media for 45 min at 37∘C prior to fixation. For staining with
Phalloidin (Sigma, P5282), cells were incubated with 50 𝜇g/ml of Phalloidin for 20 min prior
to DAPI staining.
Imaging was conducted on an ImageXpress Micro high content screening system (Molec-
ular Devices Inc). For each RBP/marker combination, 10-20 high resolution images were
acquired in the DAPI, FITC, and Cy5 channels, using a 40x objective. Automated laser
based auto-focusing and auto-exposure functions were employed for sample imaging, with
exposure times ranging from 250-3000 ms, 100-500 ms and 50-100 ms, for RBP, Marker, and
DAPI channels, respectively. Raw unprocessed grayscale images from individual channels
were acquired as high resolution TIF files of 726 kb each. An in-house Matlab script was
developed to batch normalize image intensity values and add blue, green, or red colors to
the respective channels, which were subsequently merged as colour JPEG files. The final
images were uploaded on a server accessible through the RBP Image Database website. A
MySQL relational database (version 5.1.73) was implemented, along with a MyISAM storage
engine, to store the images, data annotations, and characteristics. A controlled vocabulary
of descriptors was devised to document RBP subcellular localization features.
Image analysis to quantify nuclear/cytoplasmic staining ratios, or to assess the degree
of RBP targeting to punctate subcellular structures (e.g. Cajal bodies, nuclear speckles,
nuceloli, Golgi, P-bodies), was conducted using ‘Granularity’, ‘Colocalization’, and ‘Multi
Wavelength Cell Scoring’ analysis modules from the MetaXpress v3.1 software (Molecu-
lar Devices Inc), according to manufacturer recommendations. For localization categories
including microtubules, actin, cell cortex, ER, focal adhesions, mitochondria and mitotic ap-
paratus, manual localization grading was conducted by ranking candidate RBPS as strongly
or weakly co-localized with respective protein markers. The Circos plot of localization co-
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occurrance (Fig. 3-7b) was generated by drawing one line between every pair of categories
for each RBP that shared both localization annotations. Nuclear annotations are indicated
in purple, cytoplasmic in red, and lines between nuclear and cytoplasmic annotations are
indicated in orange.
3.6.9 ChIP-seq - experimental methods
Chromatin immunoprecipitation was implemented according to ChIP Protocol optimized
for RNA binding proteins (https://www.encodeproject.org/documents/e8a2fef1-580b-45ad-
b29c-fffc3d527202/@@download/attachment/
ChIP-seq_Protocol_for_RNA-Binding_Proteins_ENCODE_Fu_lab_RuiXiao.pdf). In brief,
prior to coupling with RBP antibodies, magnetic beads were equilibrated by washing with
ChIP dilution buffer and blocked with glycogen, BSA, and tRNA in ChIP dilution buffer.
10-20 million HepG2 and K562 cells were crosslinked in 1% formaldehyde diluted in PBS for
20 minutes and then quenched by adding glycine. Cell nuclei were extracted by resuspending
cell pellet with cell lysis buffer with occasional inversion. Nucleus pellets, resuspended in nu-
clear lysis buffer, were sonicated with Branson Sonifier cell disruptor. 95% of nuclear lysate
diluted in the final concentration of 1% triton X-100, 0.1% sodium deoxycholate, and 1X
proteinase inhibitor cocktail was subjected to immunoprecipitation with antibody-coupled
beads and 5% of nuclear lysate was used as input chromatin. Stringent washes were per-
formed before elution. Input and immunoprecipitated chromatin DNAs were recovered by
de-crosslinking, RNase A digestion, proteinase K treatment, phenol/chloroform extraction,
and precipitation with ethanol. Library construction was mainly followed the instruction of
the Illumina Preparing Samples for ChIP sequencing. Each library was barcoded for pooled
sequencing. DNA Libraries between 200-400 bp were gel purified, quantified with Qubit,
and subjected to Illumina HiSeq 2000/2500 sequencing.
3.6.10 ChIP-seq - data processing
Data processing was performed in accordance with ENCODE uniform transcription factor
ChIP-seq pipeline (https://www.encodeproject.org/chip-seq/transcription_factor) and us-
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ing hg19 as the reference human genome. All datasets containing >10 million usable reads
from each replicate, passing IDR, and generating >200 peaks were used for final analysis.
3.6.11 Integrated Analysis
Saturation Analysis
Saturation analysis of eCLIP and KD/RNA-seq data was performed by randomly shuffling
the order of datasets 100 times, subsampling 1 through all datasets, and calculating the
desired metrics. Gene level saturation analysis of RBP binding was calculated first by taking
all unique genes that were bound by an IDR-filtered peak in an eCLIP experiment. Then,
each eCLIP experiment was iteratively added to the previous experiment, counting only
unique genes in any experiment. Saturation analysis of differentially expression genes from
KD/RNA-seq was similarly performed, based on differentially expressed genes identified with
DESeq2. Genes were identified as differentially expressed if they had a |log2(fold-change)| >
1 and an adjusted 𝑝-value < 0.05 between knockdown and control. Alternative versions of
this analysis used: 3-2b) all genes (Fig.; only genes with TPM > 1 in HepG2 and K562 (Fig.
3-S2a); or only genes with TPM > 1 in either HepG2 or K562 (Fig. 3-S2b), using average
gene-level expression from two rRNA-depleted RNA-seq experiments in HepG2 (ENCODE
accession ENCFF533XPJ, ENCFF321JIT) and K562 (ENCFF286GLL, ENCFF986DBN).
The set of differentially expressed and bound genes was determined by taking all genes
differentially expressed upon RBP KD that contained at least one IDR-filtered peak in the
corresponding eCLIP experiment in the same cell type.
Differentially spliced events were defined as those meeting 𝑝-value < 0.05, FDR < 0.1,
and |∆Ψ| > 0.05 from rMATS analysis (described above). The number of unique events
was defined as the number of non-overlapping events upon combining all experiments for
a given sampling. A differentially spliced event was considered bound if for any RBP in
which the event was differentially included upon KD, there was an eCLIP peak for the same
RBP in the same cell type between the start of the upstream flanking exon and the end of
the downstream flanking exon for cassette exons and mutually exclusive exons, start of the
upstream flanking exon and end of the common exon region for A3SS, start of the common
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exon and end of the common exon region for A5SS, and start of the upstream and stop of
the downstream exons for retained introns.
To perform saturation of transcript regions, the highest expressed transcript for each
gene was first identified using transcript-level quantifications from the same rRNA-depleted
RNA-seq experiments described above (K562, accession numbers
ENCFF424CXV, ENCFF073NHK; HepG2, accession numbers ENCFF205WUQ,
ENCFF915JUZ). The following regions were then identified: the entire unspliced transcript
(pre-mRNA), all exons (exon), 5’ untranslated regions (5’ UTR), coding sequence (CDS),
3’ untranslated regions (3’ UTR), all introns (intron), 100 nt intronic regions flanking the
5’ and 3’ splice sites (splice site), proximal intronic regions extending from 100 nt to 500 nt
from the 5’ and 3’ splice site (prox. intron), and distal intronic regions extending from 500
nt and beyond from the 5’ and 3’ splice sites. Saturation calculations were then performed
as described above for all genes (Fig. 3-2c-d, Fig. 3-S2e-g) or only genes with TPM >
1 in both K562 and HepG2 (Fig. 3-S2d), and plotted as either the total number of bases
covered (Fig. 3-2c), or the fraction of covered bases divided by the total number of bases
in that annotation across all genes (Fig. 3-2d, Fig. 3-S2d). The ratio of bases covered was
calculated by dividing the number of bases covered in subsampling of 𝑁+1 datasets divided
by the number covered in subsampling 𝑁 datasets.
Analysis of the fold-increase between one and two datasets (Fig. 3-S2f) was determined
by first taking all 55 RBPs profiled in both HepG2 and K562, and calculating the fold-
increase in covered bases by considering 110 comparisons including HepG2 followed by K562
and K562 followed by HepG2. Then, for each of the 110 datasets, 10 random other datasets
were chosen from the same cell type, and for each of the 10 the fold-increase in covered bases
from adding that dataset to the first was calculated. To compare the fold-increase between
profiling new RBPs in additional cell lines, eCLIP datasets profiling RBFOX2, IGF2BP1,
IGF2BP2, and IGF2BP3 in H9 human embryonic stem cells were obtained from the Gene
Expression Omnibus (GSE78509, Conway et al. [2016]) and added as the 181st dataset.
These were compared against profiling a new RBP in K562 or HepG2 (calculated by adding
each of the 126 profiled RBPs as the 179 (if it was profiled in both cell types) or 180 (if
it was profiled in only one cell type) datasets for other RBPs), or a profiled RBP done in
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second cell type (calculated by sampling 180 datasets, and adding the 181st if it was an RBP
already profiled in the other cell type).
Motif comparisons between RBNS and eCLIP
eCLIP 6mer Z-scores in Fig. 3-3b were calculated as previously described (Kapeli et al.
[2016]). Briefly, peaks and a shuffled background set of peaks that preserves the region of
binding (3’ UTR, 5’ UTR, CDS, exon, proximal and distal intron) were generated. EMBOSS
compseq (http://structure.usc.edu/emboss/compseq.html) was used on these two peak sets
and the Z-scores of the difference between real and background 6mer frequencies was calcu-
lated.
To produce eCLIP logos in a similar manner for comparison with RBNS logos, an anal-
ogous procedure was carried out on the eCLIP peak sequences (only eCLIP peaks at least
2-fold enriched were used): the two halves of the RBNS pulldown read set were replaced
with the two eCLIP replicate peak sequence sets (each peak was extended 50 nt upstream
of its 5’ end as some RBPs have motif enrichments symmetrically around or only upstream
of the peak starts), and the input RBNS sequences were replaced by random regions within
the same gene as each peak that preserved peak length and transcript region (5’ and 3’ UTR
peaks were chosen randomly within that region; intronic and CDS peaks were shuffled to
a position within the same gene that preserved the peak start’s distance to the closest in-
tron/exon boundary to match sequence biases resulting from CDS and splicing constraints).
The enrichment Z-score threshold for 5mers included in eCLIP logos was 2.8, as this thresh-
old produced eCLIP logos containing the most similar number of 5mers to that of the Z≥3
5mer RBNS logos. Each eCLIP motif logo was filtered to include only 5mers that occurred
in both of the corresponding eCLIP replicate logos. eCLIP motif logos were made separately
for all eCLIP peaks, only 3’ UTR peaks, only CDS peaks, and only intronic peaks, with the
eCLIP logo of those 4 (or 8 if CLIP was performed in both cell types) with highest similarity
score to the RBNS logo shown in Fig. 3-3a, where the similarity score was the same as
previously described to cluster RBNS logos (eCLIP logos for all transcript regions shown in
Fig. 3-S3a). To determine significance of overlap between RBNS and eCLIP, a hypergeo-
metric test was performed with 5mers in all RBNS logos, eCLIP logo 5mers (for peaks in
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the region with highest similarity score to the RBNS logo), and 5mers in their intersection,
relative to the background of all 1,024 5mers; overlap was deemed significant if 𝑝 < 0.05.
The top ‘eCLIP-only’ logo in each region was the highest eCLIP logo, if any, comprised of
5mers that had no overlap with any RBNS Z≥3 5mers (always using at least the top 10
RBNS 5mers if there were fewer than 10 with Z≥3).
All eCLIP/RBNS comparisons were for the same RBP with the following exceptions in
which the eCLIP RBP was compared to a closely related RBNS protein: KHDRBS2 eCLIP
versus KHDRBS1 RBNS; PABPN1 eCLIP versus PABPN1L RBNS; PTBP1 eCLIP versus
PTBP3 RBNS; PUM2 eCLIP versus PUM1 RBNS; and RBM15 eCLIP versus RBM15B
RBNS.
Splicing regulatory effects of RBNS+ and RBNS- eCLIP peaks
To assess the splicing regulatory effects of RBNS+ and RBNS- eCLIP peaks for Fig. 3-
3c, only rMATS SEs with a Ψ between 0.05 and 0.95 in at least one of the control or
KD were considered for each RBP. Each eCLIP peak (extended 50 nt 5’ of the peak start)
was first checked if it overlapped the SE, and if not then if it overlapped the upstream or
downstream flanking 250 nt. To compare the magnitude of splicing changes upon KD for
eCLIP+ vs eCLIP- SEs while minimizing the confounding factors of different wildtype host
gene expression level and SE Ψ values among these two sets of SEs, a matched set of eCLIP-
SEs was created by selecting for each eCLIP+ SE an SE in the same decile of wildtype
gene expression and wildtype Ψ for each corresponding SE with an eCLIP peak. A CDF
of the |∆Ψ| changes upon KD was compared for the eCLIP+ versus eCLIP- SEs in each of
the 6 SE direction/eCLIP region combinations ([included, excluded SE] × [peak over SE,
upstream intron, downstream intron]), with significance 𝑝 < 0.05 for a one-sided Wilcoxon
rank-sum test that |∆Ψ|SE,peak > |∆Ψ|SE,no peak. If the eCLIP+ vs eCLIP- comparison was
significant, the eCLIP peaks were divided into those that did and did not contain the top
RBNS 5mer. The |∆Ψ| values for all RBPs in each of the 6 SE direction/eCLIP regions were
combined for comparison in Fig. 3-3c; see Fig. 3-S4a for RBPs that were significant in
each region (12 included/4 excluded upon KD, upstream intron eCLIP peak; 11 included/2
excluded upon KD, SE eCLIP peak; 7 included/7 excluded upon KD, downstream intron
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eCLIP peak). To assess eCLIP peaks with or without the top ‘eCLIP-only’ 5mer, the top
5mer from the aforementioned ‘eCLIP-only’ logo was used from the first region with an
eCLIP-only logo among: all peaks; CDS peaks; intron peaks; and 3’ UTR peaks (the more
highly enriched 5mer if eCLIP was performed in both cell types). The resulting ‘eCLIP-only’
5mers for Fig. 3-S4b were: CELF1 (CUCUC); EIF4G2 (GUGUG); EWSR1 (CGCGG);
FUBP3 (UUGUU); FUS (GUGUG); HNRNPC (GUCGC); HNRNPK (UCCCC); HNRNPL
(none); IGF2BP1 (GUGUG); IGF2BP2 (CGCCG); KHDRBS2: (none); KHSRP (none);
PABPN1L (CGCGG); PCBP2 (CGGCG); PTBP3 (GAAGA); PUM2 (UUUUU); RBFOX2
(GGGGG); RBM22 (GGUAA); SFPQ (UCCGG); SRSF5 (CGGCG); SRSF9 (CUGGA);
TAF15 (AGGGA); TARDBP (GAAGA); TIA1 (CGCCG); TRA2A (GAGGG).
Overlaps between RBP binding and gene expression perturbation upon KD/RNA-
seq
To increase sensitivity for gene expression analysis, significant binding was determined at the
level of transcript regions (including 5’ UTR, CDS, 3’ UTR, and introns) instead of using
peaks. To identify significant enrichment between binding and expression changes, genes
with significantly enriched binding to regions (𝑝 ≤ 0.00001 and log2(fold-enrichment)≥ 4, as
described above) were overlapped with the set of genes with significantly altered expression
in KD/RNA-seq (|log2(fold-change)| > 1 and an adjusted 𝑝-value < 0.05 between knockdown
and control from DEseq2 analysis). Enrichment was calculated separately for knockdown-
increased and knockdown-decreased genes, with significance determined by Fisher Exact test
(or Yates’ Chi-Square test if all observed and expected values were above 5).
For cumulative distribution plots, genes were separated based on their eCLIP fold-
enrichment in IP versus input for the indicated transcript region. To filter out non-expressed
genes, genes were included only if the region had at least 10 reads in one of IP or input, and
where at least 10 reads would be expected in the comparison dataset given the total number
of usable reads.
To perform TIA1 motif enrichment analysis, first the fold-enrichment of each 5mer was
calculated by comparing the frequency in 3’ UTRs of genes increased or decreased upon
TIA1 knockdown in K562 or HepG2 with the frequency in a set of control genes upon
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knockdown (changed genes upon KD: DEseq2 adjusted 𝑝-val < 0.05 and |fold-change| >
1.5; control genes: DEseq2 𝑝-val > 0.5 and |fold-change| < 1.1, subsetted to match the
starting expression of changing genes upon KD). The top 15 5mers in TIA1 RBNS were
then highlighted among in the ranked ordering of all 1,024 5mers. For positional analysis,
a meta-3’ UTR was created by normalizing all 3’ UTRs to a 100 nt window. For each
normalized position, the frequency of the top 10 TIA1 RBNS 5mers was calculated for each
of the up-regulated, down-regulated, and control gene sets. Significance at each position was
determined by 𝑝 < 0.05 in a binomial test comparing the number of up- or down-regulated
genes that have one of the top 10 RBNS 5mers at that position under the null frequency
that it is equal to the corresponding frequency observed in control genes.
RBP binding correlation with knockdown-perturbed splicing (splicing maps)
RBP binding/splicing maps were generated using eCLIP normalized (reads per million)
read densities overlapped with alternatively spliced (AS) regions from rMATS Junction-
CountsOnly files from the same cell type. First, the set of differentially alternatively spliced
events of the desired type (cassette/skipped exons (SE), alternative 5’ splice site (A5SS),
or alternative 3’ splice site (A3SS) events were identified (Fig. 3-S6a), requiring rMATS
𝑝-value < 0.05, FDR < 0.1, and |∆Ψ| > 0.05 in knockdown versus control RNA-seq. To
eliminate potential double counting of CLIP densities, overlapping AS events were addition-
ally filtered to choose only the events containing the highest average inclusion junction count
(IJC) among all replicates (using the bedtools v2.26 command merge (-o collapse -c 4) and
pybedtools 0.7.9).
Next, for each splicing event, read densities were normalized across all regions separately
for IP and input, in order to equally weigh each event. Per-position input probability densi-
ties were then subtracted from IP probability densities to attain position-level enrichment or
depletion, for regions extending 50 nt into each exon and 300 nt into each intron composing
the event, referred to as ‘Normalized eCLIP enrichment’ (Fig. 3-S6b). For shorter exons
(<100 nt) and introns (<600 nt), densities were only counted until the boundary of the
neighboring feature. Skipped exon (SE) maps were plotted using eCLIP densities overlap-
ping the following 4 regions around AS events: 3’ end of the upstream exon, 5’ end of the
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cassette, 3’ end of the cassette, and 5’ end of the downstream exon. Alternative 3’ splice site
(A3SS) maps were defined with three regions: 3’ end of the upstream exon, 5’ end of the
longer transcript, and the 5’ end of the shorter transcript. Alternative 5’ splice site (A5SS)
maps were defined with three regions: 3’ end of the shorter transcript, 3’ end of the longer
transcript, and the 5’ end of the downstream exon.
Plots of eCLIP signal enrichment (referred to as ‘splicing maps’) were then created by
calculating the mean and standard error of the mean over all events after removing the
highest (2.5%) and lowest (2.5%) outlying signal at each position, referred to as ‘Average
eCLIP enrichment’ (Fig. 3-S6c). Splicing maps were only considered for RBPs with 100 or
more altered cassette exon events, or 50 or more alternative 5’ or 3’ splice site events. As a
background reference for cassette exon comparisons, sets of 1,832 (HepG2) and 2,244 (K562)
‘native’ cassette exons were identified which had 0.05 < Ψ < 0.95 in at least half of control
shRNA RNA-seq datasets for that cell type. Similar sets of 208 (K562) and 164 (HepG2)
native alternative 5’ splice site and 393 (K562) and 361 (HepG2) native alternative 3’ splice
site events were identified that had 0.05 < Ψ < 0.95 in at least half of control shRNA RNA-
seq datasets for that cell type. RBP-responsive event eCLIP enrichment was then calculated
as eCLIP signal enrichment at RBP-regulated events minus eCLIP signal enrichment at
native control events, referred to as ‘Enrichment relative to control events’ (Fig. 3-S6d).
Native versus constitutive enrichment (Fig. 3-S7c) was similarly calculated as the eCLIP
signal enrichment at native exons minus the eCLIP signal enrichment at constitutive exons
(defined as exons with zero reads supporting exclusion in any control RNA-seq in that cell
type).
Correlation between splicing maps was defined as the Pearson correlation (𝑅) between
a vector containing both included-upon knockdown and excluded-upon knockdown RBP-
responsive event eCLIP enrichment for each RBP. If an RBP had less than the minimum
required number of events (100 for cassette exons or 50 for alternative 5’ or 3’ splice site
events) for either knockdown-included or knockdown-excluded events, the correlation was
only calculated using the other event type.
To calculate the number of RBPs bound per exon, the set of spliceosomal RBPs was taken
from manual annotation of RBP functions (described above and listed in Supplementary
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Table 1). The number of reproducible (IDR) peaks at each position relative to splice sites
was summed across all RBPs and divided by the total number of cassette or constitutive
exons, respectively.
Comparison of DNA and RNA binding properties of RBPs
For integrative analyses, DNaseI HS data (http://genome.ucsc.edu/cgi-bin/hgFileUi?
db=hg19&g=wgEncodeOpenChromSynth), histone modifications by ChIP-seq from EN-
CODE/Broad Institute (http://genome.ucsc.edu/cgi-bin/hgFileUi?db=hg19&g=
wgEncodeBroadHistone), and eCLIP-seq data from ENCODE were downloaded and com-
pared with RBP ChIP-seq data.
To explore the possibility that some RBP-chromatin association events might be coupled
with their direct RNA binding activities in cells, RNA binding peaks were compared with
DNA binding signals as assayed by ChIP-seq to quantify enrichment. Only eCLIP peaks in
gene body regions (excluding promoter and terminator regions, defined as the 1 kb surround-
ing regions of TSS and TTS) were considered. The ChIP-seq signals were calculated for each
eCLIP peak, together with surrounding regions that are 10 times the length of eCLIP peak
on each side. Wilcoxon rank-sum tests were then performed to see whether ChIP-seq signal
was enriched at the middle third regions.
To see whether those differentially-expressed genes after RBP knockdown were enriched in
RBP binding at the chromatin level, an equal number of genes with similar expression level
either with or without binding were randomly sampled, and the number of differentially-
expressed genes after knockdown of the RBP were counted (fold change > 1.5 or < 2/3,
adjusted 𝑝-value < 0.05 by DESeq2), and one-tailed Fisher’s exact tests were then performed
to test the dependence of RBP binding and differential expression. The above procedure was
performed 100 times to give the distribution of the odds ratio. A significant dependence was
defined when the null hypothesis was rejected at level of 0.05 for at least 95 times. The
correlations between RBP association and genes with regulated alternative splicing events
(A3SS, A5SS, RI, MXE and SE events) were investigated similarly.
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Analysis of RBP regulatory features in subcellular space
Localization annotations and calculation of nuclear versus cytoplasmic ratio were generated
from immunofluorescence imaging as described above. ‘Nuclear RBPs’ were defined as those
with nuclear/cytoplasmic ratio ≥ 2, and ‘Cytoplasmic RBPs’ were defined as those with
nuclear/cytoplasmic ratio ≤ 0.5. Spliced reads were defined as reads mapping across an
annotated GENCODE v19 splice junction (extending at least 10 bases into each exon) and
unspliced reads were defined as reads that overlapped an exon-intron junction (extending
at least 10 bases into both the exon and intron regions). Significance between groups was
determined by Wilcoxon rank-sum test.
Prediction of RNA secondary structure was performed using the RNAfold webserver
(http://rna.tbi.univie.ac.at//cgi-bin/RNAWebSuite/RNAfold.cgi, Gruber et al. [2008]) with
default parameters. Shown is the MFE secondary structure prediction.
Preservation of RBP regulation across cell types
To consider binding across cell types, first the highest expressed transcript for each gene
was identified using transcript-level quantifications from the same rRNA-depleted RNA-seq
experiments described above (K562, accession numbers ENCFF424CXV, ENCFF073NHK;
HepG2, accession numbers ENCFF205WUQ, ENCFF915JUZ) and used as representative
for that gene. Next, genes were categorized based on their absolute fold-difference (FD)
between K562 and HepG2: unchanged (FD ≤ 1.2), weakly (1.2 < FD ≤ 2), moderately (2
< FD ≤ 5) or strongly (FD > 5) differential (for each, requiring TPM ≥ 1 in both K562
and HepG2), or cell type-specific genes (TPM < 0.1 in one cell type and TPM ≥ 1 in the
other). Peaks were then categorized based upon the expression change of their associated
gene. Significance between groups was determined by Kolmogorov-Smirnov test.
Analysis of preservation of binding across cell types was considered in three ways. First,
for each peak identified in one cell type, the fold-enrichment for that region in the other
cell type was calculated and considered for each gene type (as in Fig. 3-8a). Two groups
of peaks were then identified: those that were ≥4-fold enriched in the other cell type, and
those that were not enriched in the other cell type. The fraction of peaks associated with a
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gene class that were either ≥4-fold or not enriched were then considered for each gene class
separately (Fig. 3-8b). Second, the set of peaks ≥4-fold enriched (and the set not enriched)
was compiled across all genes, and the fractions associated with each gene class were then
reported (Fig. 3-S10b). Finally, binding preservation was calculated by determining the
fraction of IDR peaks identified in one cell type that overlap (requiring at least 1 nt overlap)
IDR peaks identified in the second cell type (Fig. 3-S10c).
Correlation between splicing maps was performed as described above, considering all
RBPs profiled by eCLIP and RNA-seq in both K562 and HepG2 that had at least 100
differentially included or excluded cassette exon events in both cell types.
RBP expression in tissues
Tissue specificity was measured as the entropy deviation from a uniform distribution among
all tissues as in Gerstberger et al. [2014]. For each RBP, the 𝑙𝑜𝑔2(TPM+1) was calculated
for each of the 42 samples (HepG2, K562, and 40 tissues profiled by the GTEx consortium,
GTEx Consortium [2015]), and the tissue specificity was computed as the difference between
the logarithm of the total number of samples (𝑁 = 42) and the Shannon entropy of the
expression values for an RBP:
𝑆 = 𝐻max −𝐻obs = log2(𝑁)−
∑︁
𝑖=1,...,𝑁
[𝑝𝑖 × log2(𝑝𝑖)] ,
Where 𝑝𝑖 = 𝑥𝑖 /
(︁∑︀
𝑖=1,...,𝑁 𝑥𝑖
)︁
for 𝑥𝑖 = log2(TPM𝑖 + 1) in sample 𝑖.
The data used for the analyses were obtained from dbGaP accession number phs000424.v2.p1
in Jan. 2015. TPMs were measured using kallisto (Bray et al. [2016]) on the following
samples: Adipose-Subcutaneous: SRR1081567; AdrenalGland: SRR1120913; Artery-Tibial:
SRR817094; Bladder: SRR1086236; Brain-Amygdala: SRR1085015; Brain-AnteriorCingulateCortex:
SRR814989; Brain-CaudateBasalGanglia: SRR657731; Brain-CerebellarHemisphere: SRR1098519;
Brain-Cerebellum: SRR627299; Brain-Cortex: SRR816770; Brain-FrontalCortex: SRR657777;
Brain-Hippocampus: SRR614814; Brain-Hypothalamus: SRR661179; Brain-NucleusAccumben:
SRR602808; Brain-SpinalCord: SRR613807; Brain-SubstantiaNigra: SRR662138; Breast-
MammaryTissue: SRR1084674; Cervix: SRR1096057; Colon: SRR1091524; Esophagus:
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SRR1085211; FallopianTube: SRR1082520; Heart-LeftVentricle: SRR815517; Kidney-Cortex:
SRR809943; Liver: SRR1090556; Lung: SRR1081283; MinorSalivaryGland: SRR1081589;
Muscle-Skeletal: SRR820907; Nerve-Tibial: SRR612911; Ovary: SRR1102005; Pancreas:
SRR1081259; Pituitary: SRR1077968; Prostate: SRR1099402; Skin: SRR807775; Small-
Intestine: SRR1093314; Spleen: SRR1085087; Stomach: SRR814268; Testis: SRR1081449;
Thyroid: SRR808886; Uterus: SRR820026; Vagina: SRR1095599.
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Chapter 4
Conclusion
Integration of the RBP characterizations included here with further cellular and functional
data will pave the way for understanding, defining, and perhaps even predicting a code of
RNA recognition and RBP functional activity in cells. Large-scale binding (e.g., eCLIP) and
functional (KD/RNA-seq) data provides a catalog of information on the RNA side of RBP-
RNA interactions, while biochemical and structural RBP binding data provide a molecular
basis for defining cellular RBP-RNA interactions with greater confidence, creating a foun-
dation for greater mechanistic understanding of post-transcriptional gene regulation. Inter-
disciplinary work, which this thesis endeavors to expand, will be needed to fully understand
RBP-mediated RNA processing mechanisms and their aberrations in human disease.
4.1 Summary
Chapter 2 presented the affinity landscapes of 78 human RBPs using RNA Bind-n-Seq
(RBNS), an unbiased assay that determines the sequence, structure, and context prefer-
ences of an RBP in vitro by deep sequencing of bound RNAs selected from a random pool
of oligos. “RNA maps” of RBP activity in regulating alternative splicing events and gene
expression levels were made using just the RBNS motifs without incorporation of data from
crosslinking-based assays. An unexpectedly low diversity of RNA motifs was bound by the
assayed RBPs, implying frequent convergence of binding specificity toward a relatively small
set of RNA motifs, many with low compositional complexity composed primarily of one
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or two bases. However, extensive preferences for contextual features distinct from short
linear RNA motifs were observed, including spaced ‘bipartite’ motifs, biased flanking nu-
cleotide composition, and bias away from or occasionally towards RNA structure. These
cis contextual features are likely to play an important role in RNA recognition, adding to
RBP regulation conferred at the trans level (e.g., RBP expression, subcellular localization,
or post-translational modifications), and they likely enable targeting of distinct subsets of
transcripts by different RBPs that recognize the same linear motif.
Chapter 3 presented an integration of five assays, each focused on a distinct aspect of
RBP activity, to expand the catalog of functional elements encoded in the human genome by
addition of those that function at the RNA level through interaction with RBPs. At least one
of the assays (transcriptome-wide RNA binding sites of RBPs through eCLIP; determina-
tion of RBP-responsive genes and alternative splicing events through RBP KD/RNA-seq; in
vitro RBP binding motifs through RBNS; RBP subcellular localization through systematic
imaging; and RBP association with chromatin through ChIP-seq) was applied to 352 human
RBPs involved in diverse cellular functions containing a multitude of RNA binding domain
types. In addition to describing the generation of over 1000 replicated data sets and methods
for processing them, findings included that in vivo binding is largely determined by in vitro
binding specificity; dozens of RBPs are associated with changes in gene expression levels or
alternative splicing, enabling construction of RNA maps of RBP context-dependent regula-
tion of cassette exon, A3SS, and A5SS splicing; many RBPs are associated with chromatin
and this coupling can affect gene expression levels and splicing outcomes; RBPs display a
broad diversity of subcellular localization patterns with most factors exhibiting targeting to
multiple structures in the nucleus and cytoplasm; and RBP binding is typically preserved
among events expressed in different cell types.
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4.2 Future Directions
4.2.1 Impact of post-transcriptional RNA and post-translational
protein modifications on RBP-RNA binding
While the presence of RNA modifications in select RNA subtypes such as rRNAs, snR-
NAs, and snoRNAs has been known for decades, recent work enabled by high-throughput
sequencing-based mapping technologies has uncovered at least seven ‘epitranscriptomic’ RNA
modifications in mRNA: N6-methyladenosine (m6A), 2’-O-dimethyl-adenosine (m6Am), N1-
methyladenosine (m1A), pseudouridine (𝜓), inosine (I), 5-methylcytidine (m5C), and 5-
hydroxymethylcytidine (hm5C) (Kleiner [2017]). While m6A, the most abundant inter-
nal modification of mRNA, has been implicated in diverse molecular functions including
mRNA export, cap-independent translation, translational efficiency, mRNA stability, and
mRNA structure (Gilbert et al. [2016]), less is known about the molecular consequences
or functional significance of the other modifications. m6A not only recruits effector YTH
domain-containing reader proteins, but it has also been shown to bind HNRNPA2B1 to af-
fect alternative splicing and primary microRNA processing (Alarcón et al. [2015]). Another
recent study used a systematic mass spectrometry-based proteomics screen to identify 21
m6A reader proteins in HeLa cells, including five proteins investigated in the RBNS assay
in Chapter 2 (KHSRP, FUBP3, TARDBP, HNRNPF, and HNRNPH) as well as the stress
granule protein G3BP1, whose binding was repelled by m6A to negate that RBP’s normal
activity of stabilizing mRNAs in cells (Edupuganti et al. [2017]). Through transcriptome-
wide profiling in HeLa and multiple mouse tissues, 5-methylcytosine (m5C) has been mapped
to regions immediately downstream of translation initiation sites, with the RRM-containing
ALYREF export factor functioning as a specific mRNA m5C-binding protein and mRNA
export being promoted by the m5C modification (Yang et al. [2017]). As these epitran-
scriptomic modifications may function at least in part by regulating the binding of specific
RBPs, identifying which RBP(s) are affected by each modification and the functional out-
comes resulting from such post-transcriptional RNA changes will be an important area of
investigation going forward.
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In additional to post-transcriptional modifications to the RNA, post-translational modi-
fications (PTMs) of the protein trans-factors can affect RBP binding and RNA processing.
While PTMs have classically been shown to alter RBP subcellular localization (including
sub-nuclear localization and nucleocytoplasmic shuffling), protein complex formation, and
enzymatic activity (Lovci et al. [2016]), studies have also shown that particular PTMs af-
fect RNA binding ability and mediate cellular outcomes. For example, phosphorylation of
HuR (ELAVL1) RRM1 induces its association with TRA2𝛽 exon 2 to regulate alternative
splicing programs under oxidative stress (Akaike et al. [2014]), arginine methylation of the
RG repeats of Sam68 abrogates that region’s poly(U) binding activity in vitro and in vivo
(Rho et al. [2007]), phosphorylation of a highly conserved serine in HNRNPL RRM4 induces
binding to an RNA element in the Slo1 potassium channel transcript to regulate membrane
depolarization/calcium signaling (Liu et al. [2012]), and tyrosine phosphorylation of the QKI
C-terminus modulates its RNA binding activity to regulate central nervous system myeli-
nation (Zhang et al. [2003]). The effects of PTMs on RBP function have thus far been
unpredictable (Lovci et al. [2016]), necessitating experimental probing of the effect of partic-
ular PTMs on individual RBPs. As the bacterially expressed and purified RBPs studied in
Chapter 2 did not contain any PTMs the RBPs might have in mammalian cells, strategies
to profile the effects of PTMs on RNA binding could include incubating the purified RBP
with the known or putative PTM catalytic enyzme or purifying the RBP from human cells
to obtain PTM-modified proteins.
4.2.2 Role of alternative protein isoforms and low-complexity do-
mains in RNA binding specificity and higher-order protein
assemblies
Over 95% of human multi-exonic genes undergo alternative splicing to produce different pro-
tein isoforms (Wang et al. [2008]). These alternative splicing patterns are often regulated
in a tissue- and/or developmental-specific manner, resulting in distinct protein repertoires
in different cell types. Recent work has demonstrated that many splicing factors are them-
selves alternatively spliced with different regulatory capacities of different protein isoforms
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representing an important and recurrent mechanism underlying splicing regulation. While
the RBNS assay in Chapter 2 was only performed on one isoform of each human RBP
(typically the Uniprot reference isoform), as alternative splicing of RBPs can affect which
RBD binding domain(s) are included in the protein and may directly alter RNA binding
specificity or affinity, performing RBNS on different isoforms may provide insight into this
mode of RNA binding regulation. For example, inclusion of alternative exon 2 of HNRNPD
inhibits its RNA binding ability by about 10-fold, reducing its ability to mediate mRNA de-
cay via binding to AU-rich elements. As this exon immediate precedes RRM1, its inclusion
may affect the conformation of the RRM or its access to RNA substrates (Zucconi et al.
[2010]). Autoregulation of the Fox proteins via alternative splicing of a highly conserved
93 nt exon produces an isoform that lacks the second half of its sole RRM, producing a
dominant negative version of this splicing factor (Damianov and Black [2010]).
In addition to directly altering RBD regions, alternative splicing of RBPs can produce
different isoforms to modulate their subcellular localization, interaction with protein part-
ners, or functional activity. For example, mammalian-specific alternatively spliced exons in
nearly all members of the hnRNP A and D families lead to differential inclusion of low-
complexity, GY (glycine/tyrosine)-rich intrinsically disordered regions that control the for-
mation of higher-order assemblies of these proteins to affect alternative splicing outcomes
(Gueroussov et al. [2017]). Cataloging the repertoire of RBP isoforms present in different cell
types or disease states, predicting the variants’ effects on protein structure and/or function,
and experimentally interrogating their influence on RNA binding ability (through RBNS)
or binding locations and functional activity (through isoform-specific adaptations of eCLIP
and RBP perturbation/RNA-seq) will be an interesting area of study going forward.
4.2.3 Integrative analysis of RBP binding data sets to relate genetic
variation to RBP regulation & RBNS assay variants to probe
altered interactions
The breadth of the RBP data presented in Chapter 3 enables integrative analyses to relate
genetic variation to RBP regulation. For example, among the 18 RBPs with eCLIP, RBNS,
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and KD/RNA-seq data, we identified 26 variants from the Exome Aggregation Consortium
(ExAC, Lek et al. [2016]) that overlapped an eCLIP peak, disrupted an RBNS motif, and
produced a splicing change upon knockdown of the corresponding RBP (Van Nostrand et al.
[2017]). One such variant was in intron 66 of UTRN (dystrophin-related protein 1), which
harbors an RBFOX2 eCLIP peak downstream of an alternatively spliced exon (Fig. 4-
1A). The G→C variant disrupts the RBFOX2 binding motif (GCAUG) at the first position.
RBNS data reveal that this variant substantially changes the RBFOX2 binding site: this
top 5mer (GCAUG) has an enrichment value of 13.58, while the variant 5mer (CCAUG) has
a enrichment of 0.89 (Fig. 4-1B), suggesting that the mutation disrupts RBFOX2 binding
in vivo. Indeed, KD/RNA-seq of RBFOX2 in HepG2 indicated that in wildtype cells, the
upstream exon was included in 87% of messages, whereas the inclusion of the exon was
decreased to 28% in the RBFOX2 knockdown cells (Fig. 4-1A). Taken together, these data
argue that this G→C variant disrupts RBFOX2 binding, leading to decreased inclusion of
the upstream exon in over half of UTRN messages and an altered composition of protein
isoforms. Overall, the actual number of variants that influence RNA metabolism is likely to
be much larger than the 26 identified as other variants may affect aspects of RNA biology
other than splicing (e.g., mRNA expression levels or translation). Furthermore, only 18
RBPs had all three assays (RBNS, eCLIP, and KD/RNA-seq) performed at the time of this
analysis, so it will be worthwhile to revisit such analyses upon subsequent studies in which
many more RBPs have been profiled with complementary in vitro, in vivo, and functional
assays.
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Figure 4-1: Integrative analyses of RBP data can identify genetic variants that
may impact RBP regulation
To be included as panels of a figure in Moore et al.
(A) Control and RBFOX2 knockdown RNA-seq of exons 65-67 of the UTRN gene in HepG2
cells. Inclusion of the alternatively spliced exon 66 is reduced from 87% in control cells to
29% in RBFOX2 KD cells.
(B) (right) A strong RBFOX2 eCLIP binding peak in the downstream intron is consistent
with this splicing factor enhancing inclusion of the upstream alternative exon. The minor
allele of an ExAC SNP in the eCLIP peak in is expected to abrogate RBFOX2 binding as
it abolishes the high affinity binding site determined from RBNS. (left) Effect of the ExAC
variant on the RBFOX2 binding site as determined from RBNS data. The G→C SNP in the
eCLIP peak changes the most enriched 5mer that likely mediates RBFOX2 binding (GCAUG
𝑅 = 13.78) to a 5mer with no detectable in vitro binding (CCAUG 𝑅 = 0.89).
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An orthogonal approach that measures the affect of genetic variants on RBP binding
could be achieved through a version of the RBNS assay that includes natural sequences
rather than the random sequences used in Chapter 2. A natural sequence library of 109 nt
long oligos derived from sequences flanking constitutive and alternative exons has successfully
been used to measure secondary structure effects on an RBP’s ability to bind these natural
pre-mRNA regions in vitro (Taliaferro et al. [2016]), and a similar approach is currently
being used in the Burge lab for a library of oligos derived from natural 3’ UTR sequences.
Adaptation of a natural sequence RBNS library to include oligos that contain not only the
reference genome sequence but also disease SNPs in the transcriptome could define sets of
RBP/genetic variant interactions that are abrogated or created in the context of specific
human diseases. While this experiment is more limited in some respects than full integrative
analysis of in vitro, in vivo, and functional assays, it does have the advantage that many
RBPs can be profiled for their ability to bind the oligos in parallel, and RBPs and transcript
sequences that exist only in restricted cell types can be assayed without performing eCLIP
and/or KD/RNA-seq in new cell types. Going forward, utilizing high-throughput binding
and functional technologies to understand RBP/RNA interactions in normal and disease
states will be a ripe area of investigation.
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